No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1azcA, 0.7972, 1.88, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
2, 1azbA, 0.7971, 1.88, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
3, 1cuoA, 0.7963, 1.87, 0.177, 129, 124, CRYSTAL STRUCTURE ANALYSIS OF ISOMER-2 AZURIN FROM METHYLOMONAS J
4, 1azbB, 0.7963, 1.87, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
5, 2azaA, 0.7961, 1.97, 0.161, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
6, 1azcB, 0.7961, 1.87, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
7, 1uriA, 0.7960, 1.99, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
8, 1dz0A, 0.7960, 1.99, 0.137, 129, 124, REDUCED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
9, 1dyzA, 0.7960, 1.99, 0.137, 129, 124, OXIDISED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
10, 1a4aA, 0.7958, 1.98, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
11, 1aizA, 0.7954, 1.92, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
12, 1uriB, 0.7953, 1.84, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
13, 1aizB, 0.7953, 1.89, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
14, 2azaB, 0.7942, 1.95, 0.161, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
15, 1a4aB, 0.7940, 1.91, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
16, 1a4bA, 0.7930, 1.95, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
17, 1rkrA, 0.7927, 1.97, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
18, 2ccwA, 0.7924, 2.02, 0.137, 129, 124, CRYSTAL STRUCTURE OF AZURIN II AT ATOMIC RESOLUTION (1.13 ANGSTROM)
19, 1rkrC, 0.7923, 1.99, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
20, 1uatA, 0.7918, 1.97, 0.177, 129, 124, THE SIGNIFICANCE OF THE FLEXIBLE LOOP IN THE AZURIN (AZ-ISO2) FROM THE OBLIGATE METHYLOTROPH METHYLOMONAS SP. STRAIN J
21, 1rkrD, 0.7918, 1.99, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
22, 1a4cD, 0.7916, 1.99, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
23, 1rkrB, 0.7913, 2.00, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
24, 1a4cC, 0.7913, 2.07, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
25, 1a4cB, 0.7909, 1.91, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
26, 1a4bB, 0.7907, 1.93, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
27, 2tsbA, 0.7897, 1.77, 0.139, 128, 122, AZURIN MUTANT M121A-AZIDE
28, 2oj1B, 0.7893, 1.89, 0.138, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
29, 1nwpA, 0.7891, 1.84, 0.138, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
30, 6mjtB, 0.7888, 1.96, 0.154, 128, 123, AZURIN 122F/124W/126RE 
31, 1a4cA, 0.7887, 2.02, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
32, 4hz1D, 0.7886, 1.84, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
33, 2tsaA, 0.7886, 1.79, 0.139, 128, 122, AZURIN MUTANT M121A
34, 2oj1A, 0.7884, 1.89, 0.138, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
35, 3azuD, 0.7883, 2.00, 0.138, 128, 123, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
36, 2xv3A, 0.7881, 1.98, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
37, 5azuD, 0.7875, 2.01, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
38, 3iboC, 0.7875, 1.87, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
39, 4ko5B, 0.7874, 1.88, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
40, 2h47C, 0.7873, 1.91, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 1)
41, 3azuA, 0.7872, 1.81, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
42, 2tsbD, 0.7871, 1.81, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
43, 1e5zD, 0.7871, 1.80, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
44, 1e5yD, 0.7871, 1.79, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
45, 2tsaD, 0.7870, 1.81, 0.131, 128, 122, AZURIN MUTANT M121A
46, 1jzjA, 0.7870, 1.92, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
47, 1vlxD, 0.7868, 1.80, 0.139, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
48, 1gr7B, 0.7868, 1.69, 0.157, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
49, 6gyiC, 0.7867, 1.99, 0.146, 128, 123, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
50, 3fszA, 0.7867, 1.98, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
51, 1ilsD, 0.7867, 2.01, 0.138, 128, 123, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
52, 1e5zC, 0.7866, 1.97, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
53, 6gyiB, 0.7865, 1.79, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
54, 3ugeD, 0.7862, 1.81, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
55, 1nwoB, 0.7862, 1.90, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
56, 1e65D, 0.7862, 1.80, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
57, 1nwpB, 0.7861, 1.87, 0.138, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
58, 5azuC, 0.7860, 1.98, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
59, 1vlxC, 0.7860, 1.99, 0.146, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
60, 1jziA, 0.7860, 1.96, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
61, 1gr7C, 0.7860, 1.69, 0.157, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
62, 2xv3B, 0.7859, 2.02, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
63, 3ft0B, 0.7858, 1.99, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
64, 4ko6C, 0.7857, 1.93, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
65, 3jtbD, 0.7857, 1.98, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
66, 1jzeA, 0.7857, 1.98, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(BPY)2(IM)(HIS83)
67, 1e65C, 0.7857, 1.98, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
68, 4azuD, 0.7856, 1.81, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
69, 3ft0A, 0.7856, 2.01, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
70, 1jvoJ, 0.7854, 2.03, 0.146, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
71, 1azrD, 0.7854, 1.80, 0.139, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
72, 1jzhA, 0.7853, 1.98, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(TPY)(BPY)(HIS83)
73, 1e5yA, 0.7852, 1.81, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
74, 1etjD, 0.7851, 1.81, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
75, 1etjC, 0.7851, 1.81, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
76, 4qlwA, 0.7850, 1.82, 0.131, 128, 122, AZURIN MUTANT M121E WITH IRON
77, 4ko6B, 0.7850, 1.94, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
78, 4kobD, 0.7849, 1.95, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
79, 3fszB, 0.7849, 2.02, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
80, 3fswB, 0.7849, 2.02, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
81, 1jvoH, 0.7849, 2.05, 0.146, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
82, 1e5yC, 0.7849, 2.02, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
83, 1azrC, 0.7849, 2.00, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
84, 2azuD, 0.7848, 1.82, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
85, 1xb8A, 0.7848, 1.84, 0.139, 127, 122, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
86, 1nwoA, 0.7848, 1.91, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
87, 1jvoL, 0.7848, 2.04, 0.146, 128, 123, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
88, 1e5zA, 0.7848, 1.82, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
89, 3ugeA, 0.7847, 2.03, 0.138, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
90, 1jziB, 0.7847, 1.98, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
91, 5azuA, 0.7846, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
92, 4ko9D, 0.7846, 1.97, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
93, 4azuC, 0.7846, 2.01, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
94, 2azuA, 0.7845, 1.83, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
95, 1e65A, 0.7845, 1.81, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
96, 1jvoD, 0.7844, 1.82, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
97, 1e67D, 0.7844, 1.82, 0.139, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
98, 6mjsA, 0.7843, 1.91, 0.154, 128, 123, AZURIN 122W/124W/126RE 
99, 3ugeC, 0.7843, 2.02, 0.138, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
100, 2i7sD, 0.7843, 1.94, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
101, 1nzrD, 0.7843, 1.81, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
102, 1jvoC, 0.7843, 1.82, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
103, 2tsbC, 0.7842, 1.83, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
104, 4ko6A, 0.7841, 1.96, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
105, 2gi0A, 0.7841, 1.99, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
106, 1xb3A, 0.7841, 1.92, 0.138, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
107, 1jvoB, 0.7841, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
108, 1gr7A, 0.7841, 1.89, 0.156, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
109, 4ko7C, 0.7840, 1.98, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
110, 4ko5A, 0.7840, 1.95, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
111, 4azuA, 0.7840, 1.82, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
112, 1vlxA, 0.7840, 1.82, 0.139, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
113, 1jzgA, 0.7840, 2.01, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA REDUCED AZURIN (CU1+) RU(TPY)(PHEN) (HIS83)
114, 1jvoG, 0.7840, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
115, 1e67C, 0.7840, 2.01, 0.146, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
116, 1jvoE, 0.7839, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
117, 1e5zB, 0.7839, 1.87, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
118, 2fnwB, 0.7838, 1.75, 0.139, 128, 122, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
119, 2azuB, 0.7838, 1.85, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
120, 4mfhC, 0.7837, 1.97, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
121, 4ko7D, 0.7837, 1.94, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
122, 1gr7D, 0.7837, 1.90, 0.156, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
123, 6mjrA, 0.7836, 2.00, 0.154, 128, 123, AZURIN 122W/124F/126RE 
124, 3azuC, 0.7836, 1.84, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
125, 1jvoI, 0.7836, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
126, 6gyiD, 0.7835, 1.81, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
127, 4azuB, 0.7835, 2.06, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
128, 2idfA, 0.7835, 1.99, 0.138, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
129, 2azuC, 0.7835, 1.85, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
130, 1nzrC, 0.7835, 2.02, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
131, 1jvoA, 0.7835, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
132, 6iavA, 0.7834, 1.82, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
133, 4hz1A, 0.7834, 1.85, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
134, 2tsaC, 0.7834, 1.84, 0.139, 128, 122, AZURIN MUTANT M121A
135, 2idfB, 0.7834, 1.99, 0.138, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
136, 2ghzA, 0.7834, 2.00, 0.138, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
137, 1ilsA, 0.7834, 1.82, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
138, 1ezlA, 0.7834, 1.81, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
139, 5azuB, 0.7833, 1.88, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
140, 3jtbA, 0.7833, 2.02, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
141, 3iboB, 0.7833, 1.95, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
142, 2tsaB, 0.7833, 1.85, 0.131, 128, 122, AZURIN MUTANT M121A
143, 1iluK, 0.7833, 1.86, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
144, 1ilsC, 0.7833, 2.02, 0.130, 128, 123, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
145, 4jknA, 0.7832, 1.82, 0.139, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
146, 2i7sB, 0.7832, 1.91, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
147, 1i53A, 0.7832, 1.98, 0.138, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
148, 4jknC, 0.7831, 2.05, 0.138, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
149, 1jzjB, 0.7831, 2.06, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
150, 1jzfA, 0.7831, 2.02, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA OXIDIZED AZURIN(CU2+) RU(TPY)(PHEN) (HIS83)
151, 1jvoF, 0.7831, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
152, 3jtbB, 0.7830, 1.79, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
153, 1jvoK, 0.7830, 1.85, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
154, 1jvlB, 0.7830, 1.99, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
155, 1jvlA, 0.7830, 1.99, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
156, 2tsbB, 0.7829, 1.85, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
157, 1xb6A, 0.7829, 1.95, 0.146, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
158, 1vlxB, 0.7829, 2.08, 0.146, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
159, 1e67A, 0.7829, 1.83, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
160, 2gi0B, 0.7828, 2.01, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
161, 1e67B, 0.7828, 2.06, 0.146, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
162, 4kobA, 0.7827, 1.96, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
163, 2iaaC, 0.7827, 1.97, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 2)
164, 1e5yB, 0.7827, 1.87, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
165, 2i7sC, 0.7826, 1.95, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
166, 1etjA, 0.7826, 1.85, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
167, 4mfhA, 0.7825, 1.99, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
168, 1nzrB, 0.7825, 2.06, 0.146, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
169, 4ko9C, 0.7824, 1.97, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
170, 3u25A, 0.7824, 1.90, 0.148, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
171, 1ezlD, 0.7824, 1.89, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
172, 1azrB, 0.7824, 2.07, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
173, 1azrA, 0.7824, 1.83, 0.139, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
174, 1aznA, 0.7824, 1.86, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
175, 1ag0A, 0.7824, 1.97, 0.130, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
176, 4ko7B, 0.7823, 2.00, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
177, 4jknB, 0.7823, 2.03, 0.146, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
178, 1ag0B, 0.7823, 1.97, 0.130, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
179, 6iavC, 0.7822, 1.85, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
180, 4mfhB, 0.7822, 2.02, 0.130, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
181, 1e65B, 0.7822, 2.07, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
182, 2h3xF, 0.7821, 1.94, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
183, 2h3xC, 0.7821, 1.94, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
184, 2ghzB, 0.7821, 2.02, 0.138, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
185, 1xb8C, 0.7821, 1.74, 0.149, 126, 121, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
186, 1bexB, 0.7821, 2.06, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
187, 4ko7A, 0.7820, 2.01, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
188, 3iboD, 0.7820, 1.95, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
189, 1iluI, 0.7820, 1.90, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
190, 1i53B, 0.7820, 1.96, 0.138, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
191, 4hz1C, 0.7819, 1.87, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
192, 3fpyA, 0.7819, 2.00, 0.122, 128, 123, AZURIN C112D/M121L
193, 1nzrA, 0.7819, 1.84, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
194, 4kobC, 0.7818, 1.96, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
195, 3azuB, 0.7818, 1.86, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
196, 1r1cA, 0.7818, 1.83, 0.172, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
197, 1bexA, 0.7818, 2.06, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
198, 5i26A, 0.7817, 1.96, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM I
199, 4ko9A, 0.7817, 1.98, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
200, 1ilsB, 0.7817, 1.87, 0.131, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
201, 6mjrC, 0.7816, 1.86, 0.156, 128, 122, AZURIN 122W/124F/126RE 
202, 3ugeB, 0.7816, 1.88, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
203, 3jtbC, 0.7816, 2.04, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
204, 1iluD, 0.7816, 1.89, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
205, 1etjB, 0.7816, 2.06, 0.138, 128, 123, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
206, 4qlwC, 0.7815, 1.83, 0.131, 128, 122, AZURIN MUTANT M121E WITH IRON
207, 6mjsB, 0.7814, 1.74, 0.157, 126, 121, AZURIN 122W/124W/126RE 
208, 4kobB, 0.7813, 1.99, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
209, 4ko9B, 0.7812, 1.99, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
210, 1joiA, 0.7812, 2.07, 0.130, 128, 123, STRUCTURE OF PSEUDOMONAS FLUORESCENS HOLO AZURIN
211, 1iluA, 0.7812, 1.86, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
212, 5i28J, 0.7810, 1.97, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
213, 6iavB, 0.7808, 1.83, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
214, 6gyiA, 0.7808, 1.83, 0.139, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
215, 5i28G, 0.7808, 1.96, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
216, 4ko6D, 0.7808, 2.02, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
217, 3u25B, 0.7808, 1.89, 0.156, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
218, 4qlwB, 0.7805, 2.04, 0.130, 128, 123, AZURIN MUTANT M121E WITH IRON
219, 1r1cD, 0.7805, 1.93, 0.163, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
220, 1iluM, 0.7805, 1.87, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
221, 1iluC, 0.7805, 1.90, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
222, 4jknD, 0.7804, 1.85, 0.139, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
223, 3jt2B, 0.7804, 1.87, 0.139, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
224, 1iluB, 0.7804, 1.91, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
225, 3fq1A, 0.7803, 2.02, 0.130, 128, 123, AZURIN C112D/M121I
226, 2i7oA, 0.7802, 1.96, 0.138, 128, 123, STRUCTURE OF RE(47-DIMETHYL-PHEN)(THR124HIS)(LYS122TRP)(HIS83GLN) AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
227, 1iluH, 0.7802, 1.90, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
228, 1iluE, 0.7802, 1.88, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
229, 3jt2A, 0.7801, 1.86, 0.139, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
230, 6mjsD, 0.7800, 1.76, 0.157, 126, 121, AZURIN 122W/124W/126RE 
231, 2i7sA, 0.7800, 1.97, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
232, 1aznB, 0.7799, 1.86, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
233, 5i28P, 0.7798, 1.99, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
234, 5i28H, 0.7796, 2.02, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
235, 2hxaB, 0.7795, 1.95, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
236, 6iavD, 0.7793, 1.80, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
237, 1iluL, 0.7793, 1.91, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
238, 1iluF, 0.7790, 1.88, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
239, 4k9jA, 0.7789, 1.87, 0.156, 127, 122, STRUCTURE OF RE(CO)3(47-DIMETHYL-PHEN)(THR126HIS)(LYS122TRP) (HIS83GLU)(TRP48PHE)(TYR72PHE)(TYR108PHE)AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
240, 2fnwA, 0.7789, 1.95, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
241, 1ezlB, 0.7787, 1.92, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
242, 5i28A, 0.7786, 2.00, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
243, 4bwwB, 0.7784, 2.02, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
244, 4bwwA, 0.7784, 2.02, 0.131, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
245, 3fqyA, 0.7784, 2.04, 0.130, 128, 123, AZURIN C112D
246, 6mjsC, 0.7782, 1.72, 0.158, 125, 120, AZURIN 122W/124W/126RE 
247, 1aznC, 0.7780, 1.88, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
248, 3iboA, 0.7779, 1.97, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
249, 5i26B, 0.7778, 1.97, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM I
250, 1iluG, 0.7778, 1.91, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
251, 4kocA, 0.7777, 2.04, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I/Y108F)
252, 5i28K, 0.7776, 2.03, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
253, 6mjtA, 0.7775, 1.89, 0.156, 128, 122, AZURIN 122F/124W/126RE 
254, 1aznD, 0.7775, 1.91, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
255, 3np3A, 0.7773, 2.04, 0.130, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
256, 3fswD, 0.7773, 1.88, 0.139, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
257, 4hz1B, 0.7771, 1.97, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
258, 6mjrD, 0.7770, 2.11, 0.154, 128, 123, AZURIN 122W/124F/126RE 
259, 5i28E, 0.7770, 2.02, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
260, 1r1cB, 0.7770, 1.90, 0.164, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
261, 3in0C, 0.7769, 1.89, 0.131, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
262, 5i28N, 0.7768, 2.03, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
263, 5i28M, 0.7768, 2.04, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
264, 4bwwC, 0.7768, 2.03, 0.131, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
265, 5i28I, 0.7767, 2.05, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
266, 5i28O, 0.7766, 2.05, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
267, 5i28D, 0.7765, 2.04, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
268, 4bwwD, 0.7765, 2.03, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
269, 1xb6B, 0.7763, 2.02, 0.138, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
270, 5i28C, 0.7761, 2.05, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
271, 4qlwD, 0.7759, 1.94, 0.139, 128, 122, AZURIN MUTANT M121E WITH IRON
272, 1ov8C, 0.7758, 1.99, 0.179, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
273, 1ov8B, 0.7758, 1.99, 0.179, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
274, 1ov8A, 0.7758, 1.99, 0.179, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
275, 3fq2A, 0.7757, 2.05, 0.130, 128, 123, AZURIN C112D/M121F
276, 1ov8D, 0.7754, 1.99, 0.179, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
277, 5i28B, 0.7753, 2.05, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
278, 1qhqA, 0.7751, 2.00, 0.179, 139, 123, AURACYANIN A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUM CHLOROFLEXUS AURANTIACUS
279, 3np4A, 0.7750, 2.05, 0.122, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
280, 2iweA, 0.7750, 2.11, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
281, 3in0A, 0.7747, 1.94, 0.131, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
282, 5i28F, 0.7746, 2.02, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
283, 3in0D, 0.7745, 1.96, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
284, 4hhgA, 0.7744, 1.96, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN RUH107NO YOH109
285, 1r1cC, 0.7744, 2.19, 0.154, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
286, 1xb3B, 0.7743, 2.04, 0.138, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
287, 2n0mA, 0.7742, 2.03, 0.130, 130, 123, THE SOLUTION STRUCTURE OF THE SOLUBLE FORM OF THE LIPID-MODIFIED AZURIN FROM NEISSERIA GONORRHOEAE
288, 6mjrB, 0.7741, 1.98, 0.156, 128, 122, AZURIN 122W/124F/126RE 
289, 5i28L, 0.7741, 2.04, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
290, 2hx8B, 0.7741, 2.01, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
291, 3fswA, 0.7739, 1.92, 0.139, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
292, 1ezlC, 0.7738, 2.19, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
293, 3ay2A, 0.7734, 1.97, 0.115, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
294, 4wkxB, 0.7730, 2.06, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
295, 3ay2B, 0.7730, 1.97, 0.115, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
296, 2hxaA, 0.7730, 1.81, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
297, 2iweG, 0.7729, 2.15, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
298, 2iweJ, 0.7724, 2.16, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
299, 2hx7B, 0.7723, 2.02, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
300, 4hhwB, 0.7719, 2.00, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
301, 2iweD, 0.7718, 2.17, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
302, 2hx9A, 0.7717, 1.82, 0.150, 124, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
303, 3in2A, 0.7712, 1.94, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
304, 3in0B, 0.7711, 1.94, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
305, 2hx8A, 0.7711, 1.81, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
306, 4hipB, 0.7702, 2.03, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
307, 5i26D, 0.7700, 2.14, 0.139, 126, 122, AZURIN T30R1 CRYSTAL FORM I
308, 1azuA, 0.7699, 1.86, 0.149, 126, 121, STRUCTURAL FEATURES OF AZURIN AT 2.7 ANGSTROMS RESOLUTION
309, 3n2jE, 0.7696, 2.31, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
310, 4hipA, 0.7695, 2.02, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
311, 4hhwA, 0.7695, 2.13, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
312, 3n2jL, 0.7693, 2.34, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
313, 2hx9B, 0.7689, 2.00, 0.149, 125, 121, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
314, 3n2jF, 0.7675, 2.12, 0.148, 128, 122, AZURIN H117G OXIDIZED FORM
315, 2hx7A, 0.7674, 1.85, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
316, 3n2jK, 0.7672, 2.08, 0.131, 128, 122, AZURIN H117G OXIDIZED FORM
317, 5i26C, 0.7667, 1.79, 0.143, 124, 119, AZURIN T30R1 CRYSTAL FORM I
318, 3n2jB, 0.7667, 2.30, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
319, 3n2jA, 0.7666, 2.15, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
320, 3n2jJ, 0.7665, 2.29, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
321, 3n2jD, 0.7665, 2.16, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
322, 1cc3B, 0.7663, 2.36, 0.136, 130, 125, PURPLE CUA CENTER
323, 3n2jI, 0.7660, 2.31, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
324, 4wkxA, 0.7659, 2.13, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
325, 3n2jC, 0.7656, 2.32, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
326, 3n2jG, 0.7655, 2.16, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
327, 3n2jH, 0.7654, 2.16, 0.148, 128, 122, AZURIN H117G OXIDIZED FORM
328, 4qktB, 0.7649, 2.03, 0.132, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
329, 1cc3A, 0.7628, 2.46, 0.144, 130, 125, PURPLE CUA CENTER
330, 4qktA, 0.7621, 2.05, 0.132, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
331, 2ftaC, 0.7617, 1.88, 0.143, 124, 119, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
332, 2aanA, 0.7581, 1.96, 0.183, 123, 120, AURACYANIN A: A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUMCHLOROFLEXUS AURANTIACUS
333, 2ftaD, 0.7577, 1.73, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
334, 3fswC, 0.7571, 1.94, 0.151, 124, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
335, 2ftaB, 0.7567, 1.86, 0.144, 123, 118, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
336, 2ftaA, 0.7556, 1.75, 0.154, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
337, 3oqrA, 0.7526, 2.04, 0.134, 123, 119, C112D/M121E AZURIN PH 10.0
338, 2xv0A, 0.7514, 2.10, 0.142, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.8
339, 2ft8A, 0.7485, 1.84, 0.145, 122, 117, STRUCTURE OF CU(I)AZURIN PH8 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
340, 2ft7A, 0.7484, 1.85, 0.145, 122, 117, STRUCTURE OF CU(I)AZURIN AT PH 6 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
341, 2ft6A, 0.7474, 1.86, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
342, 2xv2A, 0.7455, 2.18, 0.142, 124, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.2
343, 3fs9A, 0.7443, 2.19, 0.133, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM)
344, 3fsaA, 0.7382, 2.19, 0.134, 122, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM); CHEMICALLY REDUCED.
345, 5yt7C, 0.6933, 2.02, 0.128, 130, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
346, 5yt7B, 0.6922, 1.95, 0.138, 132, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
347, 5yt7D, 0.6897, 2.07, 0.128, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
348, 5yt7A, 0.6896, 2.03, 0.128, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
349, 3zbmA, 0.6611, 1.94, 0.214, 455, 103, STRUCTURE OF M92A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII
350, 2yqbA, 0.6611, 1.94, 0.223, 454, 103, STRUCTURE OF P93A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.4 A RESOLUTION
351, 6fjaA, 0.6605, 1.96, 0.214, 455, 103, CRYSTAL STRUCTURE OF T2D THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
352, 3ziyA, 0.6605, 1.95, 0.214, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE  FROM RALSTONIA PICKETTII AT 1.01 A RESOLUTION
353, 5oboA, 0.6603, 1.96, 0.214, 456, 103, CRYSTAL STRUCTURE OF NITRITE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
354, 5ocfA, 0.6601, 1.96, 0.214, 455, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND TO THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
355, 1ndrC, 0.6599, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
356, 1ndrB, 0.6599, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
357, 1ndrA, 0.6599, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
358, 5ocbA, 0.6598, 1.96, 0.214, 453, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
359, 4ax3C, 0.6598, 1.96, 0.214, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
360, 6f1qA, 0.6597, 1.97, 0.214, 456, 103, CRYSTAL STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII IN I213 SPACE GROUP 
361, 4ax3D, 0.6595, 1.97, 0.214, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
362, 1ndsA, 0.6595, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
363, 4ax3B, 0.6593, 1.97, 0.214, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
364, 1ndsC, 0.6593, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
365, 1ndsB, 0.6593, 1.95, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
366, 4ax3A, 0.6591, 1.97, 0.214, 456, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
367, 2avfE, 0.6589, 1.97, 0.233, 315, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
368, 1ndtA, 0.6586, 1.97, 0.233, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
369, 1gs8A, 0.6586, 1.97, 0.233, 336, 103, CRYSTAL STRUCTURE OF  MUTANT D92N ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
370, 1gs6X, 0.6586, 1.97, 0.223, 336, 103, CRYSTAL STRUCTURE OF M144A MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
371, 2vm4A, 0.6585, 1.98, 0.233, 334, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE IN SPACE GROUP R3 - 2 OF 2
372, 2vm3A, 0.6585, 1.98, 0.233, 333, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS IN SPACE GROUP R3 - 1 OF 2
373, 1wa1X, 0.6585, 1.98, 0.233, 335, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
374, 5onyA, 0.6584, 1.98, 0.233, 335, 103, AS-ISOLATED RESTING STATE COPPER NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
375, 4cspF, 0.6584, 1.98, 0.233, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
376, 2vw6B, 0.6584, 1.98, 0.233, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
377, 2jfcA, 0.6584, 1.97, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
378, 1hauA, 0.6584, 1.97, 0.233, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9 A RESOLUTION
379, 2xxfA, 0.6583, 1.97, 0.233, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
380, 2xwzD, 0.6583, 1.98, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
381, 2xwzA, 0.6583, 1.97, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
382, 2jfcF, 0.6583, 1.97, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
383, 1oe1A, 0.6583, 1.98, 0.233, 335, 103, ATOMIC RESOLUTION STRUCTURE OF THE WILDTYPE NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
384, 5b1kA, 0.6582, 1.98, 0.233, 334, 103, CRYSTAL STRUCTURE OF THE CHLORIDE-BOUND FORM OF BLUE COPPER NITRITE REDUCTASE
385, 2xxfB, 0.6582, 1.97, 0.233, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
386, 2xwzF, 0.6582, 1.98, 0.233, 334, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
387, 2vw4B, 0.6582, 1.98, 0.233, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
388, 2avfC, 0.6582, 1.96, 0.233, 316, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
389, 1waeA, 0.6582, 1.98, 0.233, 334, 103, CRYSTAL STRUCTURE OF H129V MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
390, 1wa0X, 0.6582, 1.98, 0.233, 335, 103, CRYSTAL STRUCTURE OF W138H MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
391, 1nibB, 0.6582, 1.97, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
392, 1gs7A, 0.6582, 1.97, 0.233, 336, 103, CRYSTAL STRUCTURE OF H254F MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
393, 4cspA, 0.6581, 1.98, 0.233, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
394, 2vw6A, 0.6581, 1.98, 0.233, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
395, 2nrdA, 0.6581, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
396, 2jfcD, 0.6581, 1.98, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
397, 1mzzC, 0.6581, 1.98, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
398, 2vw7A, 0.6580, 1.98, 0.233, 335, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
399, 1oe2A, 0.6580, 1.97, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF D92E MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
400, 1hawA, 0.6580, 1.98, 0.233, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION
401, 2zonC, 0.6579, 1.99, 0.233, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
402, 2vw4A, 0.6579, 1.98, 0.233, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
403, 1kcbA, 0.6578, 1.98, 0.233, 333, 103, CRYSTAL STRUCTURE OF A NO-FORMING NITRITE REDUCTASE MUTANT: AN ANALOG OF A TRANSITION STATE IN ENZYMATIC REACTION
404, 1bq5A, 0.6578, 1.97, 0.233, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS GIFU 1051
405, 5onxA, 0.6577, 1.99, 0.233, 335, 103, RESTING STATE COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY
406, 5b1jA, 0.6577, 1.98, 0.233, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
407, 4cszA, 0.6577, 1.99, 0.233, 335, 103, STRUCTURE OF F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS WITH NITRITE BOUND
408, 2xx0A, 0.6577, 1.97, 0.233, 335, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
409, 2vw7B, 0.6577, 1.99, 0.233, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
410, 1oe3A, 0.6576, 1.98, 0.233, 335, 103, ATOMIC RESOLUTION STRUCTURE OF  HALF APO  NIR
411, 1nieA, 0.6576, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
412, 1nicA, 0.6576, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
413, 2zonA, 0.6575, 1.98, 0.233, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
414, 2xx0B, 0.6575, 1.97, 0.233, 336, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
415, 1niaB, 0.6575, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
416, 5b1jB, 0.6574, 1.97, 0.233, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
417, 2zonB, 0.6574, 1.98, 0.233, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
418, 2bp0B, 0.6574, 1.98, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
419, 1wa2X, 0.6574, 1.99, 0.233, 334, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE WITH NITRITE BOUND
420, 2xxgC, 0.6573, 1.99, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
421, 1et7A, 0.6573, 1.98, 0.233, 339, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASP MUTANT FROM ALCALIGENES FAECALIS S-6
422, 5og6A, 0.6572, 1.98, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.24MGY 
423, 5i6pA, 0.6572, 1.99, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 27.60 MGY
424, 2bo0A, 0.6572, 1.98, 0.223, 335, 103, CRYSTAL STRUCTURE OF THE C130A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
425, 1nidA, 0.6572, 1.99, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
426, 1nibA, 0.6572, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
427, 5ofhA, 0.6571, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
428, 2xx1F, 0.6571, 1.98, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
429, 2xwzE, 0.6571, 1.99, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
430, 2afnC, 0.6571, 1.98, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
431, 1ntdA, 0.6571, 1.97, 0.223, 336, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE MUTANT M150E THAT CONTAINS ZINC
432, 6gbbA, 0.6570, 1.99, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE CELL POLYMORPH DATASET 1 
433, 6gb8A, 0.6570, 1.99, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: SMALL CELL POLYMORPH DATASET 1 
434, 5ogfA, 0.6570, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.27MGY 
435, 5og3A, 0.6570, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
436, 5f7bA, 0.6570, 1.98, 0.233, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
437, 5d4iA, 0.6570, 1.98, 0.233, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
438, 2xx1A, 0.6570, 1.97, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
439, 2vn3A, 0.6570, 2.00, 0.233, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
440, 2bp8B, 0.6570, 1.99, 0.223, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
441, 1rzqC, 0.6570, 1.99, 0.233, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
442, 1rzqB, 0.6570, 1.99, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
443, 1niaC, 0.6570, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
444, 1et8A, 0.6570, 1.98, 0.233, 339, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASN MUTANT FROM ALCALIGENES FAECALIS
445, 5oggA, 0.6569, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.30MGY 
446, 5og4A, 0.6569, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.18MGY 
447, 5ofgA, 0.6569, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.06MGY 
448, 5n8hA, 0.6569, 1.99, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 3.
449, 5i6oA, 0.6569, 1.99, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 20.70 MGY
450, 2zooA, 0.6569, 2.07, 0.223, 438, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM PSEUDOALTEROMONAS HALOPLANKTIS TAC125
451, 2xwzB, 0.6569, 1.99, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
452, 2jfcB, 0.6569, 2.00, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
453, 1j9rB, 0.6569, 1.98, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
454, 6gcgA, 0.6568, 1.99, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE POLYMORPH DATASET 15 
455, 5og5A, 0.6568, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.21MGY 
456, 5og2A, 0.6568, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.09MGY 
457, 5n8gA, 0.6568, 1.99, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 2.
458, 5n8fA, 0.6567, 1.99, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 1.
459, 5f7aA, 0.6567, 1.98, 0.233, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
460, 2jfcE, 0.6567, 2.00, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
461, 2bp8A, 0.6567, 1.99, 0.223, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
462, 1rzpC, 0.6567, 1.99, 0.233, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
463, 1nifA, 0.6567, 2.00, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
464, 1nibC, 0.6567, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
465, 1niaA, 0.6567, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
466, 6gtjA, 0.6566, 2.00, 0.233, 333, 103, NEUTRON CRYSTAL STRUCTURE FOR COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.8 A RESOLUTION 
467, 5offA, 0.6566, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.03MGY 
468, 5i6nA, 0.6566, 1.99, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 11.73 MGY
469, 2xxgA, 0.6566, 2.00, 0.233, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
470, 1mzzB, 0.6566, 2.00, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
471, 1j9rC, 0.6566, 1.98, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
472, 6gtiA, 0.6565, 2.00, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.0 
473, 2ppfC, 0.6565, 1.99, 0.233, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
474, 2bwdA, 0.6565, 2.00, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH ENDOGENOUSLY BOUND NITRITE AND NO
475, 1npnB, 0.6565, 1.98, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
476, 1mzzA, 0.6565, 2.00, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
477, 6gbyA, 0.6564, 2.00, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: NON- POLYMORPH SEPARATED DATASET 1 
478, 5i6lA, 0.6564, 2.00, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 2.76 MGY
479, 2jfcC, 0.6564, 2.00, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
480, 2afnB, 0.6564, 1.98, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
481, 2afnA, 0.6564, 1.98, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
482, 6gtlA, 0.6563, 2.00, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.0 
483, 6gtkA, 0.6563, 2.00, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.5 
484, 5i6kA, 0.6563, 2.00, 0.233, 334, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 0.69 MGY
485, 5d4iC, 0.6563, 1.99, 0.233, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
486, 2ppdC, 0.6563, 1.98, 0.223, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
487, 2bw5A, 0.6563, 2.00, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NO-BOUND ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
488, 2bp0A, 0.6563, 1.99, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
489, 1snrC, 0.6563, 1.99, 0.233, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
490, 1npnC, 0.6563, 1.99, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
491, 5ue6F, 0.6562, 1.98, 0.223, 307, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
492, 5tb7C, 0.6562, 1.98, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
493, 5i6mA, 0.6562, 2.00, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 7.59 MGY
494, 3h56A, 0.6562, 1.99, 0.223, 335, 103, MET150LEU/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
495, 2ppaC, 0.6562, 1.99, 0.233, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
496, 2fjsC, 0.6562, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
497, 1rzpB, 0.6562, 2.00, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
498, 1npjB, 0.6562, 1.98, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
499, 1j9tB, 0.6562, 1.98, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
500, 1et5A, 0.6562, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE ASP98ASN MUTANT FROM ALCALIGENES FAECALIS S-6
501, 2xwzC, 0.6561, 2.00, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
502, 2b08C, 0.6561, 1.99, 0.223, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
503, 1rzqA, 0.6561, 1.99, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
504, 1n70A, 0.6561, 2.00, 0.223, 334, 103, THE CRYSTAL STRUCTURE OF NITRITE REDUCTASE MUTANT HIS287ALA FROM RHODOBACTER SPHAEROIDES
505, 6gtnA, 0.6560, 2.00, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.5 
506, 5f7aB, 0.6560, 1.98, 0.233, 337, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
507, 5d4jB, 0.6560, 1.99, 0.233, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
508, 4yscA, 0.6560, 1.99, 0.233, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
509, 2y1aA, 0.6560, 2.00, 0.233, 332, 103, CRYSTAL STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH BOUND NO
510, 2ppeC, 0.6560, 1.99, 0.223, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
511, 2pp9C, 0.6560, 1.98, 0.233, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
512, 2pp7C, 0.6560, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
513, 1l9pC, 0.6560, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
514, 1j9tC, 0.6560, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
515, 5ue6C, 0.6559, 1.98, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
516, 5tb7A, 0.6559, 1.98, 0.223, 312, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
517, 5ofdA, 0.6559, 2.00, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
518, 5f7bB, 0.6559, 1.98, 0.233, 337, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
519, 2ppaB, 0.6559, 1.99, 0.233, 337, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
520, 2dv6D, 0.6559, 1.98, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
521, 2b08B, 0.6559, 1.99, 0.223, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
522, 1sjmC, 0.6559, 1.99, 0.233, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
523, 1l9pB, 0.6559, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
524, 1j9sB, 0.6559, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
525, 1as8B, 0.6559, 1.99, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
526, 5ofcA, 0.6558, 2.00, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 21.65MGY 
527, 2ppcC, 0.6558, 1.99, 0.233, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
528, 1l9qB, 0.6558, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
529, 1l9oC, 0.6558, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
530, 1l9oB, 0.6558, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
531, 1as7B, 0.6558, 1.98, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
532, 5f7bC, 0.6557, 1.99, 0.233, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
533, 5f7aC, 0.6557, 1.99, 0.233, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
534, 5d4iB, 0.6557, 1.98, 0.233, 341, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
535, 5d4hA, 0.6557, 1.99, 0.233, 337, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
536, 3h4fB, 0.6557, 1.99, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
537, 2ppfB, 0.6557, 1.99, 0.233, 337, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
538, 1mzyA, 0.6557, 2.01, 0.223, 331, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE
539, 1l9rC, 0.6557, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
540, 1l9rB, 0.6557, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
541, 1l9qC, 0.6557, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
542, 1aq8B, 0.6557, 1.99, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
543, 6gt0A, 0.6556, 2.00, 0.233, 333, 103, NITRITE-BOUND COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
544, 5ue6I, 0.6556, 1.98, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
545, 5d4hC, 0.6556, 2.00, 0.233, 339, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
546, 5d4hB, 0.6556, 1.99, 0.233, 341, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
547, 2pp8C, 0.6556, 1.99, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
548, 1zdsC, 0.6556, 1.99, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
549, 1j9sC, 0.6556, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
550, 1j9qC, 0.6556, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
551, 1as8C, 0.6556, 1.99, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
552, 1as7C, 0.6556, 1.99, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
553, 6gsqA, 0.6555, 2.01, 0.233, 333, 103, OXIDISED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
554, 5of8A, 0.6555, 2.00, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
555, 2ppdB, 0.6555, 1.99, 0.223, 337, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
556, 2pp8B, 0.6555, 1.99, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
557, 2p80C, 0.6555, 2.00, 0.233, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
558, 2e86C, 0.6555, 1.99, 0.233, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
559, 2a3tA, 0.6555, 2.00, 0.223, 328, 103, CU-CONTAINING NITRITE REDUCTASE
560, 1sjmB, 0.6555, 1.99, 0.233, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
561, 1l9tC, 0.6555, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
562, 1kbwC, 0.6555, 1.99, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
563, 1kbwB, 0.6555, 1.99, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
564, 1as8A, 0.6555, 1.99, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
565, 5of7A, 0.6554, 2.01, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
566, 4yscB, 0.6554, 1.99, 0.233, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
567, 2ppeA, 0.6554, 1.99, 0.223, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
568, 2pp8A, 0.6554, 1.99, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
569, 2fjsB, 0.6554, 1.99, 0.233, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
570, 2bwiA, 0.6554, 2.01, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE -SOAKED ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
571, 2bw4A, 0.6554, 2.01, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF RESTING STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
572, 1npjC, 0.6554, 1.99, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
573, 1l9sC, 0.6554, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
574, 1kbwF, 0.6554, 1.99, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
575, 1kbwA, 0.6554, 1.99, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
576, 1as6C, 0.6554, 1.99, 0.233, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
577, 1aq8C, 0.6554, 1.99, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
578, 5tb7B, 0.6553, 1.99, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
579, 3h4fC, 0.6553, 1.99, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
580, 2ppeB, 0.6553, 1.99, 0.223, 337, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
581, 2pp9B, 0.6553, 1.99, 0.233, 337, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
582, 2fjsA, 0.6553, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
583, 2e86B, 0.6553, 1.99, 0.233, 337, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
584, 1snrB, 0.6553, 1.99, 0.233, 337, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
585, 1l9tB, 0.6553, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
586, 1kbwE, 0.6553, 1.99, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
587, 1kbvA, 0.6553, 1.99, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
588, 1j9tA, 0.6553, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
589, 1j9qB, 0.6553, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
590, 5ue6H, 0.6552, 1.99, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
591, 5d4jC, 0.6552, 2.00, 0.233, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
592, 5akrA, 0.6552, 2.01, 0.233, 337, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE BOUND STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE AT 0.87 A RESOLUTION
593, 3h4hB, 0.6552, 2.00, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
594, 2ppdA, 0.6552, 2.00, 0.223, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
595, 2pp7B, 0.6552, 1.99, 0.233, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
596, 2dwsA, 0.6552, 2.01, 0.223, 328, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 8.4 WITH BOUND NITRITE
597, 1rzpA, 0.6552, 2.01, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
598, 1npnA, 0.6552, 2.00, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
599, 1kbwD, 0.6552, 1.99, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
600, 6gt2A, 0.6551, 2.01, 0.233, 333, 103, REDUCED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
601, 3h4fA, 0.6551, 2.00, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
602, 2ppfA, 0.6551, 2.00, 0.233, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
603, 2ppcB, 0.6551, 1.99, 0.233, 337, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
604, 2pp9A, 0.6551, 1.99, 0.233, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
605, 2p80B, 0.6551, 2.00, 0.233, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
606, 2dv6C, 0.6551, 1.99, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
607, 1zdsB, 0.6551, 2.00, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
608, 1l9sB, 0.6551, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
609, 4yseB, 0.6550, 2.00, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
610, 1npjA, 0.6550, 2.00, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
611, 1kbvD, 0.6550, 1.98, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
612, 1as7A, 0.6550, 2.00, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
613, 1as6B, 0.6550, 1.99, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
614, 5of6A, 0.6549, 2.01, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
615, 2ppaA, 0.6549, 2.00, 0.233, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
616, 2b08A, 0.6549, 2.00, 0.223, 335, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
617, 1snrA, 0.6549, 2.00, 0.233, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
618, 1as6A, 0.6549, 1.99, 0.233, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
619, 5ue6E, 0.6548, 1.99, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
620, 3h4hC, 0.6548, 2.00, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
621, 2ppcA, 0.6548, 2.00, 0.233, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
622, 2dwtA, 0.6548, 2.02, 0.223, 329, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 6.0 WITH BOUND NITRITE
623, 1l9rA, 0.6548, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
624, 1j9sA, 0.6548, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
625, 2pp7A, 0.6547, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
626, 2dv6F, 0.6547, 1.99, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
627, 2dv6B, 0.6547, 1.99, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
628, 1sjmA, 0.6547, 2.00, 0.233, 335, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
629, 5ue6B, 0.6546, 2.00, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
630, 5n8iA, 0.6546, 2.02, 0.233, 334, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 100K REFERENCE DATASET.
631, 1zdqC, 0.6546, 2.00, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
632, 1l9pA, 0.6546, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
633, 1j9rA, 0.6546, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
634, 1j9qA, 0.6546, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
635, 5d4jA, 0.6545, 2.00, 0.233, 335, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
636, 4yseA, 0.6545, 2.01, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
637, 2dy2A, 0.6545, 2.01, 0.223, 329, 103, NITRITE REDUCTASE PH 6.0
638, 2dv6A, 0.6545, 1.99, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
639, 1l9tA, 0.6545, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
640, 2e86A, 0.6544, 2.00, 0.233, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
641, 1zdqB, 0.6544, 2.00, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
642, 1kbvE, 0.6544, 2.00, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
643, 1kbvC, 0.6544, 2.00, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
644, 1aq8A, 0.6544, 2.00, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
645, 5ue6D, 0.6543, 1.99, 0.223, 309, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
646, 2p80A, 0.6543, 2.01, 0.233, 335, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
647, 2dv6E, 0.6543, 1.99, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
648, 1zv2A, 0.6543, 2.01, 0.223, 328, 103, CU-CONTAINING NITRITE REDUCTASE
649, 1l9oA, 0.6543, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
650, 1kbvF, 0.6543, 2.00, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
651, 1l9qA, 0.6542, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
652, 1l9sA, 0.6541, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
653, 3h4hA, 0.6540, 2.01, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
654, 1kbvB, 0.6539, 2.00, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
655, 1zdsA, 0.6538, 2.01, 0.223, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
656, 5ue6G, 0.6536, 2.00, 0.223, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
657, 2xx1D, 0.6534, 2.04, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
658, 1zdqA, 0.6532, 2.02, 0.223, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
659, 5ue6A, 0.6529, 2.01, 0.223, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
660, 1e30A, 0.6527, 2.30, 0.162, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
661, 5of5A, 0.6525, 2.05, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 
662, 4yseC, 0.6524, 2.02, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
663, 1e30B, 0.6517, 2.33, 0.162, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
664, 2xx1B, 0.6513, 2.07, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
665, 2xx1E, 0.6512, 2.06, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
666, 2xx1C, 0.6511, 2.06, 0.233, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
667, 1gy2B, 0.6511, 2.31, 0.162, 155, 105, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
668, 1a8zA, 0.6507, 2.31, 0.171, 153, 105, STRUCTURE DETERMINATION OF A 16.8KDA COPPER PROTEIN RUSTICYANIN AT 2.1A RESOLUTION USING ANOMALOUS SCATTERING DATA WITH DIRECT METHODS
669, 1a3zA, 0.6505, 2.33, 0.171, 150, 105, REDUCED RUSTICYANIN AT 1.9 ANGSTROMS
670, 1gy1B, 0.6502, 2.34, 0.171, 154, 105, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
671, 1gy2A, 0.6500, 2.34, 0.162, 155, 105, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
672, 3fsvA, 0.6496, 2.77, 0.110, 118, 109, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAHAAAM)
673, 2cakA, 0.6496, 2.31, 0.171, 154, 105, 1.27ANGSTROM STRUCTURE OF RUSTICYANIN FROM THIOBACILLUS FERROOXIDANS
674, 5zl1A, 0.6495, 1.84, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
675, 1gy1A, 0.6495, 2.33, 0.171, 154, 105, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
676, 5zl1D, 0.6494, 1.84, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
677, 5zl1C, 0.6494, 1.84, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
678, 1rcyA, 0.6494, 2.33, 0.171, 151, 105, RUSTICYANIN (RC) FROM THIOBACILLUS FERROOXIDANS
679, 5zl1B, 0.6492, 1.85, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
680, 2calA, 0.6478, 2.34, 0.162, 153, 105, CRYSTAL STRUCTURE OF HIS143MET RUSTICYANIN
681, 4knsC, 0.6457, 1.83, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
682, 4knsB, 0.6456, 1.84, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
683, 4knuD, 0.6455, 1.63, 0.222, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
684, 4knsD, 0.6453, 1.84, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
685, 4knuF, 0.6452, 1.84, 0.220, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
686, 4knuB, 0.6452, 1.84, 0.220, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
687, 4knuC, 0.6451, 1.84, 0.220, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
688, 4knuA, 0.6447, 1.85, 0.220, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
689, 4knsF, 0.6443, 1.85, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
690, 4knsA, 0.6442, 1.85, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
691, 4knsE, 0.6437, 1.85, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
692, 4kntA, 0.6435, 1.65, 0.222, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
693, 2avfD, 0.6435, 2.08, 0.238, 320, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
694, 4kntC, 0.6434, 1.65, 0.222, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
695, 4kntB, 0.6432, 1.65, 0.222, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
696, 4knuE, 0.6428, 1.66, 0.222, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
697, 2avfA, 0.6404, 2.10, 0.230, 314, 100, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
698, 4q89A, 0.6393, 2.70, 0.104, 501, 106, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
699, 4q8bA, 0.6384, 2.56, 0.105, 499, 105, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
700, 2bhfA, 0.6380, 2.75, 0.104, 504, 106, 3D STRUCTURE OF THE REDUCED FORM OF COTA
701, 4a68A, 0.6373, 2.75, 0.104, 502, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116N MUTANT
702, 1w8eA, 0.6372, 2.77, 0.104, 505, 106, 3D STRUCTURE OF COTA INCUBATED WITH HYDROGEN PEROXIDE
703, 1w6wA, 0.6369, 2.70, 0.104, 502, 106, 3D STRUCTURE OF COTA INCUBATED WITH SODIUM AZIDE
704, 4a67A, 0.6368, 2.70, 0.104, 504, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116E MUTANT
705, 1gskA, 0.6368, 2.70, 0.104, 502, 106, CRYSTAL STRUCTURE OF COTA AN ENDOSPORE COAT PROTEIN FROM BACILLUS SUBTILIS
706, 4a66A, 0.6365, 2.75, 0.113, 501, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116A MUTANT
707, 1of0A, 0.6365, 2.56, 0.105, 502, 105, CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH EBS
708, 5zljA, 0.6364, 2.76, 0.104, 503, 106, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME; PH8.0 
709, 2x87A, 0.6364, 2.70, 0.104, 504, 106, CRYSTAL STRUCTURE OF THE RECONSTITUTED COTA
710, 3zdwA, 0.6361, 2.57, 0.105, 502, 105, SUBSTRATE AND DIOXYGEN BINDING TO THE ENDOSPORE COAT LACCASE COTA FROM BACILLUS SUBTILIS
711, 4akpA, 0.6360, 2.71, 0.104, 504, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE:E498T MUTANT
712, 2x88A, 0.6360, 2.58, 0.105, 504, 105, CRYSTAL STRUCTURE OF HOLOCOTA
713, 5zllA, 0.6359, 2.77, 0.104, 503, 106, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493C MUTANT; PH 8.0 
714, 1w6lA, 0.6359, 2.57, 0.105, 503, 105, 3D STRUCTURE OF COTA INCUBATED WITH CUCL2
715, 4akqA, 0.6358, 2.57, 0.105, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498D MUTANT
716, 5zlmA, 0.6356, 2.57, 0.105, 502, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H491C MUTANT; PH 8.0 
717, 2wsdA, 0.6356, 2.57, 0.105, 504, 105, PROXIMAL MUTATIONS AT THE TYPE 1 CU SITE OF COTA-LACCASE: I494A MUTANT
718, 4yvnA, 0.6355, 2.72, 0.104, 505, 106, CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH ABTS AT A NOVEL BINDING SITE
719, 4akoA, 0.6353, 2.57, 0.105, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498L MUTANT
720, 4q8bB, 0.6351, 2.60, 0.105, 499, 105, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
721, 4yvuA, 0.6350, 2.57, 0.105, 506, 105, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME IN THE ACID CONDITION PH5.6
722, 1curA, 0.6349, 2.43, 0.171, 155, 105, REDUCED RUSTICYANIN NMR
723, 4q89B, 0.6346, 2.61, 0.105, 499, 105, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
724, 5zlkA, 0.6342, 2.60, 0.105, 506, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493A MUTANT; PH 8.0 
725, 3wiaC, 0.6334, 1.90, 0.192, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
726, 3wiaG, 0.6330, 1.68, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
727, 3wiaH, 0.6329, 1.92, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
728, 3wiaD, 0.6327, 1.69, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
729, 3wiaB, 0.6326, 1.69, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
730, 3wiaA, 0.6326, 1.68, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
731, 4e9yC, 0.6325, 2.21, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA4)
732, 4e9xC, 0.6324, 2.21, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA3)
733, 4e9vC, 0.6323, 2.21, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA1)
734, 3wiaE, 0.6323, 1.93, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
735, 6iqzA, 0.6316, 2.44, 0.078, 535, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
736, 5zd6A, 0.6316, 2.44, 0.078, 535, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
737, 4ysaA, 0.6316, 1.69, 0.204, 294, 98, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
738, 3wiaF, 0.6316, 1.70, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
739, 3x1nA, 0.6315, 1.69, 0.194, 298, 98, NITRITE-BOUND THERMOSTABLE COPPER NITRITE REDUCTASE AT 320 K
740, 1fwxC, 0.6315, 1.86, 0.186, 590, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
741, 1fwxA, 0.6314, 1.86, 0.186, 591, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
742, 6iqyB, 0.6313, 2.43, 0.078, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
743, 5zd7B, 0.6313, 2.43, 0.078, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
744, 4e9wC, 0.6312, 2.03, 0.192, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
745, 1qniE, 0.6312, 1.86, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
746, 3x1gA, 0.6311, 1.71, 0.204, 296, 98, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS SHOWING TWO COORDINATION GEOMETRIES AT THE T2CU SITE
747, 3x1fA, 0.6310, 1.71, 0.204, 296, 98, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
748, 1qniA, 0.6309, 1.86, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
749, 1qniB, 0.6308, 1.85, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
750, 5ytlA, 0.6307, 1.71, 0.204, 294, 98, CRYSTAL STRUCTURE OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE DETERMINED WITH AN ANAEROBICALLY MANIPULATED CRYSTAL 
751, 3gdcB, 0.6307, 1.93, 0.172, 285, 99, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
752, 4e9vA, 0.6306, 2.06, 0.192, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA1)
753, 4zk8A, 0.6304, 1.71, 0.204, 294, 98, COPPER-CONTAINING NITRITE REDUCTASE FROM THERMOPHILIC BACTERIUM GEOBACILLUS THERMODENITRIFICANS (RE-REFINED)
754, 4ysrA, 0.6304, 1.71, 0.204, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.6 MGY
755, 4yspA, 0.6304, 1.71, 0.204, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.32 MGY
756, 4e9yA, 0.6304, 2.06, 0.192, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
757, 4e9xA, 0.6304, 2.06, 0.192, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA3)
758, 4e9wA, 0.6304, 2.06, 0.192, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
759, 3gyrI, 0.6304, 2.79, 0.170, 587, 106, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
760, 2zwnC, 0.6304, 2.05, 0.192, 316, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
761, 2zwnA, 0.6304, 2.06, 0.192, 317, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
762, 4ysuA, 0.6303, 1.72, 0.204, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 25.0 MGY
763, 4yssA, 0.6303, 1.72, 0.204, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.7 MGY
764, 5i5mB, 0.6302, 1.85, 0.144, 576, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
765, 4ystA, 0.6302, 1.72, 0.204, 294, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 24.9 MGY
766, 4ysqA, 0.6302, 1.72, 0.204, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.38 MGY
767, 3gyrC, 0.6302, 2.80, 0.151, 587, 106, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
768, 3gdcC, 0.6302, 1.93, 0.172, 286, 99, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
769, 1qniC, 0.6302, 1.87, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
770, 5ytnA, 0.6301, 1.72, 0.194, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH PEROXIDE 
771, 3x1eA, 0.6300, 1.72, 0.204, 295, 98, STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS WITHOUT CHLORIDE
772, 1qniD, 0.6300, 1.87, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
773, 5ytmA, 0.6299, 1.72, 0.194, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS DETERMINED BY IN-OUSE SOURCE 
774, 3wniA, 0.6299, 1.72, 0.204, 298, 98, 1.50 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
775, 1qniF, 0.6299, 1.87, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
776, 5i5mA, 0.6298, 1.85, 0.144, 575, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
777, 4ysoA, 0.6298, 1.72, 0.204, 295, 98, COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 0.064 MGY
778, 3wnjA, 0.6297, 1.72, 0.204, 298, 98, 1.20 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
779, 3wkpA, 0.6297, 1.72, 0.194, 295, 98, C135A MUTANT OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE IN COMPLEX WITH NITRITE
780, 3gdcA, 0.6290, 1.98, 0.172, 288, 99, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
781, 2zwnB, 0.6277, 2.10, 0.192, 316, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
782, 3g5wA, 0.6276, 2.07, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
783, 1fwxB, 0.6274, 1.83, 0.187, 589, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
784, 6rkzB, 0.6271, 1.94, 0.224, 586, 98, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
785, 4e9xB, 0.6271, 2.11, 0.192, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA3)
786, 4e9yB, 0.6270, 2.10, 0.192, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
787, 1fwxD, 0.6268, 1.85, 0.187, 588, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
788, 4e9wB, 0.6267, 2.11, 0.192, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
789, 4e9vB, 0.6266, 2.11, 0.192, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA1)
790, 2iwfA, 0.6266, 1.84, 0.198, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
791, 3g5wE, 0.6265, 2.07, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
792, 2iwkA, 0.6265, 1.85, 0.198, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
793, 2iwkB, 0.6263, 1.85, 0.198, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
794, 3wiaI, 0.6260, 1.69, 0.206, 272, 97, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
795, 3g5wC, 0.6259, 2.09, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
796, 6rl0C, 0.6258, 1.92, 0.227, 582, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
797, 3gyrE, 0.6258, 1.86, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
798, 3g5wD, 0.6258, 2.08, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
799, 3g5wF, 0.6257, 2.09, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
800, 2iwfB, 0.6256, 1.85, 0.198, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
801, 3gyrJ, 0.6255, 1.86, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
802, 3gyrB, 0.6253, 1.86, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
803, 3g5wB, 0.6253, 2.08, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
804, 3gyrK, 0.6249, 1.87, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
805, 3gyrF, 0.6249, 1.87, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
806, 3gyrA, 0.6248, 1.87, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
807, 6rl0D, 0.6247, 1.93, 0.227, 581, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
808, 6rl0A, 0.6242, 1.94, 0.227, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
809, 3gyrG, 0.6241, 1.88, 0.202, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
810, 6fc7G, 0.6240, 2.39, 0.129, 281, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
811, 3gyrH, 0.6239, 1.88, 0.202, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
812, 3gyrD, 0.6239, 1.87, 0.202, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
813, 6rl0B, 0.6237, 1.93, 0.227, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
814, 6fc7J, 0.6237, 2.39, 0.129, 281, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
815, 4bdvA, 0.6237, 2.57, 0.154, 612, 104, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
816, 3gyrL, 0.6236, 1.88, 0.202, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
817, 3sbpF, 0.6234, 1.94, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
818, 3sbrF, 0.6227, 1.96, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
819, 3sbpG, 0.6227, 1.95, 0.227, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
820, 2uxtA, 0.6227, 2.40, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
821, 6rhqF, 0.6226, 2.21, 0.130, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
822, 5o4iA, 0.6226, 2.41, 0.129, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
823, 3sbqB, 0.6225, 1.94, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
824, 3sbrE, 0.6224, 1.93, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
825, 3sbqA, 0.6224, 1.95, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
826, 6rkzA, 0.6223, 1.93, 0.227, 586, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
827, 3sbpH, 0.6223, 1.94, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
828, 3sbpE, 0.6223, 1.94, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
829, 3kw8A, 0.6222, 2.16, 0.130, 273, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR AT 2.3 A RESOLUTION
830, 5mkmA, 0.6221, 2.39, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
831, 6fc7A, 0.6219, 2.21, 0.140, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
832, 4enzA, 0.6218, 2.18, 0.180, 1029, 100, STRUCTURE OF HUMAN CERULOPLASMIN AT 2.6 A RESOLUTION
833, 3sbrG, 0.6217, 1.97, 0.227, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
834, 5o4qJ, 0.6216, 2.41, 0.129, 280, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
835, 5o4qG, 0.6216, 2.40, 0.129, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
836, 5o3kG, 0.6216, 2.16, 0.140, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
837, 3sbpA, 0.6216, 1.97, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
838, 3sbrD, 0.6215, 1.95, 0.227, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
839, 2fqdA, 0.6215, 2.58, 0.127, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
840, 3sbpD, 0.6214, 1.96, 0.227, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
841, 3cg8C, 0.6214, 2.17, 0.130, 272, 100, LACCASE FROM STREPTOMYCES COELICOLOR
842, 3sbrA, 0.6213, 1.99, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
843, 3cg8B, 0.6213, 2.17, 0.130, 272, 100, LACCASE FROM STREPTOMYCES COELICOLOR
844, 6rhqD, 0.6212, 2.21, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
845, 6rh9G, 0.6212, 2.22, 0.150, 279, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
846, 4wtqB, 0.6212, 2.16, 0.110, 269, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
847, 6s0oD, 0.6211, 2.22, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
848, 5o4iB, 0.6211, 2.18, 0.130, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
849, 2fqgA, 0.6211, 2.58, 0.127, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
850, 1kcwA, 0.6211, 2.20, 0.180, 1017, 100, X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS
851, 6fdjA, 0.6209, 2.17, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
852, 4wtqA, 0.6209, 2.16, 0.110, 270, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
853, 3cg8A, 0.6209, 2.17, 0.130, 270, 100, LACCASE FROM STREPTOMYCES COELICOLOR
854, 6rh9J, 0.6208, 2.42, 0.139, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
855, 6fc7D, 0.6208, 2.22, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
856, 3sbpB, 0.6208, 1.98, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
857, 6rhqB, 0.6207, 2.17, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
858, 5o4iG, 0.6207, 2.18, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
859, 5b7eA, 0.6207, 2.58, 0.127, 477, 102, STRUCTURE OF PERDEUTERATED CUEO
860, 4uanC, 0.6206, 2.16, 0.110, 272, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
861, 3sbpC, 0.6206, 1.96, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
862, 2fqfA, 0.6206, 2.59, 0.127, 465, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
863, 5o4qH, 0.6205, 2.40, 0.129, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
864, 3sbrH, 0.6205, 1.95, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
865, 3sbrC, 0.6205, 1.97, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
866, 6fc7L, 0.6204, 2.04, 0.141, 276, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
867, 5o4qA, 0.6204, 2.18, 0.130, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
868, 5o4iK, 0.6204, 2.24, 0.140, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
869, 4wtqC, 0.6204, 2.40, 0.119, 269, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
870, 5b7mB, 0.6203, 2.61, 0.127, 464, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
871, 1n68A, 0.6203, 2.61, 0.127, 464, 102, COPPER BOUND TO THE MULTICOPPER OXIDASE CUEO
872, 6fdjD, 0.6202, 2.16, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
873, 2fqeA, 0.6202, 2.60, 0.127, 463, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
874, 6s0oA, 0.6201, 2.23, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
875, 6rh9D, 0.6201, 2.23, 0.150, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
876, 6fdjG, 0.6201, 2.18, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
877, 5o4iE, 0.6201, 2.18, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
878, 5o3kA, 0.6201, 2.19, 0.130, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
879, 5n0kA, 0.6201, 2.18, 0.200, 1034, 100, RAT CERULOPLASMIN ORTHORHOMBIC FORM
880, 4uahA, 0.6200, 2.16, 0.110, 272, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
881, 4ejxA, 0.6200, 2.20, 0.180, 1034, 100, STRUCTURE OF CERULOPLASMIN-MYELOPEROXIDASE COMPLEX
882, 5lhlD, 0.6199, 2.04, 0.131, 278, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
883, 3pauA, 0.6198, 2.59, 0.127, 464, 102, CUEO IN THE RESTING OXIDIZED STATE
884, 5o4qD, 0.6197, 2.19, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
885, 5b7mC, 0.6197, 2.62, 0.127, 462, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
886, 3sbrB, 0.6197, 1.97, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
887, 5o3kJ, 0.6196, 2.18, 0.130, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
888, 6rhqA, 0.6195, 2.19, 0.140, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
889, 6fc7H, 0.6194, 2.04, 0.141, 278, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
890, 5o4iD, 0.6194, 2.20, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
891, 4w1tA, 0.6191, 2.41, 0.109, 272, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
892, 2j5wA, 0.6191, 2.20, 0.180, 1029, 100, CERULOPLASMIN REVISITED: STRUCTURAL AND FUNCTIONAL ROLES OF VARIOUS METAL CATION BINDING SITES
893, 4m3hC, 0.6190, 2.41, 0.119, 270, 101, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
894, 3t9wA, 0.6188, 2.19, 0.140, 270, 100, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116
895, 2yxwA, 0.6187, 2.62, 0.127, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
896, 5o4qE, 0.6186, 2.20, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
897, 4m3hA, 0.6186, 2.18, 0.110, 269, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
898, 5o4iJ, 0.6185, 2.19, 0.130, 279, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
899, 4hakA, 0.6185, 2.61, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT E506A
900, 3nscA, 0.6183, 2.62, 0.127, 470, 102, C500S MUTANT OF CUEO BOUND TO CU(II)
901, 5o4qK, 0.6182, 2.20, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
902, 5o4qB, 0.6182, 2.21, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
903, 3nsfA, 0.6182, 2.62, 0.127, 480, 102, APO FORM OF THE MULTICOPPER OXIDASE CUEO
904, 5o3kD, 0.6181, 2.20, 0.130, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
905, 4m3hB, 0.6181, 2.19, 0.110, 269, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
906, 3pavA, 0.6181, 2.64, 0.127, 466, 102, THE REDUCED FORM OF CUEO
907, 1kv7A, 0.6181, 2.63, 0.127, 463, 102, CRYSTAL STRUCTURE OF CUEO A MULTI-COPPER OXIDASE FROM E. COLI INVOLVED IN COPPER HOMEOSTASIS
908, 6fc7E, 0.6180, 2.25, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
909, 5b7mA, 0.6180, 2.64, 0.127, 463, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
910, 6rh9A, 0.6179, 2.06, 0.141, 278, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
911, 6fdjE, 0.6179, 2.20, 0.130, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
912, 5ys5A, 0.6179, 2.50, 0.129, 457, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT WITH SEVEN COPPER IONS 
913, 5o3kB, 0.6179, 2.22, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
914, 6fdjK, 0.6178, 2.19, 0.130, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
915, 4uanA, 0.6178, 2.19, 0.110, 276, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
916, 3nsyA, 0.6178, 2.63, 0.127, 465, 102, THE MULTI-COPPER OXIDASE CUEO WITH SIX MET TO SER MUTATIONS (M358S M361SM362SM364SM366SM368S)
917, 5n4lB, 0.6177, 2.17, 0.190, 1034, 100, RAT CERULOPLASMIN TRIGONAL FORM
918, 5mkmB, 0.6177, 2.25, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
919, 4w1tC, 0.6177, 2.19, 0.110, 276, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
920, 1pf3A, 0.6177, 2.63, 0.127, 463, 102, CRYSTAL STRUCTURE OF THE M441L MUTANT OF THE MULTICOPPER OXIDASE CUEO
921, 6fdjB, 0.6176, 2.20, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
922, 4uahC, 0.6176, 2.19, 0.110, 276, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
923, 4halA, 0.6176, 2.62, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT E506I
924, 4e9tA, 0.6175, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA6)
925, 2yxwB, 0.6175, 2.61, 0.127, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
926, 5o3kH, 0.6174, 2.21, 0.140, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
927, 5o3kE, 0.6174, 2.21, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
928, 5lhlB, 0.6174, 2.43, 0.139, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
929, 6fc7I, 0.6173, 2.07, 0.141, 281, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
930, 4e9sA, 0.6173, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA5)
931, 4e9rA, 0.6173, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA4)
932, 2yxvB, 0.6173, 2.62, 0.127, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
933, 3qqxA, 0.6172, 2.64, 0.127, 474, 102, REDUCED NATIVE INTERMEDIATE OF THE MULTICOPPER OXIDASE CUEO
934, 4e9qA, 0.6171, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA2)
935, 2yxvA, 0.6171, 2.64, 0.127, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
936, 6s0oE, 0.6170, 2.19, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
937, 5lhlA, 0.6170, 2.07, 0.141, 278, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
938, 4nerA, 0.6170, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA1)
939, 3uaeA, 0.6170, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA6)
940, 3od3A, 0.6170, 2.63, 0.127, 488, 102, CUEO AT 1.1 A RESOLUTION INCLUDING RESIDUES IN PREVIOUSLY DISORDERED REGION
941, 3nt0A, 0.6170, 2.63, 0.127, 468, 102, C500S (T1D) MUTANT OF CUEO SOAKED IN AND BOUND TO CU(I)
942, 6im8A, 0.6169, 2.64, 0.127, 469, 102, CUEO-PM2 MULTICOPPER OXIDASE 
943, 3uadA, 0.6169, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA5)
944, 3uacA, 0.6169, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA4)
945, 3ta4D, 0.6169, 2.43, 0.158, 273, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
946, 2uxvB, 0.6169, 2.46, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
947, 6rhqE, 0.6168, 2.20, 0.130, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
948, 6fdjH, 0.6168, 2.20, 0.130, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
949, 5o3kK, 0.6168, 2.23, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
950, 5i5iB, 0.6168, 1.54, 0.151, 537, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
951, 4gy4A, 0.6167, 2.23, 0.130, 276, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
952, 5gnoA, 0.6166, 2.66, 0.127, 463, 102, STRUCTURE OF MULTICOPPER OXIDASE CUEO - SIGNAL PEPTIDE-FREE
953, 5b7fA, 0.6166, 2.66, 0.127, 463, 102, STRUCTURE OF CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
954, 3uabA, 0.6166, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA2)
955, 3uaaA, 0.6165, 2.63, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA1)
956, 5ys1A, 0.6164, 2.50, 0.129, 461, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT 
957, 4x4kA, 0.6163, 2.11, 0.144, 525, 97, STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT
958, 3nsdA, 0.6163, 2.64, 0.127, 462, 102, SILVER BOUND TO THE MULTICOPPER OXIDASE CUEO (UNTAGGED)
959, 6im9A, 0.6160, 2.50, 0.129, 490, 101, MDM2 BOUND CUEO-PM2 SENSOR 
960, 5k8dB, 0.6160, 2.06, 0.153, 619, 98, CRYSTAL STRUCTURE OF RFVIIIFC
961, 3j2qA, 0.6160, 2.86, 0.160, 630, 106, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
962, 3cdzA, 0.6160, 2.86, 0.160, 630, 106, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
963, 3ta4E, 0.6157, 2.22, 0.140, 267, 100, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
964, 4ef3A, 0.6156, 2.69, 0.127, 466, 102, MULTICOPPER OXIDASE CUEO (CITRATE BUFFER)
965, 5n4lA, 0.6151, 2.53, 0.109, 1034, 101, RAT CERULOPLASMIN TRIGONAL FORM
966, 5i5iA, 0.6150, 1.51, 0.140, 539, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
967, 2vmjA, 0.6150, 2.05, 0.237, 326, 97, TYPE 1 COPPER-BINDING LOOP OF NITRITE REDUCTASE MUTANT: 130- CAPEGMVPWHVVSGM-144 TO 130-CTPHPFM-136
968, 3sqrA, 0.6149, 2.11, 0.144, 539, 97, CRYSTAL STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA AT 1.67 A RESOLUTION
969, 6rikA, 0.6145, 2.61, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRTEENTH STRUCTURE OF THE SERIES WITH 5200 KGY DOSE. 
970, 6ri2A, 0.6144, 2.62, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
971, 5z1xA, 0.6144, 2.61, 0.168, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
972, 5ehfA, 0.6144, 2.61, 0.139, 497, 101, LACCASE FROM ANTRODIELLA FAGINEA
973, 6riiA, 0.6143, 2.62, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTH STRUCTURE OF THE SERIES WITH 1200 KGY DOSE. 
974, 6rhpA, 0.6143, 2.61, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTY FIRST STRUCTURE OF THE SERIES WITH 4415 KGY DOSE (COLLECTED AFTER REFREEZING). 
975, 5z22A, 0.6143, 2.61, 0.168, 494, 101, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
976, 5z1xB, 0.6143, 2.61, 0.168, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
977, 6rilA, 0.6142, 2.61, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTEENTH STRUCTURE OF THE SERIES WITH 5600 KGY DOSE (DATA WAS COLLECTED AFTER REFREEZING). 
978, 6ri8A, 0.6142, 2.62, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 800 KGY DOSE. 
979, 6rhrA, 0.6142, 2.61, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
980, 6rh9B, 0.6142, 2.23, 0.150, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
981, 6ri4A, 0.6141, 2.61, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 13 KGY DOSE. 
982, 6rhoA, 0.6141, 2.62, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
983, 6rghA, 0.6141, 2.61, 0.149, 499, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
984, 3t6zA, 0.6141, 2.62, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
985, 2r7eA, 0.6141, 2.94, 0.151, 693, 106, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
986, 6ri6A, 0.6140, 2.61, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 400 KGY DOSE. 
987, 6ri0A, 0.6140, 2.61, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
988, 6rhuA, 0.6140, 2.61, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
989, 6rhiA, 0.6140, 2.62, 0.149, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
990, 6rhhA, 0.6140, 2.61, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
991, 6rgpA, 0.6140, 2.61, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
992, 5midA, 0.6140, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 14-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 393 MIN.
993, 5micA, 0.6140, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 13-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 363 MIN.
994, 3t6vA, 0.6140, 2.62, 0.139, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
995, 6rhxA, 0.6139, 2.61, 0.158, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
996, 5migA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 16-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 453 MIN. THE CRYSTAL WAS QUICK REFREEZING BEFORE THIS DATA COLLECTION.
997, 5mieA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 15-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 423 MIN.
998, 5miaA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 11-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 303 MIN.
999, 5mi2A, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 10-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 273 MIN.
1000, 5mi1A, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 9-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 243 MIN.
1001, 5mhzA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 8-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 213 MIN.
1002, 5mhyA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SEVENTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 183 MIN.
1003, 5mhxA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SIXTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 153 MIN.
1004, 5mhvA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FOURTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 93 MIN.
1005, 5mhuA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE THIRD STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 63 MIN.
1006, 5mewA, 0.6139, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. SECOND STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 33 MIN.
1007, 5mejA, 0.6139, 2.62, 0.149, 499, 101, STRUCTURAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. FIRST STRUCTURE OF THE SERIES WITH 3 MIN TOTAL X-RAY EXPOSITION TIME.
1008, 5e9nA, 0.6139, 2.62, 0.149, 495, 101, STECCHERINUM MURASHKINSKYI LACCASE AT 0.95 RESOLUTION
1009, 3t6vB, 0.6139, 2.63, 0.149, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
1010, 5mibA, 0.6138, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 12-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 333 MIN.
1011, 5mhwA, 0.6138, 2.62, 0.149, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FIFTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 123 MIN.
1012, 6iqyA, 0.6136, 2.25, 0.090, 536, 100, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
1013, 6iqxB, 0.6136, 2.25, 0.090, 535, 100, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
1014, 6iqxA, 0.6136, 2.25, 0.090, 535, 100, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
1015, 5zd7A, 0.6136, 2.25, 0.090, 536, 100, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
1016, 2uxvA, 0.6136, 2.58, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
1017, 3t6wB, 0.6135, 2.64, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
1018, 3t6vC, 0.6135, 2.62, 0.149, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
1019, 6evgA, 0.6134, 2.61, 0.088, 444, 102, STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF A BACTERIAL LACCASE-LIKE MULTI-COPPER OXIDASE CUEO FROM LIGNIN-DEGRADING BACTERIUM OCHROBACTRUM SP. WITH OXIDASE ACTIVITY TOWARDS LIGNIN MODEL COMPOUNDS AND LIGNOSULFONATE 
1020, 3t71A, 0.6133, 2.63, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1021, 3t6wA, 0.6133, 2.63, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
1022, 3t6zC, 0.6132, 2.62, 0.149, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
1023, 3t6xA, 0.6132, 2.62, 0.149, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
1024, 3t71B, 0.6130, 2.64, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1025, 3t6xB, 0.6129, 2.65, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
1026, 3t6wC, 0.6129, 2.63, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
1027, 3t6xC, 0.6128, 2.64, 0.149, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
1028, 3kw7A, 0.6128, 2.62, 0.149, 502, 101, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
1029, 3kw7B, 0.6127, 2.63, 0.149, 502, 101, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
1030, 3t71C, 0.6125, 2.64, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1031, 3t6zB, 0.6125, 2.66, 0.149, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
1032, 1v10A, 0.6124, 2.66, 0.139, 487, 101, STRUCTURE OF RIGIDOPORUS LIGNOSUS LACCASE FROM HEMIHEDRALLY TWINNED CRYSTALS
1033, 2xllB, 0.6121, 2.29, 0.120, 533, 100, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1034, 2xllD, 0.6120, 2.29, 0.120, 533, 100, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1035, 2xllC, 0.6120, 2.29, 0.120, 533, 100, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1036, 2xllA, 0.6120, 2.29, 0.120, 533, 100, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1037, 1kyaC, 0.6118, 2.63, 0.139, 499, 101, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1038, 1kyaB, 0.6118, 2.63, 0.139, 499, 101, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1039, 1kyaA, 0.6118, 2.63, 0.139, 499, 101, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1040, 1kyaD, 0.6117, 2.63, 0.139, 499, 101, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1041, 3v9cA, 0.6114, 2.63, 0.129, 499, 101, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION
1042, 3cdzB, 0.6113, 2.07, 0.153, 631, 98, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
1043, 3pxlA, 0.6112, 2.63, 0.129, 499, 101, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA
1044, 3x1bA, 0.6111, 2.66, 0.109, 500, 101, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
1045, 2q9oB, 0.6111, 2.44, 0.152, 558, 99, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1046, 2q9oA, 0.6111, 2.44, 0.152, 558, 99, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1047, 4bdvB, 0.6110, 2.31, 0.162, 606, 99, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
1048, 3x1bB, 0.6109, 2.66, 0.109, 500, 101, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
1049, 2ih8B, 0.6109, 2.44, 0.152, 559, 99, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1050, 3fpxA, 0.6107, 2.65, 0.119, 499, 101, NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA
1051, 3divA, 0.6106, 2.64, 0.139, 497, 101, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.76A RESOLUTION
1052, 2h5uA, 0.6104, 2.64, 0.149, 497, 101, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION
1053, 2hzhA, 0.6102, 2.65, 0.139, 499, 101, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLUS ZONATUS AT 2.6 A RESOLUTION
1054, 6im7A, 0.6098, 2.28, 0.131, 461, 99, CUEO-12.1 MULTICOPPER OXIDASE 
1055, 2xybA, 0.6097, 2.65, 0.149, 497, 101, CRYSTAL STRUCTURE OF A FULLY FUNCTIONAL LACCASE FROM THE LIGNINOLYTIC FUNGUS PYCNOPORUS CINNABARINUS
1056, 5lduA, 0.6095, 2.65, 0.129, 499, 101, RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA
1057, 3dkhA, 0.6095, 2.48, 0.152, 558, 99, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1058, 3dkhB, 0.6094, 2.48, 0.152, 558, 99, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1059, 3fu9A, 0.6091, 2.47, 0.152, 559, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1060, 3fu7B, 0.6087, 2.26, 0.153, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1061, 2qt6A, 0.6087, 2.67, 0.149, 498, 101, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
1062, 1gycA, 0.6086, 2.66, 0.139, 499, 101, CRYSTAL STRUCTURE DETERMINATION AT ROOM TEMPERATURE OF A LACCASE FROM TRAMETES VERSICOLOR IN ITS OXIDISED FORM CONTAINING A FULL COMPLEMENT OF COPPER IONS
1063, 3zx1A, 0.6085, 2.54, 0.186, 471, 102, MULTICOPPER OXIDASE FROM CAMPYLOBACTER JEJUNI: A METALLO-OXIDASE
1064, 5nq9A, 0.6084, 2.67, 0.139, 497, 101, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1065, 2qt6B, 0.6083, 2.67, 0.149, 498, 101, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
1066, 1gw0A, 0.6083, 2.48, 0.141, 559, 99, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1067, 1gw0B, 0.6080, 2.47, 0.141, 559, 99, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1068, 5jrrA, 0.6078, 2.57, 0.186, 439, 102, CRYSTAL STRUCTURE OF NATIVE LACCASE FROM THERMUS THERMOPHILUS HB27
1069, 5afaA, 0.6076, 2.57, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH AG CRYSTAL OF THE HOLOENZYME SOAKED FOR 30 M IN 5 MM AGNO3 AT 278 K.
1070, 5k5kA, 0.6073, 2.58, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASSE FROM THERMUS THERMOPHILUS HB27 (ASCORBIC ACID 10 MIN)
1071, 3abgA, 0.6073, 2.39, 0.100, 508, 100, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1072, 6hbeB, 0.6072, 2.45, 0.110, 425, 100, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
1073, 5k84A, 0.6072, 2.58, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 10 MIN)
1074, 5nq9C, 0.6070, 2.70, 0.129, 497, 101, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1075, 3ta4F, 0.6069, 2.54, 0.218, 282, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1076, 5jx9A, 0.6068, 2.59, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 5 MIN)
1077, 4ysdA, 0.6068, 2.22, 0.184, 299, 98, ROOM TEMPERATURE STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
1078, 2yaoA, 0.6068, 2.58, 0.186, 437, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (50.0-62.5 PERCENT DOSE)
1079, 5nq8A, 0.6067, 2.69, 0.129, 497, 101, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II
1080, 5k7aA, 0.6067, 2.59, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FRON THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 1.5 MIN)
1081, 2yaeA, 0.6067, 2.59, 0.186, 438, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27(0.0-12.5 PERCENT DOSE)
1082, 2xu9A, 0.6067, 2.58, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27
1083, 2yarA, 0.6066, 2.59, 0.186, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (87.5-100.0 PERCENT DOSE)
1084, 2yapA, 0.6066, 2.59, 0.186, 437, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (62.5-75.0 PERCENT DOSE)
1085, 2yafA, 0.6066, 2.59, 0.186, 438, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (12.5-25.0 PERCENT DOSE)
1086, 5k15A, 0.6065, 2.59, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU2PO 8 MIN)
1087, 2yamA, 0.6065, 2.59, 0.186, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (37.5-50.0 PERCENT DOSE)
1088, 5k0dA, 0.6063, 2.59, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 3 MIN)
1089, 5g3cA, 0.6063, 2.59, 0.186, 435, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS TERMOPHILUS MULTICOPPER OXIDASE
1090, 6hbeA, 0.6062, 2.44, 0.110, 425, 100, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
1091, 5g3hA, 0.6062, 2.59, 0.186, 438, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1092, 5g3eA, 0.6062, 2.59, 0.186, 437, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1093, 5g3dA, 0.6062, 2.59, 0.186, 438, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CCASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1094, 2yaqA, 0.6062, 2.59, 0.186, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (75.0-87.5 PERCENT DOSE)
1095, 2yahA, 0.6062, 2.59, 0.186, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (25.0-37.5 PERCENT DOSE)
1096, 5k3kA, 0.6061, 2.59, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CUSO4 20 MIN)
1097, 3j2qB, 0.6061, 2.42, 0.141, 631, 99, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
1098, 6hbeC, 0.6059, 2.45, 0.110, 427, 100, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
1099, 4a2dA, 0.6057, 2.72, 0.139, 495, 101, CORIOLOPSIS GALLICA LACCASE T2 COPPER DEPLETED AT PH  4.5
1100, 4a2hA, 0.6056, 2.72, 0.149, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLOPSIS GALLICA PH 7.0
1101, 5anhA, 0.6054, 2.74, 0.158, 496, 101, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1102, 4a2fA, 0.6053, 2.73, 0.139, 495, 101, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 12.65 KEV
1103, 2hrhA, 0.6053, 2.71, 0.158, 496, 101, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII
1104, 2hrgA, 0.6052, 2.73, 0.149, 496, 101, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII COMPLEXED WITH P-METHYLBENZOATE
1105, 5anhC, 0.6051, 2.74, 0.149, 496, 101, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1106, 4jhvA, 0.6050, 2.71, 0.149, 496, 101, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA
1107, 4jhuA, 0.6049, 2.73, 0.139, 496, 101, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA SOAKED WITH CUCL
1108, 3wkqA, 0.6049, 2.25, 0.184, 299, 98, COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH FORMATE
1109, 4a2gA, 0.6048, 2.73, 0.139, 495, 101, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 8.98 KEV
1110, 4a2eA, 0.6048, 2.73, 0.139, 495, 101, CRYSTAL STRUCTURE OF A CORIOLOPSIS GALLICA LACCASE AT 1.7 A RESOLUTION PH 5.5
1111, 2xuwA, 0.6048, 2.60, 0.186, 437, 102, CRYSTAL STRUCTURE OF APOLACCASE FROM THERMUS THERMOPHILUS HB27
1112, 5nq7A, 0.6047, 2.72, 0.129, 497, 101, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM I
1113, 3j2sB, 0.6046, 2.20, 0.143, 631, 98, MEMBRANE-BOUND FACTOR VIII LIGHT CHAIN
1114, 5anhB, 0.6042, 2.73, 0.158, 496, 101, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1115, 3abgB, 0.6038, 2.40, 0.100, 518, 100, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1116, 5lhlC, 0.6029, 2.86, 0.175, 275, 103, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1117, 5o3kI, 0.6027, 2.68, 0.168, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1118, 5o4qI, 0.6026, 2.85, 0.175, 275, 103, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1119, 5o4qC, 0.6026, 2.56, 0.178, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1120, 6fc7B, 0.6023, 2.85, 0.175, 281, 103, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1121, 6rh9L, 0.6022, 2.85, 0.175, 275, 103, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1122, 3wi9A, 0.6021, 2.16, 0.186, 303, 97, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS KAUSTOPHILUS
1123, 5o4qF, 0.6020, 2.57, 0.178, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1124, 5a7eA, 0.6018, 3.00, 0.126, 495, 103, CRYSTALLOGRAPHIC STRUCTURAL DETERMINATION OF A TRIGONAL LACCASE FROM CORIOLOPSIS GALLICA (CGL) TO 1.5 A RESOLUTION
1125, 4n8uC, 0.6017, 2.84, 0.175, 275, 103, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1126, 6rh9F, 0.6014, 2.52, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1127, 6rhqC, 0.6010, 2.57, 0.178, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1128, 5o4iC, 0.6009, 2.53, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1129, 4n8uA, 0.6009, 2.86, 0.175, 275, 103, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1130, 6rh9I, 0.6008, 2.52, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1131, 6fc7K, 0.6008, 2.85, 0.175, 282, 103, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1132, 6fc7C, 0.6006, 2.52, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1133, 5mkmE, 0.6005, 2.58, 0.178, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1134, 4w1tB, 0.6005, 2.86, 0.175, 269, 103, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
1135, 5o4iI, 0.6004, 2.54, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1136, 4uahB, 0.6004, 2.86, 0.175, 271, 103, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
1137, 6s0oB, 0.6003, 2.57, 0.178, 280, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1138, 4n8uB, 0.6002, 2.84, 0.175, 276, 103, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1139, 5o4qL, 0.6001, 2.54, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1140, 6s0oF, 0.6000, 2.54, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1141, 6rh9K, 0.6000, 2.55, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1142, 6rh9H, 0.6000, 2.55, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1143, 5mkmF, 0.6000, 2.59, 0.178, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1144, 5lhlE, 0.5999, 2.55, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1145, 6fdjI, 0.5998, 2.54, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1146, 6fdjL, 0.5996, 2.56, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1147, 6fdjF, 0.5996, 2.54, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1148, 5lhlF, 0.5996, 2.59, 0.178, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1149, 5g3bA, 0.5996, 2.60, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE: THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1150, 4ai7A, 0.5996, 2.67, 0.186, 437, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 2 H IN 5 MM HGCL2 AT 278 K.
1151, 5g3fA, 0.5994, 2.60, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1152, 3tbcA, 0.5994, 2.87, 0.175, 279, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1153, 5g3gA, 0.5993, 2.60, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1154, 4nb7A, 0.5992, 2.60, 0.168, 280, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 180 MIN SOAKING
1155, 4najA, 0.5992, 2.60, 0.168, 279, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 90 MIN SOAKING
1156, 3tasA, 0.5992, 2.88, 0.175, 300, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1157, 2avfB, 0.5991, 2.51, 0.144, 316, 97, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
1158, 5o3kC, 0.5990, 2.54, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1159, 6rh9E, 0.5989, 2.56, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1160, 5o4iH, 0.5989, 2.55, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1161, 4gybA, 0.5989, 2.60, 0.168, 279, 101, TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AT 2.4 A RESOLUTION AC1709
1162, 6fdjC, 0.5988, 2.56, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1163, 5o4iF, 0.5987, 2.55, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1164, 5o3kL, 0.5987, 2.55, 0.170, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1165, 3tbbB, 0.5987, 2.84, 0.175, 278, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1166, 3tasB, 0.5987, 2.89, 0.175, 301, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1167, 2avfF, 0.5987, 2.52, 0.134, 323, 97, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
1168, 5mkmC, 0.5986, 2.55, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1169, 5k8dA, 0.5986, 2.18, 0.112, 611, 98, CRYSTAL STRUCTURE OF RFVIIIFC
1170, 1hfuA, 0.5986, 2.65, 0.140, 500, 100, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION
1171, 4gxfC, 0.5985, 2.60, 0.168, 279, 101, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1172, 2xvbA, 0.5985, 2.68, 0.186, 438, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 5 MIN. IN 5 MM HGCL2 AT 278 K.
1173, 5o3kF, 0.5984, 2.59, 0.170, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1174, 3tasC, 0.5984, 2.86, 0.175, 300, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1175, 5o4iL, 0.5983, 2.56, 0.170, 280, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1176, 6fc7F, 0.5980, 2.54, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1177, 6rh9C, 0.5978, 2.55, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1178, 4uanB, 0.5978, 2.55, 0.170, 270, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
1179, 4gxfB, 0.5975, 2.57, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1180, 4gxfA, 0.5973, 2.58, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1181, 6fdjJ, 0.5972, 2.56, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1182, 1a65A, 0.5971, 2.85, 0.129, 504, 101, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS
1183, 5ofeA, 0.5966, 2.71, 0.133, 334, 98, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
1184, 6s0oC, 0.5965, 2.57, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1185, 5mkmD, 0.5965, 2.56, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1186, 4gy4B, 0.5962, 2.59, 0.170, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1187, 3tbcC, 0.5962, 2.57, 0.170, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1188, 4gy4C, 0.5961, 2.59, 0.170, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1189, 3tbbC, 0.5959, 2.58, 0.170, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1190, 3aw5A, 0.5959, 2.68, 0.170, 438, 100, STRUCTURE OF A MULTICOPPER OXIDASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROBACULUM AEROPHILUM
1191, 3tbcB, 0.5958, 2.58, 0.170, 278, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1192, 5lwxA, 0.5957, 2.22, 0.165, 554, 97, CRYSTAL STRUCTURE OF THE H253D MUTANT OF MCOG FROM ASPERGILLUS NIGER
1193, 3tbbA, 0.5949, 2.58, 0.170, 279, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1194, 4yscC, 0.5948, 2.35, 0.146, 335, 96, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
1195, 5lm8A, 0.5944, 2.24, 0.165, 549, 97, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER
1196, 1zpuB, 0.5941, 2.59, 0.150, 529, 100, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1197, 5lwwA, 0.5934, 2.26, 0.165, 550, 97, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM ASPERGILLUS NIGER BOUND TO ZINC
1198, 1zpuF, 0.5931, 2.40, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1199, 1zpuD, 0.5931, 2.40, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1200, 1zpuC, 0.5931, 2.40, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1201, 1zpuA, 0.5930, 2.40, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1202, 1zpuE, 0.5929, 2.40, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1203, 1aozA, 0.5905, 2.48, 0.173, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
1204, 1aozB, 0.5900, 2.50, 0.173, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
1205, 1aspA, 0.5894, 2.50, 0.173, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1206, 1aspB, 0.5881, 2.61, 0.172, 552, 99, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1207, 1asoA, 0.5881, 2.67, 0.170, 552, 100, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1208, 1asoB, 0.5870, 2.70, 0.170, 552, 100, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1209, 1asqB, 0.5868, 2.71, 0.170, 552, 100, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1210, 1asqA, 0.5868, 2.70, 0.170, 552, 100, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1211, 3fu9B, 0.5860, 2.98, 0.150, 559, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1212, 6f5kA, 0.5831, 3.06, 0.140, 557, 100, CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA 
1213, 4f7kB, 0.5831, 2.68, 0.122, 373, 98, CRYSTAL STRUCTURE OF LAC15 FROM A MARINE MICROBIAL METAGENOME
1214, 4f7kA, 0.5830, 2.54, 0.124, 377, 97, CRYSTAL STRUCTURE OF LAC15 FROM A MARINE MICROBIAL METAGENOME
1215, 3fu8B, 0.5828, 2.84, 0.152, 558, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1216, 3fu7A, 0.5817, 2.79, 0.173, 558, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1217, 2ih9A, 0.5817, 2.78, 0.173, 559, 98, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1218, 2ih8A, 0.5815, 2.66, 0.155, 559, 97, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1219, 3fu8A, 0.5812, 2.79, 0.173, 558, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1220, 2ih9B, 0.5812, 2.77, 0.173, 559, 98, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1221, 3ppsD, 0.5802, 2.80, 0.153, 564, 98, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1222, 3ppsA, 0.5802, 2.72, 0.163, 564, 98, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1223, 3ppsB, 0.5799, 3.01, 0.152, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1224, 3ppsC, 0.5796, 2.89, 0.162, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1225, 3qpkB, 0.5793, 2.74, 0.165, 559, 97, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1226, 3qpkA, 0.5793, 2.75, 0.155, 559, 97, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1227, 3pnrB, 0.5781, 3.69, 0.043, 129, 115, STRUCTURE OF PBICP-C IN COMPLEX WITH FALCIPAIN-2
1228, 1ibzA, 0.5758, 1.65, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1229, 2uxtB, 0.5754, 2.25, 0.105, 420, 95, SUFI PROTEIN FROM ESCHERICHIA COLI
1230, 1ic0E, 0.5752, 1.67, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1231, 1ibzB, 0.5752, 1.95, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1232, 1ibyA, 0.5752, 1.84, 0.222, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1233, 1ic0C, 0.5749, 1.68, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1234, 1ibyB, 0.5743, 1.92, 0.222, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1235, 1ibyC, 0.5740, 1.92, 0.222, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1236, 1ic0D, 0.5736, 1.73, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1237, 1ic0B, 0.5731, 1.74, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1238, 2wo3B, 0.5721, 3.12, 0.036, 142, 110, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINA2 COMPLEX
1239, 1ibzC, 0.5720, 1.62, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1240, 5i5jB, 0.5717, 1.25, 0.141, 529, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1241, 5i5jA, 0.5714, 1.26, 0.141, 531, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1242, 3v9eA, 0.5707, 2.75, 0.165, 539, 97, STRUCTURE OF THE L499M MUTANT OF THE LACCASE FROM B.ACLADA
1243, 1ibyD, 0.5704, 1.79, 0.225, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1244, 1ic0F, 0.5703, 1.62, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1245, 4m4rF, 0.5698, 3.21, 0.036, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1246, 1ibzD, 0.5696, 1.82, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1247, 4l0pB, 0.5690, 3.24, 0.036, 139, 111, STRUCTURE OF THE HUMAN EPHA3 RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH EPHRIN-A5
1248, 1ikoP, 0.5685, 3.21, 0.055, 141, 110, CRYSTAL STRUCTURE OF THE MURINE EPHRIN-B2 ECTODOMAIN
1249, 4m4rD, 0.5677, 3.27, 0.036, 140, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1250, 4m4rB, 0.5666, 3.20, 0.045, 141, 110, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1251, 1ic0A, 0.5665, 1.75, 0.216, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1252, 3d12E, 0.5655, 3.06, 0.075, 141, 106, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1253, 2wo2B, 0.5648, 3.08, 0.046, 136, 108, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINB2 COMPLEX
1254, 2yevB, 0.5625, 2.40, 0.213, 319, 94, STRUCTURE OF CAA3-TYPE CYTOCHROME OXIDASE
1255, 2yevE, 0.5623, 2.40, 0.213, 319, 94, STRUCTURE OF CAA3-TYPE CYTOCHROME OXIDASE
1256, 6ci0D, 0.5622, 2.50, 0.117, 257, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1257, 3omnD, 0.5620, 2.50, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1258, 3om3D, 0.5618, 2.51, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1259, 3omaD, 0.5617, 2.50, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1260, 3omiD, 0.5616, 2.50, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1261, 3fyeD, 0.5616, 2.50, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1262, 2gsmD, 0.5616, 2.50, 0.117, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1263, 2gsmB, 0.5616, 2.51, 0.117, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1264, 4m4rH, 0.5615, 3.36, 0.036, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1265, 3omiB, 0.5615, 2.51, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1266, 3om3B, 0.5615, 2.51, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1267, 3fyiD, 0.5613, 2.51, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1268, 3ehbB, 0.5612, 2.47, 0.149, 252, 94, A D-PATHWAY MUTATION DECOUPLES THE PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE BY ALTERING THE SIDE CHAIN ORIENTATION OF A DISTANT CONSERVED GLUTAMATE
1269, 3omaB, 0.5611, 2.52, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1270, 3dtuD, 0.5611, 2.51, 0.117, 258, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1271, 6ci0B, 0.5610, 2.51, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1272, 3omnB, 0.5608, 2.52, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1273, 3fyeB, 0.5608, 2.52, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1274, 3fyiB, 0.5606, 2.52, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1275, 3hb3B, 0.5604, 2.50, 0.149, 252, 94, HIGH RESOLUTION CRYSTAL STRUCTURE OF PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE
1276, 1ar1B, 0.5603, 2.50, 0.149, 252, 94, STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1277, 1m56B, 0.5601, 2.52, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1278, 3dtuB, 0.5599, 2.53, 0.117, 259, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1279, 6adqE, 0.5598, 2.57, 0.137, 312, 95, RESPIRATORY COMPLEX CIII2CIV2SOD2 FROM MYCOBACTERIUM SMEGMATIS 
1280, 6adqQ, 0.5597, 2.57, 0.137, 312, 95, RESPIRATORY COMPLEX CIII2CIV2SOD2 FROM MYCOBACTERIUM SMEGMATIS 
1281, 1qleB, 0.5597, 2.48, 0.149, 252, 94, CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1282, 1m56H, 0.5593, 2.53, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1283, 5wehB, 0.5589, 2.35, 0.108, 254, 93, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1284, 1m57H, 0.5587, 2.56, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1285, 1m57B, 0.5585, 2.55, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1286, 6hwhL, 0.5573, 2.59, 0.137, 281, 95, STRUCTURE OF A FUNCTIONAL OBLIGATE RESPIRATORY SUPERCOMPLEX FROM MYCOBACTERIUM SMEGMATIS 
1287, 5wehH, 0.5570, 2.37, 0.108, 253, 93, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1288, 6hwhP, 0.5564, 2.61, 0.137, 281, 95, STRUCTURE OF A FUNCTIONAL OBLIGATE RESPIRATORY SUPERCOMPLEX FROM MYCOBACTERIUM SMEGMATIS 
1289, 4f2fA, 0.5562, 1.78, 0.149, 100, 87, CRYSTAL STRUCTURE OF THE METAL BINDING DOMAIN (MBD) OF THE STREPTOCOCCUS PNEUMONIAE D39 CU(I) EXPORTING P-TYPE ATPASE COPA WITH CU(I)
1290, 3mx0D, 0.5562, 3.39, 0.027, 138, 110, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1291, 1shwA, 0.5562, 3.41, 0.036, 138, 110, EPHB2 / EPHRINA5 COMPLEX STRUCTURE
1292, 6hu9b, 0.5560, 2.57, 0.138, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1293, 2x11B, 0.5554, 3.42, 0.036, 138, 110, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN A5 RECEPTOR BINDING DOMAIN
1294, 4bkfD, 0.5547, 3.25, 0.103, 141, 107, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1295, 4bkfC, 0.5547, 3.25, 0.103, 141, 107, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1296, 3d12B, 0.5547, 3.25, 0.103, 141, 107, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1297, 6hu9n, 0.5546, 2.57, 0.138, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1298, 2vsmB, 0.5543, 3.37, 0.082, 137, 110, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1299, 4w9zA, 0.5542, 2.57, 0.128, 138, 94, CRYSTAL STRUCTURE OF THE PERIPLASMIC DOMAIN OF SUBUNIT II OF CYTOCHROME OXIDASE (COXB) OF BRADYRHIZOBIUM JAPONICUM
1300, 3mx0B, 0.5539, 3.38, 0.036, 138, 110, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1301, 4uf7C, 0.5534, 3.25, 0.064, 138, 109, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1302, 4uf7E, 0.5533, 3.26, 0.055, 139, 109, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1303, 5z62B, 0.5515, 2.57, 0.128, 227, 94, STRUCTURE OF HUMAN CYTOCHROME C OXIDASE 
1304, 1kgyE, 0.5511, 3.08, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1305, 5x1bO, 0.5510, 2.59, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1306, 3abkO, 0.5506, 2.58, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1307, 5b1bO, 0.5505, 2.58, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1308, 5sydB, 0.5503, 2.17, 0.182, 131, 88, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1309, 6j8mO, 0.5502, 2.60, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1310, 3ag4O, 0.5502, 2.59, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1311, 5b3sO, 0.5501, 2.61, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1312, 5zcqO, 0.5499, 2.61, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1313, 5b1aO, 0.5499, 2.61, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1314, 3ag2O, 0.5499, 2.60, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1315, 5z86O, 0.5498, 2.61, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1316, 3ag3O, 0.5498, 2.59, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1317, 5zcoO, 0.5496, 2.61, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1318, 3abmO, 0.5496, 2.60, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1319, 2y69O, 0.5495, 2.61, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1320, 5xdqO, 0.5494, 2.61, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1321, 5x1fO, 0.5494, 2.60, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1322, 3wg7O, 0.5494, 2.61, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1323, 5z84O, 0.5493, 2.62, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1324, 1shxA, 0.5493, 3.75, 0.035, 138, 113, EPHRIN A5 LIGAND STRUCTURE
1325, 5z85O, 0.5492, 2.62, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1326, 3asoO, 0.5492, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1327, 3ag3B, 0.5492, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1328, 5zcpO, 0.5491, 2.62, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1329, 5sydA, 0.5491, 2.17, 0.170, 130, 88, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1330, 5x19O, 0.5490, 2.61, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1331, 3x2qO, 0.5490, 2.62, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1332, 3abkB, 0.5490, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1333, 1v55O, 0.5490, 2.61, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1334, 1v54O, 0.5490, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1335, 3asnO, 0.5489, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1336, 2eikO, 0.5489, 2.61, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1337, 6nmfO, 0.5488, 2.64, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1338, 3gxuB, 0.5488, 3.27, 0.056, 138, 108, CRYSTAL STRUCTURE OF EPH RECEPTOR AND EPHRIN COMPLEX
1339, 3ag1O, 0.5488, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1340, 2zxwO, 0.5488, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1341, 2eikB, 0.5488, 2.62, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1342, 1v54B, 0.5488, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1343, 6j8mB, 0.5487, 2.65, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1344, 5waub, 0.5487, 2.61, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1345, 5iy5O, 0.5487, 2.62, 0.117, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1346, 5z86B, 0.5486, 2.65, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1347, 5wauB, 0.5486, 2.63, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1348, 2dyrO, 0.5486, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1349, 1v55B, 0.5486, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1350, 5xdxO, 0.5485, 2.60, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1351, 5w97b, 0.5485, 2.62, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1352, 3wg7B, 0.5485, 2.65, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1353, 3ag1B, 0.5485, 2.64, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1354, 2eijO, 0.5485, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1355, 5b3sB, 0.5484, 2.65, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1356, 3ag4B, 0.5484, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1357, 3ablO, 0.5484, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1358, 2dyrB, 0.5484, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1359, 1ocrO, 0.5484, 2.63, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1360, 5zcpB, 0.5483, 2.65, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1361, 5z85B, 0.5483, 2.65, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1362, 3heiL, 0.5483, 3.25, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1363, 2eijB, 0.5483, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1364, 5z84B, 0.5482, 2.65, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1365, 5iy5B, 0.5482, 2.65, 0.117, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1366, 2eimO, 0.5482, 2.62, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1367, 2eimB, 0.5482, 2.62, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1368, 2eilO, 0.5482, 2.63, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1369, 2dysO, 0.5482, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1370, 1shxB, 0.5482, 3.82, 0.035, 138, 113, EPHRIN A5 LIGAND STRUCTURE
1371, 6nmpO, 0.5481, 2.63, 0.117, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1372, 5zcqB, 0.5481, 2.65, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1373, 5zcoB, 0.5481, 2.66, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1374, 3ag2B, 0.5481, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1375, 2y69B, 0.5481, 2.66, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1376, 2einB, 0.5481, 2.64, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1377, 2eilB, 0.5481, 2.64, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1378, 1kgyF, 0.5481, 3.24, 0.056, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1379, 6nknO, 0.5480, 2.64, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1380, 5x1fB, 0.5480, 2.63, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1381, 5x1bB, 0.5480, 2.63, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1382, 3x2qB, 0.5480, 2.65, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1383, 3abmB, 0.5480, 2.66, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1384, 2dysB, 0.5480, 2.63, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1385, 1ocrB, 0.5480, 2.64, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1386, 1kgyH, 0.5480, 3.14, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1387, 6nmfB, 0.5478, 2.65, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1388, 5xdqB, 0.5478, 2.66, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1389, 5xtiWD, 0.5477, 2.66, 0.117, 227, 94, struct.pdbx_descriptor              
1390, 5xtiUA, 0.5477, 2.66, 0.117, 227, 94, struct.pdbx_descriptor              
1391, 5xthUA, 0.5477, 2.66, 0.117, 227, 94, struct.pdbx_descriptor              
1392, 5lufy, 0.5477, 2.66, 0.117, 227, 94, CRYO-EM OF BOVINE RESPIRASOME
1393, 5gupVB, 0.5477, 2.66, 0.117, 227, 94, 
1394, 5gpnIB, 0.5477, 2.66, 0.117, 227, 94, 
1395, 2ybbM, 0.5477, 2.66, 0.117, 227, 94, FITTED MODEL FOR BOVINE  MITOCHONDRIAL SUPERCOMPLEX I1III2IV1 BY SINGLE PARTICLE CRYO-EM (EMD-1876)
1396, 2einO, 0.5477, 2.64, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1397, 1occO, 0.5477, 2.66, 0.117, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1398, 1occB, 0.5477, 2.66, 0.117, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1399, 5b1bB, 0.5476, 2.64, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1400, 5b1aB, 0.5476, 2.66, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1401, 2occO, 0.5476, 2.65, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1402, 3asoB, 0.5475, 2.65, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1403, 2zxwB, 0.5475, 2.65, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1404, 5x19B, 0.5474, 2.64, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1405, 5xdxB, 0.5473, 2.64, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1406, 3asnB, 0.5473, 2.66, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1407, 2occB, 0.5473, 2.66, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1408, 3heiN, 0.5472, 3.27, 0.056, 132, 107, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1409, 3heiJ, 0.5471, 3.40, 0.056, 132, 108, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1410, 3ablB, 0.5471, 2.67, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1411, 1oczO, 0.5469, 2.66, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1412, 1kgyG, 0.5469, 3.16, 0.075, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1413, 6nknB, 0.5468, 2.67, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1414, 1oczB, 0.5468, 2.67, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1415, 5w97B, 0.5467, 2.66, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1416, 1ocoO, 0.5466, 2.66, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1417, 1ocoB, 0.5465, 2.66, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1418, 4bkaC, 0.5463, 3.49, 0.036, 136, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5
1419, 6nmpB, 0.5462, 2.68, 0.117, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1420, 3heiP, 0.5461, 3.42, 0.056, 132, 108, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1421, 3czuB, 0.5460, 3.29, 0.066, 130, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2- EPHRIN A1 COMPLEX
1422, 4bk5C, 0.5458, 3.50, 0.036, 136, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)
1423, 3heiH, 0.5454, 3.29, 0.056, 132, 107, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1424, 2hleB, 0.5449, 3.12, 0.067, 133, 104, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE EPHB4-EPHRINB2 PROTEIN PROTEIN INTERACTION AND RECEPTOR SPECIFICITY.
1425, 2vskD, 0.5435, 3.01, 0.058, 131, 104, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1426, 4txvD, 0.5434, 2.57, 0.129, 133, 93, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1427, 4txvB, 0.5430, 2.77, 0.117, 142, 94, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1428, 3heiD, 0.5427, 3.32, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1429, 4f2eA, 0.5426, 1.90, 0.163, 98, 86, CRYSTAL STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE D39 COPPER CHAPERONE CUPA WITH CU(I)
1430, 2vskB, 0.5426, 3.01, 0.038, 131, 104, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1431, 3heiB, 0.5424, 3.37, 0.074, 132, 108, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1432, 2mryA, 0.5395, 1.98, 0.163, 98, 86, NMR SOLUTION STRUCTURE OF COPPER BINDING PROTEIN IN THE APO FORM
1433, 6giqb, 0.5394, 2.70, 0.149, 235, 94, SACCHAROMYCES CEREVISIAE RESPIRATORY SUPERCOMPLEX III2IV 
1434, 3heiF, 0.5330, 3.49, 0.074, 132, 108, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1435, 3mbwB, 0.5325, 3.34, 0.067, 127, 105, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 LBD AND CRD DOMAINS IN COMPLEX WITH EPHRIN A1
1436, 1ayrA, 0.5309, 3.68, 0.029, 368, 105, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1437, 1ayrC, 0.5303, 3.68, 0.029, 368, 105, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1438, 5yu5A, 0.5302, 3.78, 0.046, 444, 109, CRYSTAL STRUCTURE OF SHAFT PILIN SPAD FROM LACTOBACILLUS RHAMNOSUS GG 
1439, 3p2dB, 0.5282, 3.69, 0.048, 352, 104, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1440, 3ugxA, 0.5263, 3.79, 0.029, 369, 105, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1441, 3f83A, 0.5261, 4.03, 0.096, 508, 115, STRUCTURE OF FUSION COMPLEX OF THE MINOR PILIN CFAE AND MAJOR PILIN CFAB OF CFA/I PILI FROM ETEC E. COLI
1442, 3p2dA, 0.5255, 3.65, 0.038, 354, 104, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1443, 1g4rA, 0.5247, 3.63, 0.058, 353, 104, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1444, 1zshA, 0.5244, 3.62, 0.058, 354, 104, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE (IP6)
1445, 4jqiA, 0.5241, 3.95, 0.066, 353, 106, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
1446, 1jsyA, 0.5237, 3.62, 0.058, 358, 104, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
1447, 4mbrA, 0.5229, 3.95, 0.072, 316, 111, 3.65 ANGSTROM CRYSTAL STRUCTURE OF SERINE-RICH REPEAT PROTEIN (SRR2) FROM STREPTOCOCCUS AGALACTIAE
1448, 1ylbB, 0.5210, 2.53, 0.135, 99, 89, NMR SOLUTION STRUCTURE OF THE REDUCED SPINACH PLASTOCYANIN
1449, 7pcyA, 0.5208, 2.68, 0.165, 98, 91, THE CRYSTAL STRUCTURE OF PLASTOCYANIN FROM A GREEN ALGA ENTEROMORPHA PROLIFERA
1450, 5j7yZB, 0.5205, 2.80, 0.118, 227, 93, 
1451, 5j4zZB, 0.5205, 2.80, 0.118, 227, 93, 
1452, 2wtrB, 0.5204, 3.57, 0.050, 367, 101, FULL LENGTH ARRESTIN2
1453, 6c6qF, 0.5203, 3.81, 0.064, 113, 109, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR 
1454, 4ydjH, 0.5202, 4.15, 0.070, 238, 114, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1455, 1rmfH, 0.5202, 3.88, 0.089, 216, 112, STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
1456, 1cf1D, 0.5202, 3.75, 0.029, 368, 104, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1457, 5yxoA, 0.5197, 3.91, 0.046, 415, 108, CRYSTAL STRUCTURE OF SHAFT PILIN SPAD FROM LACTOBACILLUS RHAMNOSUS GG IN BENT CONFORMATION 
1458, 3iyoD, 0.5197, 4.14, 0.045, 461, 110, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1459, 1g4mA, 0.5194, 3.79, 0.057, 356, 105, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1460, 3iyoB, 0.5191, 3.87, 0.056, 468, 107, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1461, 3iyoA, 0.5191, 3.87, 0.056, 468, 107, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1462, 1jxgB, 0.5190, 2.67, 0.132, 100, 91, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1463, 5fc9B, 0.5189, 2.10, 0.184, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1464, 4n5eC, 0.5189, 3.82, 0.110, 199, 109, 42F3 TCR PCPA12/H-2LD COMPLEX
1465, 6e47G, 0.5187, 3.76, 0.065, 112, 108, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND GLYCOCHENODEOXYCHOLIC ACID 
1466, 1kiuO, 0.5187, 2.90, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1467, 1kiuM, 0.5187, 2.91, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1468, 1kiuK, 0.5187, 2.90, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1469, 1kiuI, 0.5187, 2.90, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1470, 1g4mB, 0.5186, 3.69, 0.049, 357, 103, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1471, 5fc9A, 0.5183, 2.12, 0.184, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1472, 1jerA, 0.5183, 3.10, 0.146, 110, 96, CUCUMBER STELLACYANIN CU2+ PH 7.0
1473, 3vacB, 0.5181, 4.30, 0.077, 356, 117, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1474, 3ugxC, 0.5181, 3.66, 0.029, 358, 102, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1475, 2pltA, 0.5181, 2.66, 0.143, 98, 91, STRUCTURE DETERMINATION OF PLASTOCYANIN FROM A CRYSTAL SPECIMEN WITH HEMIHEDRAL TWINNING FRACTION OF ONE-HALF
1476, 2wtrA, 0.5177, 3.67, 0.058, 356, 104, FULL LENGTH ARRESTIN2
1477, 3m4eD, 0.5174, 4.17, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1478, 3gd1C, 0.5173, 3.62, 0.059, 345, 102, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
1479, 3m4eA, 0.5172, 4.08, 0.054, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1480, 3vacA, 0.5171, 4.24, 0.085, 356, 117, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1481, 7ahlF, 0.5170, 4.06, 0.072, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1482, 3m4eC, 0.5170, 4.14, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1483, 3m4eB, 0.5170, 4.17, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1484, 4ydjA, 0.5169, 4.19, 0.070, 238, 115, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1485, 3m3rA, 0.5169, 4.07, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1486, 3m4dE, 0.5168, 4.10, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1487, 5fc9D, 0.5167, 2.18, 0.184, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1488, 3m2lE, 0.5167, 4.20, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1489, 3m4eF, 0.5166, 4.17, 0.054, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1490, 3m4eE, 0.5166, 4.17, 0.054, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1491, 3m3rG, 0.5166, 4.28, 0.062, 293, 113, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1492, 2j7lA, 0.5166, 3.30, 0.143, 210, 98, E.COLI P PILUS CHAPERONE PAPD IN COMPLEX WITH A PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1493, 2ckbA, 0.5166, 3.91, 0.100, 202, 110, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1494, 5fc9C, 0.5164, 2.13, 0.184, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1495, 3m3rE, 0.5164, 4.20, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1496, 1ws7A, 0.5164, 3.08, 0.135, 107, 96, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1497, 3m4dF, 0.5163, 4.17, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1498, 3m3rB, 0.5163, 4.20, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1499, 1ayrD, 0.5163, 3.68, 0.029, 363, 102, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1500, 3m4dD, 0.5162, 4.05, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1501, 1lcsA, 0.5162, 4.96, 0.057, 205, 123, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
1502, 1ayrB, 0.5162, 3.68, 0.029, 363, 102, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1503, 3m4eG, 0.5161, 4.17, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1504, 3m2lA, 0.5161, 4.07, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1505, 6e48F, 0.5160, 3.89, 0.064, 113, 110, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
1506, 6c74A, 0.5160, 3.68, 0.057, 111, 106, CRYSTAL STRUCTURE OF MURINE CD300LF IN COMPLEX WITH PHOSPHOCHOLINE 
1507, 4n0cG, 0.5160, 3.96, 0.100, 197, 110, 42F3 TCR PCPE3/H-2LD COMPLEX
1508, 4dp8X, 0.5160, 2.60, 0.135, 99, 89, THE 1.07 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 4.0
1509, 3m4dC, 0.5160, 4.16, 0.054, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1510, 3m4dB, 0.5160, 4.07, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1511, 3m2lD, 0.5159, 4.18, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1512, 3m3rC, 0.5158, 4.16, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1513, 1kdjA, 0.5158, 2.71, 0.169, 102, 89, OXIDIZED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
1514, 1iuzA, 0.5158, 2.71, 0.143, 98, 91, PLASTOCYANIN
1515, 4dp1X, 0.5157, 2.67, 0.133, 99, 90, THE 1.35 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 4.0
1516, 3m4dG, 0.5157, 4.19, 0.054, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1517, 1kdiA, 0.5157, 2.68, 0.169, 102, 89, REDUCED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
1518, 3m3rD, 0.5156, 4.20, 0.062, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1519, 4yhdG, 0.5155, 4.16, 0.054, 281, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1520, 3q48A, 0.5155, 3.08, 0.125, 194, 96, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA CUPB2 CHAPERONE
1521, 4pcyA, 0.5154, 2.60, 0.135, 99, 89, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1522, 4dp4X, 0.5154, 2.49, 0.157, 99, 89, THE 1.54 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 6.0
1523, 4p24A, 0.5153, 4.08, 0.072, 292, 111, PORE FORMING TOXIN
1524, 4dp0X, 0.5153, 2.69, 0.133, 99, 90, THE 1.5 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 4.0
1525, 3uguA, 0.5153, 3.78, 0.039, 345, 103, CRYSTAL STRUCTURE OF P44 (SPLICE VARIANT OF VISUAL ARRESTIN)
1526, 3m2lG, 0.5153, 4.07, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1527, 7ahlA, 0.5152, 4.07, 0.063, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1528, 3m4dA, 0.5152, 4.07, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1529, 2hb0A, 0.5152, 4.36, 0.026, 356, 117, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1530, 2ckbC, 0.5151, 3.88, 0.109, 202, 110, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1531, 7ahlE, 0.5150, 4.12, 0.063, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1532, 4dp2X, 0.5150, 2.68, 0.133, 99, 90, THE 1.8 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 6.0
1533, 5x31A, 0.5149, 2.72, 0.114, 125, 88, PSEUDOAZURIN FROM ALCALIGENES FAECALIS (SPACE GROUP P65)
1534, 5tv1A, 0.5149, 3.50, 0.050, 337, 101, ACTIVE ARRESTIN-3 WITH INOSITOL HEXAKISPHOSPHATE
1535, 1ws7D, 0.5149, 3.01, 0.137, 105, 95, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1536, 4dp6X, 0.5148, 2.50, 0.157, 99, 89, THE 1.67 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 8.0
1537, 4p24D, 0.5147, 4.19, 0.071, 292, 112, PORE FORMING TOXIN
1538, 7ahlD, 0.5146, 4.08, 0.063, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1539, 4p24F, 0.5146, 4.07, 0.072, 290, 111, PORE FORMING TOXIN
1540, 4ei5C, 0.5146, 3.92, 0.093, 201, 108, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1541, 4dpaX, 0.5146, 2.62, 0.135, 99, 89, THE 1.05 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 6.0
1542, 4dp5X, 0.5146, 2.50, 0.157, 99, 89, THE 1.88 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 8.0
1543, 3m2lF, 0.5146, 4.09, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1544, 2hb0B, 0.5146, 4.18, 0.095, 355, 116, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1545, 1t4wA, 0.5146, 3.63, 0.067, 196, 105, STRUCTURAL DIFFERENCES IN THE DNA BINDING DOMAINS OF HUMAN P53 AND ITS C. ELEGANS ORTHOLOG CEP-1: STRUCTURE OF C. ELEGANS CEP-1
1546, 7ahlB, 0.5145, 4.19, 0.054, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1547, 4mxqC, 0.5144, 3.87, 0.100, 199, 110, 42F3 TCR PCPC5/H-2LD COMPLEX
1548, 4p24E, 0.5143, 4.06, 0.072, 291, 111, PORE FORMING TOXIN
1549, 4elkA, 0.5143, 3.75, 0.094, 199, 106, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1550, 7ahlG, 0.5141, 4.19, 0.062, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1551, 6e48G, 0.5141, 3.84, 0.065, 111, 108, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
1552, 4dpbX, 0.5141, 2.63, 0.135, 99, 89, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 8.0
1553, 3m3rF, 0.5141, 4.08, 0.054, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1554, 1plcA, 0.5141, 2.62, 0.135, 99, 89, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN AT 1.33 ANGSTROMS RESOLUTION
1555, 7ahlC, 0.5140, 4.12, 0.063, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1556, 1ws8A, 0.5140, 2.91, 0.138, 104, 94, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1557, 1cf1C, 0.5140, 3.72, 0.029, 380, 103, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1558, 1cf1A, 0.5140, 3.72, 0.029, 373, 103, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1559, 4nhuA, 0.5139, 3.79, 0.102, 197, 108, THE M33 TCR P3M33L/H-2 LD COMPLEX
1560, 4ei5G, 0.5138, 3.92, 0.093, 172, 108, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1561, 4dpcX, 0.5138, 2.63, 0.135, 99, 89, THE 1.06 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 8.0
1562, 4dp9X, 0.5138, 2.63, 0.135, 99, 89, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 6.0
1563, 3njhD, 0.5137, 3.44, 0.122, 122, 98, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1564, 5fflA, 0.5135, 3.95, 0.073, 113, 110, CRYSTAL STRUCTURE OF MOUSE CD300LF AT 1.6 ANGSTROMS RESOLUTION.
1565, 4zrgA, 0.5135, 3.68, 0.029, 343, 102, VISUAL ARRESTIN MUTANT - R175E
1566, 2pcyA, 0.5135, 2.63, 0.135, 99, 89, THE CRYSTAL STRUCTURE OF POPLAR APOPLASTOCYANIN AT 1.8- ANGSTROMS RESOLUTION. THE GEOMETRY OF THE COPPER-BINDING SITE IS CREATED BY THE POLYPEPTIDE
1567, 1ypzH, 0.5135, 4.09, 0.064, 230, 110, IMMUNE RECEPTOR
1568, 1pndA, 0.5135, 2.63, 0.135, 99, 89, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
1569, 4p24G, 0.5133, 4.21, 0.062, 292, 112, PORE FORMING TOXIN
1570, 3ugxD, 0.5133, 3.69, 0.029, 348, 102, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1571, 3anzG, 0.5133, 4.09, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1572, 1mwaA, 0.5133, 3.92, 0.100, 202, 110, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1573, 6cqrI, 0.5132, 3.77, 0.093, 201, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1574, 5u5oA, 0.5132, 3.69, 0.079, 287, 101, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P1) 
1575, 4mvbC, 0.5132, 3.84, 0.101, 199, 109, 42F3 PCPB7/H-2LD COMPLEX
1576, 3sjvS, 0.5132, 3.84, 0.112, 197, 107, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1577, 1pncA, 0.5132, 2.64, 0.135, 99, 89, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
1578, 5yu5B, 0.5131, 3.73, 0.065, 448, 107, CRYSTAL STRUCTURE OF SHAFT PILIN SPAD FROM LACTOBACILLUS RHAMNOSUS GG 
1579, 5x31B, 0.5131, 2.54, 0.115, 125, 87, PSEUDOAZURIN FROM ALCALIGENES FAECALIS (SPACE GROUP P65)
1580, 4elkC, 0.5131, 3.92, 0.093, 203, 108, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1581, 3anzY, 0.5131, 4.09, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1582, 2pcfA, 0.5131, 2.53, 0.135, 99, 89, THE COMPLEX OF CYTOCHROME F AND PLASTOCYANIN DETERMINED WITH PARAMAGNETIC NMR. BASED ON THE STRUCTURES OF CYTOCHROME F AND PLASTOCYANIN 10 STRUCTURES
1583, 1jxgA, 0.5131, 2.78, 0.132, 100, 91, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1584, 1ag6A, 0.5131, 2.68, 0.122, 99, 90, PLASTOCYANIN FROM SPINACH
1585, 4yhdE, 0.5129, 4.19, 0.062, 268, 112, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1586, 3anzK, 0.5129, 4.08, 0.072, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1587, 1sujA, 0.5129, 3.66, 0.029, 363, 102, X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN
1588, 1cf1B, 0.5128, 3.58, 0.030, 360, 101, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1589, 3anzX, 0.5126, 4.14, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1590, 1ypzF, 0.5126, 4.08, 0.064, 230, 110, IMMUNE RECEPTOR
1591, 3anzO, 0.5125, 4.11, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1592, 4yhdD, 0.5124, 4.18, 0.054, 282, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1593, 4nhuC, 0.5124, 3.81, 0.111, 199, 108, THE M33 TCR P3M33L/H-2 LD COMPLEX
1594, 3anzW, 0.5123, 4.09, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1595, 3anzF, 0.5123, 4.10, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1596, 3anzD, 0.5123, 4.09, 0.072, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1597, 6cqqI, 0.5122, 3.78, 0.093, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1598, 4ms8C, 0.5122, 3.83, 0.101, 196, 109, 42F3 TCR PCPB9/H-2LD COMPLEX
1599, 3anzZ, 0.5122, 4.10, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1600, 3anzN, 0.5122, 4.09, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1601, 4ei6C, 0.5121, 3.82, 0.093, 189, 107, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
1602, 1oowA, 0.5121, 2.66, 0.122, 99, 90, THE CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN DOUBLE MUTANT G8D/L12E GIVES INSIGHT INTO ITS LOW REACTIVITY TOWARDS PHOTOSYSTEM 1 AND CYTOCHROME F
1603, 6cqqD, 0.5120, 3.77, 0.093, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1604, 3anzL, 0.5120, 4.11, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1605, 5e8eB, 0.5119, 3.81, 0.055, 228, 110, CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB
1606, 3anzQ, 0.5119, 4.10, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1607, 3anzM, 0.5119, 4.11, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1608, 3anzJ, 0.5119, 4.10, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1609, 3anzI, 0.5119, 4.10, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1610, 3anzB, 0.5119, 4.09, 0.072, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1611, 3vxqA, 0.5118, 3.91, 0.101, 204, 109, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1612, 3d34A, 0.5118, 3.52, 0.080, 211, 100, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1613, 3anza, 0.5118, 4.10, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1614, 3anzS, 0.5118, 4.10, 0.072, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1615, 2bzcA, 0.5118, 2.73, 0.157, 102, 89, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
1616, 1bypA, 0.5118, 2.70, 0.133, 99, 90, E43KD44K DOUBLE MUTANT PLASTOCYANIN FROM SILENE
1617, 6d49B, 0.5117, 4.06, 0.064, 126, 109, CELL SURFACE RECEPTOR IN COMPLEX WITH LIGAND AT 1.80-A RESOLUTION 
1618, 5yxgB, 0.5117, 3.62, 0.067, 306, 104, CRYSTAL STRUCTURE OF C-TERMINAL FRAGMENT OF SPAD FROM LACTOBACILLUS RHAMNOSUS GG GENERATED BY LIMITED PROTEOLYSIS 
1619, 4j2qB, 0.5117, 4.19, 0.047, 346, 106, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1620, 3anzT, 0.5117, 4.09, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1621, 3anzC, 0.5117, 4.10, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1622, 1gafH, 0.5117, 4.01, 0.089, 217, 112, 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1623, 4yhdA, 0.5116, 4.22, 0.062, 281, 112, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1624, 3anzP, 0.5116, 4.12, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1625, 3anzH, 0.5116, 4.23, 0.062, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1626, 3anzE, 0.5116, 4.09, 0.072, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1627, 6avfA, 0.5115, 3.80, 0.142, 202, 106, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1628, 3anzV, 0.5115, 4.08, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1629, 1g6rA, 0.5115, 3.89, 0.110, 202, 109, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1630, 3ugxB, 0.5114, 3.72, 0.029, 352, 102, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1631, 1lcsB, 0.5114, 4.96, 0.065, 205, 123, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
1632, 6cqrD, 0.5113, 3.87, 0.083, 200, 108, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1633, 2bz7A, 0.5113, 2.79, 0.167, 102, 90, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
1634, 1ws8D, 0.5113, 2.91, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1635, 6dzrL, 0.5112, 3.95, 0.102, 218, 108, CRYSTAL STRUCTURE OF H38C2 K99R MUTATION 
1636, 2zzqA, 0.5112, 4.04, 0.056, 483, 108, CRYSTAL STRUCTURE ANALYSIS OF THE HEV CAPSID PROTEIN PORF2
1637, 3anzR, 0.5111, 4.11, 0.054, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1638, 5or7C, 0.5110, 3.91, 0.073, 111, 109, ATOMIC STRUCTURE OF THE MURINE NOROVIRUS PROTRUDING DOMAIN AND SCD300LF RECEPTOR COMPLEX
1639, 3hagA, 0.5110, 3.96, 0.056, 468, 107, CRYSTAL STRUCTURE OF THE HEPATITIS E VIRUS-LIKE PARTICLE
1640, 6b5tH, 0.5108, 3.95, 0.064, 211, 110, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
1641, 6b5sH, 0.5108, 3.94, 0.064, 215, 110, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
1642, 3sjvI, 0.5108, 3.89, 0.103, 197, 107, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1643, 2bpa1, 0.5108, 4.51, 0.062, 426, 113, ATOMIC STRUCTURE OF SINGLE-STRANDED DNA BACTERIOPHAGE PHIX174 AND ITS FUNCTIONAL IMPLICATIONS
1644, 1kvpA, 0.5108, 4.51, 0.062, 497, 113, STRUCTURAL ANALYSIS OF THE SPIROPLASMA VIRUS SPV4 IMPLICATIONS FOR EVOLUTIONARY VARIATION TO OBTAIN HOST DIVERSITY AMONG THE MICROVIRIDAE ELECTRON MICROSCOPY ALPHA CARBONS ONLY
1645, 5w0pA, 0.5107, 3.79, 0.029, 847, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1646, 4grlD, 0.5107, 3.88, 0.147, 257, 109, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
1647, 1byoA, 0.5107, 2.69, 0.133, 99, 90, WILD-TYPE PLASTOCYANIN FROM SILENE
1648, 5whzH, 0.5106, 3.95, 0.044, 341, 113, PGDM1400-10E8V4 CODV FAB
1649, 5w0pC, 0.5106, 3.77, 0.029, 849, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1650, 5d2nC, 0.5106, 3.82, 0.123, 198, 106, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
1651, 5z0zA, 0.5105, 3.91, 0.074, 445, 108, CRYSTAL STRUCTURE OF SHAFT PILIN SPAD FROM LACTOBACILLUS RHAMNOSUS GG - D242A MUTANT 
1652, 5u6fA, 0.5104, 3.61, 0.079, 288, 101, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P21) 
1653, 2qadD, 0.5104, 3.98, 0.080, 229, 112, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1654, 1zglT, 0.5104, 3.87, 0.083, 226, 109, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1655, 1zglP, 0.5104, 3.89, 0.083, 242, 109, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1656, 4n0cC, 0.5103, 3.96, 0.100, 195, 110, 42F3 TCR PCPE3/H-2LD COMPLEX
1657, 3d34B, 0.5103, 3.53, 0.080, 215, 100, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1658, 2qadH, 0.5103, 3.98, 0.080, 229, 112, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1659, 6mi2A, 0.5101, 4.16, 0.071, 209, 112, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1660, 2zpkI, 0.5101, 3.96, 0.082, 207, 110, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
1661, 6d48H, 0.5100, 4.05, 0.074, 124, 108, CELL SURFACE RECEPTOR 
1662, 3vxqD, 0.5100, 3.91, 0.101, 204, 109, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1663, 1byoB, 0.5100, 2.65, 0.135, 99, 89, WILD-TYPE PLASTOCYANIN FROM SILENE
1664, 4mayD, 0.5099, 3.90, 0.147, 255, 109, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
1665, 2b3iA, 0.5099, 2.97, 0.152, 97, 92, NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE PROCHLOROTHRIX HOLLANDICA (19 STRUCTURES)
1666, 1xedA, 0.5099, 3.42, 0.089, 111, 101, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
1667, 1a4kB, 0.5099, 4.09, 0.080, 219, 112, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1668, 6d49A, 0.5098, 4.07, 0.064, 126, 109, CELL SURFACE RECEPTOR IN COMPLEX WITH LIGAND AT 1.80-A RESOLUTION 
1669, 5ihbB, 0.5098, 4.21, 0.073, 214, 110, STRUCTURE OF THE IMMUNE RECEPTOR CD33
1670, 5brzD, 0.5098, 4.00, 0.101, 197, 109, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
1671, 4yhdB, 0.5098, 4.12, 0.063, 283, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1672, 4oiiI, 0.5098, 4.12, 0.088, 217, 113, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1673, 4oiiH, 0.5098, 4.12, 0.088, 217, 113, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1674, 5w0pB, 0.5097, 3.79, 0.029, 802, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1675, 3tpuM, 0.5097, 3.91, 0.100, 204, 110, 42F3 P5E8/H2-LD COMPLEX
1676, 3tpuA, 0.5097, 3.85, 0.100, 205, 110, 42F3 P5E8/H2-LD COMPLEX
1677, 1rb8F, 0.5097, 4.48, 0.044, 422, 113, THE PHIX174 DNA BINDING PROTEIN J IN TWO DIFFERENT CAPSID ENVIRONMENTS.
1678, 1hxmC, 0.5097, 3.75, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1679, 5j06D, 0.5096, 4.04, 0.074, 212, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1680, 4j2qA, 0.5096, 4.02, 0.029, 340, 104, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1681, 3jwnI, 0.5096, 2.98, 0.095, 198, 95, COMPLEX OF FIMC FIMF FIMG AND FIMH
1682, 4rirA, 0.5095, 4.09, 0.081, 219, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1683, 3to4D, 0.5094, 3.84, 0.065, 243, 107, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
1684, 3rohA, 0.5094, 4.07, 0.055, 282, 110, CRYSTAL STRUCTURE OF LEUKOTOXIN (LUKE) FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS COL.
1685, 3pcyA, 0.5094, 2.70, 0.133, 99, 90, THE CRYSTAL STRUCTURE OF MERCURY-SUBSTITUTED POPLAR PLASTOCYANIN AT 1.9-ANGSTROMS RESOLUTION
1686, 3jwnC, 0.5094, 3.00, 0.084, 199, 95, COMPLEX OF FIMC FIMF FIMG AND FIMH
1687, 2ztnA, 0.5094, 4.17, 0.055, 472, 109, HEPATITIS E VIRUS ORF2 (GENOTYPE 3)
1688, 2zahA, 0.5094, 4.31, 0.047, 296, 106, X-RAY STRUCTURE OF MELON NECROTIC SPOT VIRUS
1689, 6fumA, 0.5093, 3.93, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1690, 5lvcb, 0.5093, 3.92, 0.057, 289, 105, AICHI VIRUS 1: EMPTY PARTICLE
1691, 4rqqD, 0.5093, 3.86, 0.055, 237, 110, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1692, 5d2lK, 0.5092, 3.82, 0.094, 192, 106, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1693, 4b0mM, 0.5092, 3.11, 0.084, 212, 95, COMPLEX OF THE CAF1AN USHER DOMAIN CAF1M CHAPERONE AND CAF1 SUBUNIT FROM YERSINIA PESTIS
1694, 3pl6D, 0.5092, 3.90, 0.147, 257, 109, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
1695, 1m06F, 0.5091, 4.49, 0.044, 422, 113, STRUCTURAL STUDIES OF BACTERIOPHAGE ALPHA3 ASSEMBLY X-RAY CRYSTALLOGRAPHY
1696, 5w0pD, 0.5090, 3.78, 0.029, 773, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1697, 5iszD, 0.5090, 3.80, 0.103, 200, 107, CRYSTAL STRUCTURE OF LS01-TCR/M1-HLA-A*02 COMPLEX
1698, 4qokE, 0.5090, 3.85, 0.101, 244, 109, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
1699, 3tpuG, 0.5090, 3.88, 0.100, 202, 110, 42F3 P5E8/H2-LD COMPLEX
1700, 3tpuC, 0.5090, 3.85, 0.100, 204, 110, 42F3 P5E8/H2-LD COMPLEX
1701, 2n7bA, 0.5090, 4.24, 0.099, 145, 111, SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN IN COMPLEX WITH 6 SULFO SIALYL LEWISX
1702, 1g6rC, 0.5090, 3.97, 0.100, 202, 110, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1703, 6e47F, 0.5089, 3.67, 0.078, 109, 103, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND GLYCOCHENODEOXYCHOLIC ACID 
1704, 6b5pH, 0.5089, 3.97, 0.063, 212, 111, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN ANTIBODY CIS42
1705, 6pcyA, 0.5088, 2.71, 0.133, 99, 90, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1706, 6eh7A, 0.5088, 3.93, 0.136, 202, 110, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1707, 5d4kB, 0.5088, 4.08, 0.083, 536, 109, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
1708, 1hxmE, 0.5088, 3.77, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1709, 5k93A, 0.5087, 3.34, 0.143, 210, 98, PAPD WILD-TYPE CHAPERONE
1710, 5j06B, 0.5087, 4.11, 0.083, 215, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1711, 6funA, 0.5086, 3.93, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1712, 6cqnD, 0.5086, 3.81, 0.093, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1713, 4onhA, 0.5086, 3.81, 0.102, 201, 108, CRYSTAL STRUCTURE OF DN6 TCR
1714, 3hg1E, 0.5086, 3.95, 0.109, 244, 110, GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR
1715, 6frcA, 0.5085, 3.93, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1716, 5aooB, 0.5085, 3.91, 0.057, 314, 105, X-RAY STRUCTURE OF A HUMAN KOBUVIRUS: AICHI VIRUS A (AIV)
1717, 4rirH, 0.5085, 4.09, 0.081, 219, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1718, 4dwhC, 0.5084, 3.00, 0.084, 201, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1719, 6q3sD, 0.5083, 3.92, 0.110, 203, 109, ENGINEERED HUMAN HLA_A2 MHC CLASS I MOLECULE IN COMPLEX WITH TCR AND SV9 PEPTIDE 
1720, 4zsoB, 0.5083, 4.00, 0.099, 218, 111, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1721, 4z7uE, 0.5083, 3.96, 0.131, 198, 107, S13 COMPLEX
1722, 1gff1, 0.5083, 4.55, 0.071, 417, 113, THE ATOMIC STRUCTURE OF THE DEGRADED PROCAPSID PARTICLE OF THE BACTERIOPHAGE G4: INDUCED STRUCTURAL CHANGES IN THE PRESENCE OF CALCIUM IONS AND FUNCTIONAL IMPLICATIONS
1723, 6frbA, 0.5082, 3.94, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1724, 5yxnA, 0.5082, 4.00, 0.109, 192, 110, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
1725, 6furA, 0.5081, 3.94, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1726, 6eh5A, 0.5081, 4.00, 0.102, 202, 108, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
1727, 5m00G, 0.5081, 4.01, 0.101, 187, 109, CRYSTAL STRUCTURE OF MURINE P14 TCR COMPLEX WITH H-2DB AND Y4A MODIFIED GP33 PEPTIDE FROM LCMV
1728, 1tefA, 0.5081, 2.72, 0.122, 99, 90, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
1729, 6fuqA, 0.5080, 3.94, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1730, 6fupA, 0.5080, 3.95, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1731, 4dwhA, 0.5080, 3.01, 0.084, 197, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1732, 3sqbA, 0.5080, 3.03, 0.095, 191, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1733, 3qpqJ, 0.5080, 3.94, 0.099, 216, 111, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1734, 6jjdA, 0.5079, 4.34, 0.064, 193, 110, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) FULL VLP 
1735, 6eh6A, 0.5079, 3.94, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1736, 6c6qD, 0.5079, 3.78, 0.066, 109, 106, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR 
1737, 6b5rH, 0.5079, 3.98, 0.072, 211, 111, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
1738, 5j0bB, 0.5079, 4.12, 0.083, 214, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
1739, 4j3oC, 0.5079, 3.10, 0.083, 199, 96, CRYSTAL STRUCTURE OF THE FIMD USHER TRAVERSED BY THE PILUS TIP COMPLEX ASSEMBLY COMPOSED OF FIMC:FIMF:FIMG:FIMH
1740, 4dp7X, 0.5079, 2.73, 0.133, 99, 90, THE 1.08 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 4.0
1741, 2xg5A, 0.5079, 3.49, 0.143, 216, 98, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 5D
1742, 1tegA, 0.5079, 2.72, 0.122, 99, 90, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
1743, 6f2sI, 0.5078, 4.65, 0.062, 203, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1744, 3vxsD, 0.5078, 3.95, 0.101, 204, 109, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
1745, 3sknC, 0.5078, 3.82, 0.104, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
1746, 1l4iA, 0.5078, 3.04, 0.074, 189, 95, CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE
1747, 6f2sK, 0.5077, 4.64, 0.071, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1748, 5k93B, 0.5077, 3.35, 0.143, 210, 98, PAPD WILD-TYPE CHAPERONE
1749, 5d2nD, 0.5077, 3.85, 0.121, 198, 107, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
1750, 3tu6A, 0.5077, 2.70, 0.115, 127, 87, THE STRUCTURE OF A PSEUDOAZURIN FROM SINORHIZOBIUM MELILTOI
1751, 6f2sF, 0.5076, 4.65, 0.062, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1752, 5pcyA, 0.5076, 2.73, 0.133, 99, 90, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1753, 3sqbC, 0.5076, 3.03, 0.095, 200, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1754, 2j2zA, 0.5076, 3.49, 0.143, 216, 98, X-RAY STRUCTURE OF THE CHAPERONE PAPD IN COMPLEX WITH THE PILUS TERMINATOR SUBUNIT PAPH AT 2.3 ANGSTROM RESOLUTION
1755, 1qpxA, 0.5076, 3.29, 0.103, 206, 97, CRYSTAL STRUCTURES OF SELF-CAPPING PAPD CHAPERONE HOMODIMERS
1756, 1py0A, 0.5076, 2.81, 0.114, 122, 88, CRYSTAL STRUCTURE OF E51C/E54C PSAZ FROM A.FAECALIS WITH CLANP PROBE
1757, 1pdkA, 0.5076, 3.50, 0.141, 215, 99, PAPD-PAPK CHAPERONE-PILUS SUBUNIT COMPLEX FROM E.COLI P PILUS
1758, 1hxmA, 0.5076, 3.77, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1759, 6rcuB, 0.5075, 4.10, 0.054, 222, 112, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
1760, 6fr9A, 0.5075, 3.97, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1761, 5xcqA, 0.5075, 4.03, 0.072, 166, 111, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
1762, 5nmeI, 0.5075, 3.94, 0.102, 200, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1763, 5ksaC, 0.5075, 3.87, 0.075, 195, 106, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
1764, 5jziI, 0.5075, 3.98, 0.109, 207, 110, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
1765, 4jzjH, 0.5075, 4.23, 0.061, 215, 114, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
1766, 5tilK, 0.5074, 3.99, 0.093, 118, 108, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1767, 4yhdC, 0.5074, 4.11, 0.073, 279, 110, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1768, 4jfhE, 0.5074, 3.99, 0.110, 244, 109, HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
1769, 4a6yH, 0.5074, 4.14, 0.088, 215, 114, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1770, 1klfM, 0.5074, 3.08, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1771, 1klfK, 0.5074, 3.08, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1772, 6d4aB, 0.5073, 4.13, 0.064, 124, 109, CELL SURFACE RECEPTOR WITH BOUND LIGAND AT 1.75-A RESOLUTION 
1773, 5yslC, 0.5073, 4.14, 0.071, 210, 112, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1774, 4z7uG, 0.5073, 3.96, 0.131, 198, 107, S13 COMPLEX
1775, 3sjvN, 0.5073, 3.79, 0.095, 197, 105, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1776, 1klfO, 0.5073, 3.08, 0.062, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1777, 1klfI, 0.5073, 3.08, 0.062, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1778, 5bs0D, 0.5072, 4.00, 0.101, 197, 109, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
1779, 3arfC, 0.5072, 3.93, 0.167, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
1780, 6eqaE, 0.5071, 3.85, 0.101, 244, 109, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
1781, 5dgyD, 0.5071, 3.72, 0.030, 833, 101, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1782, 4zwjD, 0.5071, 3.72, 0.030, 833, 101, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1783, 4mwfA, 0.5071, 3.86, 0.064, 223, 109, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
1784, 3q48B, 0.5071, 2.90, 0.129, 186, 93, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA CUPB2 CHAPERONE
1785, 3dpaA, 0.5071, 3.40, 0.143, 218, 98, CRYSTAL STRUCTURE OF CHAPERONE PROTEIN PAPD REVEALS AN IMMUNOGLOBULIN FOLD
1786, 2nmsA, 0.5071, 4.01, 0.093, 112, 107, THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE INHIBITOR RECEPTOR EXPRESSED ON MYELOID CELLS IREM-1
1787, 6furC, 0.5070, 3.95, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1788, 6f2sJ, 0.5070, 4.47, 0.054, 195, 111, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1789, 5d2lE, 0.5070, 3.80, 0.085, 187, 106, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1790, 5cckH, 0.5070, 4.13, 0.081, 224, 111, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB
1791, 3tn0C, 0.5070, 3.97, 0.157, 203, 108, STRUCTURE OF MOUSE VA14VB8.2NKT TCR-MOUSE CD1D-A-C-GALACTOSYLCERAMIDE COMPLEX
1792, 3sknA, 0.5070, 3.99, 0.103, 197, 107, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
1793, 2uy7A, 0.5070, 3.51, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1794, 5m01G, 0.5069, 4.02, 0.101, 188, 109, CRYSTAL STRUCTURE OF MURINE P14 TCR/ H-2DB COMPLEX WITH PA MODIFIED GP33 PEPTIDE FROM LCMV
1795, 4g8eA, 0.5069, 3.92, 0.120, 201, 108, CRYSTAL STRUCTURE OF CLONE18 TCR
1796, 4elmE, 0.5069, 3.89, 0.103, 179, 107, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1797, 3bwuC, 0.5069, 3.03, 0.095, 200, 95, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N-TERMINAL DOMAIN FIMDN) WITH FIMC AND THE N-TERMINALLY TRUNCATED PILUS SUBUNIT FIMF (FIMFT)
1798, 1tkwA, 0.5069, 2.74, 0.133, 99, 90, THE TRANSIENT COMPLEX OF POPLAR PLASTOCYANIN WITH TURNIP CYTOCHROME F DETERMINED WITH PARAMAGNETIC NMR
1799, 6jjcA, 0.5068, 4.35, 0.064, 193, 110, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) SEMI-EMPTY VLP 
1800, 6fraA, 0.5068, 4.02, 0.136, 201, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1801, 6aniI, 0.5068, 4.04, 0.089, 214, 112, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1802, 3zk4B, 0.5068, 3.85, 0.038, 571, 104, STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS
1803, 3tfkC, 0.5068, 3.94, 0.100, 201, 110, 42F3-P4B10/H2-LD
1804, 3njhA, 0.5068, 3.46, 0.124, 121, 97, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1805, 2jelH, 0.5068, 4.00, 0.089, 218, 112, JEL42 FAB/HPR COMPLEX
1806, 1pazA, 0.5068, 2.70, 0.140, 120, 86, REFINEMENT OF THE STRUCTURE OF PSEUDOAZURIN FROM ALCALIGENES FAECALIS S-6 AT 1.55 ANGSTROMS RESOLUTION
1807, 1ngpH, 0.5068, 4.24, 0.088, 215, 114, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
1808, 1hxmG, 0.5068, 3.78, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1809, 8pazA, 0.5067, 2.70, 0.140, 123, 86, OXIDIZED NATIVE PSEUDOAZURIN FROM A. FAECALIS
1810, 6dc9L, 0.5067, 4.01, 0.084, 215, 107, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1811, 5i1kH, 0.5067, 3.88, 0.083, 211, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20
1812, 5dgyB, 0.5067, 3.76, 0.029, 673, 102, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1813, 4zwjB, 0.5067, 3.76, 0.029, 673, 102, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1814, 3uttI, 0.5067, 3.88, 0.093, 199, 107, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
1815, 3g6jE, 0.5067, 4.01, 0.075, 214, 107, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1816, 2y06H, 0.5067, 4.03, 0.080, 215, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
1817, 2op4H, 0.5067, 4.15, 0.071, 217, 113, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
1818, 1rzgC, 0.5067, 3.97, 0.073, 213, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
1819, 1c1eH, 0.5067, 3.95, 0.073, 219, 110, CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
1820, 4ww1A, 0.5066, 3.79, 0.086, 197, 105, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8
1821, 4a6yB, 0.5066, 4.03, 0.089, 214, 112, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1822, 3he6C, 0.5066, 3.99, 0.157, 203, 108, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
1823, 2xg4A, 0.5066, 3.40, 0.153, 216, 98, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1824, 9pcyA, 0.5065, 2.69, 0.133, 99, 90, HIGH-RESOLUTION SOLUTION STRUCTURE OF REDUCED FRENCH BEAN PLASTOCYANIN AND COMPARISON WITH THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN
1825, 5nmdC, 0.5065, 3.96, 0.102, 200, 108, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
1826, 4nwwA, 0.5065, 4.21, 0.028, 341, 108, CRYSTAL STRUCTURE OF AN N-TERMINALLY TRUNCATED CAPSID PROTEIN MUTANT OF ORSAY VIRUS
1827, 3sddC, 0.5065, 3.97, 0.157, 189, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
1828, 3jabQ, 0.5065, 4.07, 0.071, 221, 112, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1829, 3jabH, 0.5065, 4.07, 0.071, 221, 112, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1830, 3areC, 0.5065, 3.96, 0.157, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE
1831, 2nx5T, 0.5065, 3.83, 0.131, 188, 107, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1832, 12e8H, 0.5065, 4.07, 0.071, 221, 112, 2E8 FAB FRAGMENT
1833, 6fuoA, 0.5064, 3.96, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1834, 6d4aA, 0.5064, 4.11, 0.073, 123, 109, CELL SURFACE RECEPTOR WITH BOUND LIGAND AT 1.75-A RESOLUTION 
1835, 6cqlD, 0.5064, 3.88, 0.111, 200, 108, CRYSTAL STRUCTURE OF A TCR 
1836, 5yl1A, 0.5064, 4.43, 0.063, 185, 111, T=1 SUBVIRAL PARTICLE OF PENAEUS VANNAMEI NODAVIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-37  and 251-368) 
1837, 4zezG, 0.5064, 4.01, 0.109, 207, 110, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
1838, 6f2sH, 0.5063, 4.45, 0.063, 218, 111, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1839, 6cphD, 0.5063, 3.82, 0.085, 200, 106, CRYSTAL STRUCTURE OF A TCR 
1840, 3uzqA, 0.5063, 4.07, 0.054, 234, 111, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
1841, 3ncjH, 0.5063, 3.98, 0.091, 225, 110, CRYSTAL STRUCTURE OF FAB15 MUT8
1842, 3arbC, 0.5063, 3.96, 0.157, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
1843, 1ws7C, 0.5063, 2.97, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1844, 1ws7B, 0.5063, 2.98, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1845, 1ngqH, 0.5063, 4.19, 0.096, 215, 114, N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1846, 4p5tA, 0.5062, 4.03, 0.110, 197, 109, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
1847, 3rfzC, 0.5062, 3.00, 0.084, 201, 95, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
1848, 2uy7E, 0.5062, 3.45, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1849, 6at6A, 0.5061, 3.95, 0.130, 190, 108, CRYSTAL STRUCTURE OF THE KFJ5 TCR
1850, 5nmeD, 0.5061, 3.98, 0.111, 201, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1851, 4x6cG, 0.5061, 3.90, 0.102, 201, 108, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
1852, 4v4mU, 0.5061, 4.80, 0.044, 184, 113, 
1853, 1qppA, 0.5061, 3.42, 0.133, 207, 98, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
1854, 6d48F, 0.5060, 4.14, 0.083, 125, 109, CELL SURFACE RECEPTOR 
1855, 5ysgD, 0.5060, 2.73, 0.138, 120, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
1856, 5wk3U, 0.5060, 4.01, 0.081, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1857, 5udcH, 0.5060, 4.06, 0.072, 217, 111, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
1858, 5dgyC, 0.5060, 3.82, 0.029, 789, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1859, 4zwjC, 0.5060, 3.82, 0.029, 789, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1860, 4x6cE, 0.5060, 3.93, 0.093, 198, 107, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
1861, 3vxrD, 0.5060, 3.95, 0.101, 194, 109, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
1862, 3tf7C, 0.5060, 3.85, 0.111, 232, 108, 42F3 QL9/H2-LD COMPLEX
1863, 3ardC, 0.5060, 3.95, 0.167, 202, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3 DEOXY-ALPHA- GALACTOSYLCERAMIDE
1864, 2f53D, 0.5060, 3.96, 0.101, 193, 109, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
1865, 1zoxA, 0.5060, 3.88, 0.065, 110, 107, CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN
1866, 6eyoI, 0.5059, 3.94, 0.064, 208, 110, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
1867, 5jhdI, 0.5059, 4.00, 0.100, 203, 110, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
1868, 5j0bC, 0.5059, 4.16, 0.083, 212, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
1869, 5c08I, 0.5059, 3.98, 0.102, 191, 108, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
1870, 4zsoD, 0.5059, 4.27, 0.088, 219, 114, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1871, 4p1yH, 0.5059, 4.13, 0.082, 264, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
1872, 4m43H, 0.5059, 4.21, 0.080, 219, 112, CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
1873, 3b07B, 0.5059, 4.13, 0.082, 270, 110, CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1874, 5zv3H, 0.5058, 3.84, 0.083, 219, 108, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
1875, 5ysgA, 0.5058, 2.80, 0.138, 120, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
1876, 5w1vI, 0.5058, 3.92, 0.133, 202, 105, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
1877, 5npjB, 0.5058, 4.09, 0.062, 232, 112, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1878, 3cm9S, 0.5058, 4.14, 0.109, 585, 110, SOLUTION STRUCTURE OF HUMAN SIGA2
1879, 2jxmA, 0.5058, 3.00, 0.152, 97, 92, ENSEMBLE OF TWENTY STRUCTURES OF THE PROCHLOROTHRIX HOLLANDICA PLASTOCYANIN- CYTOCHROME F COMPLEX
1880, 1b3iA, 0.5058, 3.00, 0.152, 97, 92, NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE PROCHLOROTHRIX HOLLANDICA (MINIMIZED AVERAGE STRUCTURE)
1881, 5swzN, 0.5057, 4.06, 0.092, 201, 109, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1882, 3qpqH, 0.5057, 4.19, 0.088, 215, 113, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1883, 1zglV, 0.5057, 3.92, 0.083, 242, 109, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1884, 5yslG, 0.5056, 4.12, 0.071, 210, 112, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1885, 5jhdD, 0.5056, 3.97, 0.100, 201, 110, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
1886, 2uy7C, 0.5056, 3.51, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1887, 2po6C, 0.5056, 3.99, 0.092, 203, 109, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1888, 2oslH, 0.5056, 4.01, 0.099, 224, 111, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1889, 1oayH, 0.5056, 4.11, 0.080, 121, 112, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1890, 6dg2A, 0.5055, 4.07, 0.107, 217, 112, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
1891, 6dfqF, 0.5055, 3.82, 0.075, 238, 107, MOUSE DIABETOGENIC TCR I.29 
1892, 6d48E, 0.5055, 4.16, 0.073, 125, 109, CELL SURFACE RECEPTOR 
1893, 5zmjH, 0.5055, 4.06, 0.054, 227, 111, CRYSTAL STRUCTURE OF THE FAB REGION OF A NEUTRALIZING FULLY HUMAN ANTIBODY AGAINST GM-CSF 
1894, 5ysgB, 0.5055, 2.80, 0.138, 120, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
1895, 5swzT, 0.5055, 3.80, 0.123, 239, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1896, 5npjA, 0.5055, 4.10, 0.062, 232, 112, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1897, 5nmfD, 0.5055, 3.99, 0.111, 200, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
1898, 4p1yD, 0.5055, 4.13, 0.064, 264, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
1899, 3rfzF, 0.5055, 3.04, 0.084, 201, 95, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
1900, 3njmA, 0.5055, 3.47, 0.113, 122, 97, P117A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1901, 3lh9B, 0.5055, 4.01, 0.107, 288, 103, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
1902, 3g6jG, 0.5055, 4.02, 0.075, 214, 107, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1903, 3argC, 0.5055, 4.00, 0.157, 202, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)
1904, 2w65A, 0.5055, 4.12, 0.080, 212, 112, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
1905, 1z9sA, 0.5055, 3.11, 0.096, 196, 94, CRYSTAL STRUCTURE OF THE NATIVE CHAPERONE:SUBUNIT:SUBUNIT CAF1M:CAF1:CAF1 COMPLEX
1906, 1n7mL, 0.5055, 4.02, 0.072, 216, 111, GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1907, 1hxmH, 0.5055, 4.13, 0.126, 230, 111, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1908, 1hxmF, 0.5055, 4.13, 0.134, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1909, 1a4kH, 0.5055, 4.15, 0.080, 217, 112, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1910, 6pazA, 0.5054, 2.68, 0.116, 123, 86, OXIDIZED MUTANT P80I PSEUDOAZURIN FROM A. FAECALIS
1911, 5npiA, 0.5054, 4.09, 0.062, 232, 112, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1912, 5dgyA, 0.5054, 3.82, 0.029, 833, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1913, 4zwjA, 0.5054, 3.82, 0.029, 833, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1914, 4uduB, 0.5054, 3.95, 0.111, 238, 108, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR
1915, 4rqqB, 0.5054, 3.86, 0.054, 239, 111, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1916, 4ei6A, 0.5054, 4.00, 0.093, 201, 107, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
1917, 2nx5I, 0.5054, 3.88, 0.140, 188, 107, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1918, 6higH, 0.5053, 4.05, 0.073, 209, 110, HPD-1/NBO1A FAB COMPLEX 
1919, 6fn1C, 0.5053, 4.15, 0.090, 225, 111, ZOSUQUIDAR AND UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
1920, 5yxuF, 0.5053, 4.00, 0.109, 190, 110, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
1921, 5yxuA, 0.5053, 4.01, 0.109, 191, 110, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
1922, 5tjeE, 0.5053, 4.02, 0.101, 116, 109, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
1923, 5swzE, 0.5053, 3.78, 0.123, 240, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1924, 5d4kA, 0.5053, 4.07, 0.101, 539, 109, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
1925, 4pazA, 0.5053, 2.69, 0.128, 123, 86, OXIDIZED MUTANT P80A PSEUDOAZURIN FROM A. FAECALIS
1926, 4jhaH, 0.5053, 4.09, 0.072, 226, 111, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
1927, 2eysA, 0.5053, 4.03, 0.092, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
1928, 6cjkA, 0.5052, 3.83, 0.094, 216, 106, ANTI HIV FAB 10A 
1929, 5uddK, 0.5052, 4.07, 0.072, 220, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
1930, 5npiB, 0.5052, 4.18, 0.062, 233, 113, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1931, 5mhrR, 0.5052, 4.17, 0.062, 213, 113, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1932, 4rh4A, 0.5052, 2.52, 0.141, 123, 85, ZINC-SUBSTITUTED PSEUDOAZURIN SOLVED BY S/ZN-SAD PHASING
1933, 4iyaA, 0.5052, 4.24, 0.045, 283, 112, STRUCTURE OF THE Y250A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
1934, 3utpD, 0.5052, 4.00, 0.093, 199, 108, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
1935, 2cdeB, 0.5052, 3.95, 0.064, 244, 109, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
1936, 1klfA, 0.5052, 3.09, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1937, 1fytD, 0.5052, 3.97, 0.117, 198, 111, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
1938, 6fr3A, 0.5051, 4.05, 0.101, 202, 109, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
1939, 5xovJ, 0.5051, 3.87, 0.083, 245, 108, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
1940, 4rqqH, 0.5051, 3.90, 0.054, 240, 111, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1941, 3na9H, 0.5051, 4.02, 0.081, 225, 111, CRYSTAL STRUCTURE OF FAB15
1942, 2eyrA, 0.5051, 4.04, 0.092, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
1943, 1klfG, 0.5051, 3.09, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1944, 1klfE, 0.5051, 3.09, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1945, 1klfC, 0.5051, 3.09, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1946, 1dbjH, 0.5051, 3.89, 0.036, 219, 111, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1947, 1a4jH, 0.5051, 4.03, 0.080, 217, 112, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1948, 6fr5A, 0.5050, 4.02, 0.101, 202, 109, HA1.7 TCR STUDY OF CDR LOOP FLEXIBILITY 
1949, 6f2sD, 0.5050, 4.59, 0.062, 195, 112, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1950, 6dg2C, 0.5050, 4.08, 0.107, 211, 112, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
1951, 5xovH, 0.5050, 3.87, 0.083, 245, 108, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
1952, 5uddN, 0.5050, 4.08, 0.072, 221, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
1953, 5swzJ, 0.5050, 3.78, 0.123, 240, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1954, 4nobA, 0.5050, 4.06, 0.121, 112, 107, CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220]
1955, 4iycC, 0.5050, 4.12, 0.045, 280, 110, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
1956, 3to4C, 0.5050, 3.97, 0.157, 190, 108, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
1957, 3se9H, 0.5050, 4.53, 0.078, 225, 116, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120
1958, 3chnS, 0.5050, 4.16, 0.073, 585, 109, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1959, 1zglR, 0.5050, 3.96, 0.064, 238, 110, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1960, 1ymhB, 0.5050, 4.01, 0.089, 218, 112, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
1961, 6f2sA, 0.5049, 4.50, 0.054, 195, 111, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1962, 5wk3S, 0.5049, 4.09, 0.081, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1963, 5swzD, 0.5049, 4.05, 0.092, 198, 109, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1964, 5jqdD, 0.5049, 4.03, 0.054, 214, 112, ANTIBODY FAB FRAGMENT
1965, 5ivxE, 0.5049, 4.06, 0.093, 194, 108, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
1966, 3he7C, 0.5049, 4.00, 0.157, 197, 108, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
1967, 2co7B, 0.5049, 3.26, 0.137, 197, 95, SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH THE SAFB CHAPERONE (TYPE II)
1968, 1t5rD, 0.5049, 4.07, 0.045, 267, 110, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
1969, 7pazA, 0.5048, 2.69, 0.116, 123, 86, REDUCED MUTANT P80I PSEUDOAZURIN FROM A. FAECALIS
1970, 6f2sE, 0.5048, 4.40, 0.055, 195, 110, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1971, 5yxnB, 0.5048, 3.80, 0.084, 241, 107, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
1972, 5m02G, 0.5048, 4.00, 0.102, 187, 108, CRYSTAL STRUCTURE OF MURINE P14 TCR / H-2DB WITH PF MODIFIED GP33 PEPTIDE FROM LCMV
1973, 5eu6D, 0.5048, 3.99, 0.101, 204, 109, HLA CLASS I ANTIGEN
1974, 4mnqE, 0.5048, 3.77, 0.094, 240, 106, TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS
1975, 4jhwH, 0.5048, 4.09, 0.072, 226, 111, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
1976, 4hqqH, 0.5048, 3.93, 0.064, 215, 109, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
1977, 3t2nH, 0.5048, 3.99, 0.055, 203, 110, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
1978, 3t0eC, 0.5048, 3.90, 0.132, 193, 106, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
1979, 2uweL, 0.5048, 3.72, 0.095, 194, 105, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
1980, 2ntfB, 0.5048, 4.14, 0.080, 222, 113, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1981, 2bnuA, 0.5048, 4.00, 0.101, 203, 109, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
1982, 1tefB, 0.5048, 2.78, 0.122, 99, 90, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
1983, 1qppB, 0.5048, 3.37, 0.134, 212, 97, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
1984, 1dbbH, 0.5048, 3.95, 0.081, 219, 111, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
1985, 6mkrA, 0.5047, 4.08, 0.110, 195, 109, 5287 TCR BOUND TO IAB PADI4 
1986, 5mhrK, 0.5047, 4.05, 0.063, 122, 111, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1987, 5lfrB, 0.5047, 4.28, 0.126, 312, 111, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3
1988, 5d2lI, 0.5047, 3.92, 0.075, 185, 107, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1989, 4nwvA, 0.5047, 4.19, 0.037, 355, 108, CRYSTAL STRUCTURE OF ORSAY VIRUS-LIKE PARTICLE
1990, 2w07A, 0.5047, 3.39, 0.143, 215, 98, STRUCTURAL DETERMINANTS OF POLYMERIZATION REACTIVITY OF THE P PILUS ADAPTOR SUBUNIT PAPF
1991, 1dbaH, 0.5047, 3.92, 0.036, 219, 111, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
1992, 12e8P, 0.5047, 4.00, 0.072, 221, 111, 2E8 FAB FRAGMENT
1993, 6mkdA, 0.5046, 4.09, 0.119, 193, 109, 4699 TCR BOUND TO I-AB PADI4 
1994, 6eh4D, 0.5046, 4.06, 0.101, 204, 109, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
1995, 5nmgI, 0.5046, 3.98, 0.102, 200, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
1996, 4j0oC, 0.5046, 4.10, 0.045, 275, 110, STRUCTURE OF THE Y246A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
1997, 4grmD, 0.5046, 3.64, 0.086, 243, 105, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
1998, 3sjvD, 0.5046, 3.87, 0.113, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1999, 2uy6A, 0.5046, 3.47, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2000, 1tegB, 0.5046, 2.78, 0.122, 99, 90, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
2001, 1oazH, 0.5046, 4.08, 0.080, 122, 112, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
2002, 1j8hD, 0.5046, 3.97, 0.117, 198, 111, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
2003, 1bd2D, 0.5046, 4.01, 0.093, 190, 108, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7 VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
2004, 6mi2D, 0.5045, 4.23, 0.071, 210, 113, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
2005, 6fy0H, 0.5045, 3.92, 0.073, 226, 109, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2006, 6fr4A, 0.5045, 4.05, 0.101, 202, 109, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
2007, 6f2sC, 0.5045, 4.60, 0.062, 195, 112, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2008, 5yslA, 0.5045, 4.09, 0.072, 211, 111, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
2009, 5wk2H, 0.5045, 4.16, 0.080, 217, 113, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
2010, 5swzS, 0.5045, 4.07, 0.092, 203, 109, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2011, 5mhrN, 0.5045, 4.25, 0.061, 214, 114, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2012, 5lfuA, 0.5045, 4.27, 0.136, 487, 110, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) GLYCOSYLATED AND LYSINE- METHYLATED FULL EXTRACELLULAR DOMAIN
2013, 4tnwH, 0.5045, 3.98, 0.072, 223, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2014, 4r7nD, 0.5045, 4.03, 0.084, 211, 107, FAB C2E3
2015, 4ki5C, 0.5045, 4.05, 0.072, 218, 111, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
2016, 4apqC, 0.5045, 3.99, 0.157, 196, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
2017, 3hmxH, 0.5045, 4.03, 0.081, 217, 111, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
2018, 2bnrD, 0.5045, 3.99, 0.101, 203, 109, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2019, 5yxuB, 0.5044, 3.87, 0.075, 242, 107, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2020, 5wk3W, 0.5044, 4.15, 0.080, 221, 112, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2021, 5nmgD, 0.5044, 3.99, 0.120, 200, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
2022, 5ikcH, 0.5044, 4.01, 0.073, 214, 110, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2023, 5iblC, 0.5044, 3.93, 0.092, 216, 109, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
2024, 4tnwX, 0.5044, 4.00, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2025, 4tnvH, 0.5044, 4.00, 0.072, 223, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2026, 4tnvG, 0.5044, 3.92, 0.073, 224, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2027, 4bz1H, 0.5044, 4.01, 0.081, 212, 111, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
2028, 2y36H, 0.5044, 4.02, 0.098, 215, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
2029, 1t5rF, 0.5044, 4.14, 0.055, 269, 110, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2030, 5uddM, 0.5043, 4.08, 0.072, 221, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2031, 5c08D, 0.5043, 3.87, 0.093, 189, 107, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
2032, 4ye4H, 0.5043, 3.91, 0.110, 227, 109, CRYSTAL STRUCTURE OF NEUTRALIZING ANTIBODY HJ16 IN COMPLEX WITH HIV-1 GP120
2033, 4ydlB, 0.5043, 4.13, 0.072, 223, 111, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
2034, 4y19D, 0.5043, 3.91, 0.083, 205, 108, IMMUNE COMPLEX
2035, 4tnvI, 0.5043, 4.01, 0.072, 222, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2036, 4i3sH, 0.5043, 4.30, 0.080, 222, 113, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
2037, 3qi9C, 0.5043, 4.01, 0.157, 196, 108, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
2038, 3njkA, 0.5043, 3.48, 0.113, 122, 97, D116A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS AT PH5.5
2039, 2w60A, 0.5043, 4.01, 0.081, 217, 111, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
2040, 2uylY, 0.5043, 4.31, 0.079, 213, 114, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2041, 2uy7G, 0.5043, 3.47, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2042, 1pzaA, 0.5043, 2.59, 0.129, 120, 85, THE CRYSTAL STRUCTURES OF REDUCED PSEUDOAZURIN FROM ALCALIGENES FAECALIS S-6 AT TWO PH VALUES
2043, 6mxsL, 0.5042, 4.04, 0.083, 218, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
2044, 6bj2E, 0.5042, 3.89, 0.120, 241, 108, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
2045, 6am5D, 0.5042, 3.99, 0.102, 189, 108, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE SMLGIGIVPV 
2046, 5ks9G, 0.5042, 3.75, 0.086, 192, 105, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
2047, 5j0bA, 0.5042, 4.18, 0.073, 213, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
2048, 4ww2A, 0.5042, 4.00, 0.101, 203, 109, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
2049, 4tnvJ, 0.5042, 3.93, 0.073, 223, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2050, 3dpbA, 0.5042, 3.11, 0.096, 196, 94, CRYSTAL STRUCTURE OF THE COMPLEX OF THE CAF1M CHAPERONE WITH THE MINI-FIBER OF TWO CAF1 SUBUNITS (CAF1:CAF1) CARRYING THE ALA9VAL ALA11VAL AND LEU13VAL MUTATIONS IN THE GD DONOR STRAND
2051, 2z4qB, 0.5042, 4.12, 0.072, 218, 111, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2052, 2cdeD, 0.5042, 3.93, 0.064, 244, 109, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2053, 1ws8C, 0.5042, 2.97, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2054, 1rzfH, 0.5042, 4.05, 0.073, 218, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51
2055, 5wk3Q, 0.5041, 4.03, 0.081, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2056, 5tilG, 0.5041, 3.80, 0.094, 114, 106, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
2057, 5tezI, 0.5041, 4.05, 0.130, 202, 108, TCR F50 RECGONIZING M1-HLA-A2
2058, 5k59A, 0.5041, 4.33, 0.071, 292, 113, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2059, 5j06A, 0.5041, 4.19, 0.073, 213, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
2060, 5c07I, 0.5041, 3.99, 0.102, 199, 108, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
2061, 3tzvA, 0.5041, 4.04, 0.092, 196, 109, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
2062, 3lh9A, 0.5041, 3.84, 0.109, 286, 101, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
2063, 6didH, 0.5040, 3.84, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2064, 6didE, 0.5040, 3.84, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2065, 6didC, 0.5040, 3.84, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2066, 6amuE, 0.5040, 3.87, 0.075, 241, 107, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE MMWDRGLGMM 
2067, 6amuD, 0.5040, 3.97, 0.103, 195, 107, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE MMWDRGLGMM 
2068, 5yslE, 0.5040, 4.14, 0.071, 210, 112, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
2069, 5yhlH, 0.5040, 4.17, 0.070, 223, 114, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
2070, 5nmdA, 0.5040, 3.98, 0.102, 200, 108, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
2071, 5j0bD, 0.5040, 4.02, 0.085, 209, 106, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
2072, 4ydlH, 0.5040, 4.13, 0.072, 223, 111, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
2073, 4xzuA, 0.5040, 4.05, 0.072, 213, 111, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2074, 4u6hC, 0.5040, 4.01, 0.072, 217, 111, VACCINIA L1/M12B9-FAB COMPLEX
2075, 4tnvF, 0.5040, 4.00, 0.072, 222, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2076, 4r7dB, 0.5040, 4.03, 0.084, 211, 107, FAB HU 15C1
2077, 2nx5N, 0.5040, 3.91, 0.140, 188, 107, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2078, 2d7tL, 0.5040, 4.09, 0.093, 110, 107, CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
2079, 1qsfD, 0.5040, 4.00, 0.093, 200, 108, STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
2080, 1i7zA, 0.5040, 3.93, 0.112, 219, 107, ANTIBODY GNC92H2 BOUND TO LIGAND
2081, 6e15C, 0.5039, 3.05, 0.084, 199, 95, HANDOVER MECHANISM OF THE GROWING PILUS BY THE BACTERIAL OUTER MEMBRANE USHER FIMD 
2082, 6aniH, 0.5039, 4.31, 0.088, 216, 114, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
2083, 5tjeG, 0.5039, 3.89, 0.102, 112, 108, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
2084, 5mhrI, 0.5039, 4.23, 0.061, 213, 114, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2085, 5lxaH, 0.5039, 4.09, 0.071, 238, 112, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 3.0 ANGSTROM RESOLUTION
2086, 5hyjI, 0.5039, 3.90, 0.093, 193, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
2087, 5eblA, 0.5039, 4.36, 0.088, 219, 114, KCSA T75G IN THE CONDUCTIVE STATE
2088, 5c07D, 0.5039, 3.98, 0.102, 199, 108, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
2089, 4tnwW, 0.5039, 4.00, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2090, 4m6nH, 0.5039, 4.15, 0.071, 213, 113, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
2091, 4hjjH, 0.5039, 4.40, 0.070, 341, 115, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
2092, 3tzvG, 0.5039, 4.03, 0.092, 201, 109, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
2093, 1pmyA, 0.5039, 2.64, 0.093, 123, 86, REFINED CRYSTAL STRUCTURE OF PSEUDOAZURIN FROM METHYLOBACTERIUM EXTORQUENS AM1 AT 1.5 ANGSTROMS RESOLUTION
2094, 1ob1E, 0.5039, 4.00, 0.090, 219, 111, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
2095, 1oaxJ, 0.5039, 4.06, 0.080, 122, 112, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
2096, 1oarJ, 0.5039, 4.06, 0.080, 122, 112, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
2097, 1oarH, 0.5039, 4.06, 0.080, 122, 112, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
2098, 6cphE, 0.5038, 3.88, 0.112, 244, 107, CRYSTAL STRUCTURE OF A TCR 
2099, 6cjkC, 0.5038, 3.84, 0.094, 217, 106, ANTI HIV FAB 10A 
2100, 6c09C, 0.5038, 4.00, 0.093, 192, 108, TERNARY CRYSTAL STRUCTURE OF THE 3C8 TCR-CD1C-MONOACYLGLYCEROL COMPLEX
2101, 5tkjG, 0.5038, 4.02, 0.098, 208, 112, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2102, 5swzO, 0.5038, 3.77, 0.123, 241, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2103, 5iblH, 0.5038, 3.95, 0.100, 216, 110, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
2104, 4tnvV, 0.5038, 4.01, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2105, 4elmG, 0.5038, 3.78, 0.095, 171, 105, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
2106, 3wihH, 0.5038, 4.14, 0.089, 219, 112, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2107, 3ujjH, 0.5038, 4.12, 0.071, 230, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
2108, 3scmC, 0.5038, 3.99, 0.157, 191, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
2109, 3g04B, 0.5038, 3.93, 0.064, 215, 109, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY
2110, 6f2sG, 0.5037, 4.71, 0.071, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2111, 5jo4C, 0.5037, 3.96, 0.073, 221, 110, ANTIBODY FAB FRAGMENT COMPLEX
2112, 5ihbA, 0.5037, 4.20, 0.073, 213, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33
2113, 5i1jH, 0.5037, 4.12, 0.081, 213, 111, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11
2114, 4tnvX, 0.5037, 4.01, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2115, 4tnvU, 0.5037, 3.92, 0.073, 221, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2116, 4kroC, 0.5037, 4.01, 0.084, 211, 107, NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
2117, 4j0oD, 0.5037, 4.09, 0.045, 272, 110, STRUCTURE OF THE Y246A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2118, 3rifG, 0.5037, 4.02, 0.072, 214, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2119, 3kj6H, 0.5037, 4.15, 0.108, 217, 111, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
2120, 3cviH, 0.5037, 4.22, 0.071, 213, 113, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
2121, 2w65C, 0.5037, 4.09, 0.081, 211, 111, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
2122, 2r4sH, 0.5037, 4.16, 0.098, 217, 112, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2123, 1t5rB, 0.5037, 4.10, 0.045, 271, 110, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2124, 5ywyH, 0.5036, 4.17, 0.070, 223, 114, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
2125, 5w5xH, 0.5036, 4.02, 0.081, 211, 111, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY 
2126, 3wihI, 0.5036, 4.14, 0.089, 219, 112, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2127, 3dggD, 0.5036, 4.28, 0.088, 215, 114, CRYSTAL STRUCTURE OF FABOX108
2128, 2y07H, 0.5036, 4.07, 0.080, 215, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
2129, 2f54D, 0.5036, 3.97, 0.101, 205, 109, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2130, 2eytA, 0.5036, 4.05, 0.092, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2131, 2cdfB, 0.5036, 3.86, 0.083, 244, 108, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E)
2132, 2bnqD, 0.5036, 3.99, 0.101, 203, 109, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2133, 1zeaH, 0.5036, 3.97, 0.081, 209, 111, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
2134, 1za3A, 0.5036, 3.95, 0.093, 213, 107, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
2135, 1xedF, 0.5036, 4.03, 0.103, 111, 107, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2136, 1xedB, 0.5036, 3.40, 0.100, 109, 100, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2137, 1ws8B, 0.5036, 3.01, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2138, 1oaxH, 0.5036, 4.07, 0.080, 122, 112, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
2139, 6mefH, 0.5035, 3.90, 0.073, 224, 110, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2140, 6gv4A, 0.5035, 4.07, 0.029, 256, 105, HIGH-RESOLUTION CRYO-EM OF FAB-LABELED HUMAN PARECHOVIRUS 3 
2141, 4ztpL, 0.5035, 3.94, 0.113, 216, 106, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
2142, 4tnwU, 0.5035, 4.01, 0.072, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2143, 4jryD, 0.5035, 3.89, 0.121, 201, 107, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
2144, 4djmD, 0.5035, 3.17, 0.106, 204, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
2145, 3qdgE, 0.5035, 3.89, 0.075, 242, 107, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
2146, 3hujG, 0.5035, 4.02, 0.092, 202, 109, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
2147, 3ffcJ, 0.5035, 3.92, 0.120, 247, 108, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
2148, 2uylW, 0.5035, 4.28, 0.088, 213, 114, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2149, 1kiuE, 0.5035, 3.12, 0.062, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2150, 1kiuC, 0.5035, 3.12, 0.062, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2151, 6cd2A, 0.5034, 3.52, 0.152, 215, 99, CRYSTAL STRUCTURE OF THE PAPC USHER BOUND TO THE CHAPERONE-ADHESIN PAPD-PAPG 
2152, 5vkhA, 0.5034, 4.28, 0.088, 219, 113, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
2153, 5lfvB, 0.5034, 4.29, 0.126, 311, 111, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3 WITH SOAKED TRISACCHARIDE LIGAND
2154, 5lf5A, 0.5034, 4.30, 0.135, 484, 111, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) DEGLYCOSYLATED FULL EXTRACELLULAR DOMAIN WITH CO-PURIFIED LIGAND
2155, 5ks9E, 0.5034, 3.78, 0.067, 193, 105, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
2156, 5j06C, 0.5034, 4.13, 0.083, 211, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
2157, 5i1lH, 0.5034, 4.24, 0.080, 225, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
2158, 5hyjD, 0.5034, 3.85, 0.094, 193, 106, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
2159, 5d8jH, 0.5034, 4.31, 0.096, 216, 114, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
2160, 4tnvW, 0.5034, 4.01, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2161, 4r7nH, 0.5034, 4.04, 0.084, 211, 107, FAB C2E3
2162, 4p1yB, 0.5034, 4.18, 0.072, 264, 111, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2163, 4n24A, 0.5034, 3.86, 0.114, 645, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (100 UM CA2+)
2164, 4guqA, 0.5034, 3.72, 0.097, 200, 103, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
2165, 3sdcC, 0.5034, 4.02, 0.157, 191, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
2166, 2po6G, 0.5034, 4.05, 0.092, 204, 109, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2167, 2e7lA, 0.5034, 3.92, 0.110, 112, 109, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
2168, 1s5hB, 0.5034, 4.28, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
2169, 1oayJ, 0.5034, 4.08, 0.080, 121, 112, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
2170, 1kiuG, 0.5034, 3.12, 0.062, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2171, 1kiuA, 0.5034, 3.12, 0.062, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2172, 5udcB, 0.5033, 4.10, 0.072, 218, 111, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2173, 5swzI, 0.5033, 4.09, 0.092, 186, 109, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2174, 5l2kD, 0.5033, 3.99, 0.120, 185, 108, CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX
2175, 5ec2A, 0.5033, 4.28, 0.088, 219, 113, KCSA WITH V76ESTER+G77DA MUTATIONS
2176, 5c0cI, 0.5033, 3.92, 0.093, 199, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
2177, 5c09D, 0.5033, 3.90, 0.103, 197, 107, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
2178, 4uihF, 0.5033, 3.88, 0.065, 120, 107, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.
2179, 4uifI, 0.5033, 3.88, 0.065, 120, 107, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
2180, 4r7nT, 0.5033, 4.07, 0.084, 211, 107, FAB C2E3
2181, 4j1uC, 0.5033, 4.00, 0.093, 213, 107, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2182, 3sdxG, 0.5033, 4.05, 0.092, 196, 109, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2183, 3sdxE, 0.5033, 4.05, 0.092, 196, 109, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2184, 3gsnA, 0.5033, 4.01, 0.093, 199, 108, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
2185, 2nx5D, 0.5033, 3.85, 0.131, 188, 107, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2186, 5kqvC, 0.5032, 4.14, 0.072, 211, 111, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
2187, 5i1lB, 0.5032, 3.97, 0.064, 213, 109, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
2188, 5epmA, 0.5032, 4.08, 0.098, 218, 112, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
2189, 4m6mH, 0.5032, 4.16, 0.071, 215, 113, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
2190, 4jrxD, 0.5032, 3.99, 0.109, 204, 110, CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX
2191, 4jffE, 0.5032, 4.00, 0.119, 245, 109, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2192, 4j0oB, 0.5032, 4.25, 0.045, 277, 112, STRUCTURE OF THE Y246A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2193, 4djmE, 0.5032, 3.19, 0.117, 198, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
2194, 3sdaC, 0.5032, 3.96, 0.167, 196, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2195, 3qpqD, 0.5032, 4.20, 0.097, 218, 113, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2196, 3pqyT, 0.5032, 3.83, 0.104, 240, 106, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2197, 3b07F, 0.5032, 4.17, 0.072, 270, 111, CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
2198, 3b07D, 0.5032, 4.18, 0.072, 270, 111, CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
2199, 1t5rH, 0.5032, 4.09, 0.045, 270, 110, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2200, 1oauJ, 0.5032, 4.01, 0.081, 122, 111, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
2201, 1oauH, 0.5032, 4.01, 0.081, 122, 111, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
2202, 6avgC, 0.5031, 3.86, 0.142, 196, 106, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
2203, 5w23J, 0.5031, 4.17, 0.080, 219, 112, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2204, 4r7nB, 0.5031, 4.05, 0.084, 211, 107, FAB C2E3
2205, 4izlC, 0.5031, 4.10, 0.045, 278, 110, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2206, 3vxmD, 0.5031, 3.98, 0.109, 198, 110, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
2207, 3tjhC, 0.5031, 4.02, 0.100, 201, 110, 42F3-P3A1/H2-LD COMPLEX
2208, 2xwtA, 0.5031, 4.04, 0.063, 215, 111, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
2209, 1yuhH, 0.5031, 4.23, 0.088, 218, 114, FAB FRAGMENT
2210, 6h2bA, 0.5030, 4.15, 0.065, 316, 107, STRUCTURE OF THE MACROBRACHIUM ROSENBERGII NODAVIRUS 
2211, 6by3A, 0.5030, 4.29, 0.088, 219, 113, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
2212, 5nyxN, 0.5030, 3.92, 0.085, 210, 106, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2213, 5nmfI, 0.5030, 4.00, 0.120, 201, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
2214, 5iw1C, 0.5030, 4.05, 0.092, 189, 109, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
2215, 5c0cD, 0.5030, 4.01, 0.102, 200, 108, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
2216, 4tnwI, 0.5030, 4.01, 0.072, 222, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2217, 4lciH, 0.5030, 4.01, 0.064, 120, 110, ANTI CANINE CD28 ANTIBODY 1C6
2218, 3tyfC, 0.5030, 4.04, 0.092, 197, 109, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
2219, 3mlwH, 0.5030, 4.02, 0.073, 228, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
2220, 2ygtA, 0.5030, 4.37, 0.100, 282, 110, CLOSTRIDIUM PERFRINGENS DELTA-TOXIN
2221, 2qk7A, 0.5030, 4.17, 0.072, 259, 111, A COVALENT S-F HETERODIMER OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN
2222, 1uweU, 0.5030, 4.02, 0.121, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2223, 1tcrA, 0.5030, 4.07, 0.100, 202, 110, MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
2224, 5kqvP, 0.5029, 4.15, 0.081, 220, 111, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
2225, 4x8jB, 0.5029, 4.04, 0.112, 214, 107, CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
2226, 4tnvY, 0.5029, 4.01, 0.072, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2227, 3tyfA, 0.5029, 4.04, 0.092, 199, 109, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
2228, 3rifJ, 0.5029, 4.00, 0.072, 200, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2229, 3rifI, 0.5029, 4.00, 0.072, 192, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2230, 3ri5H, 0.5029, 4.02, 0.072, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2231, 3mbeG, 0.5029, 3.79, 0.142, 192, 106, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
2232, 3mbeC, 0.5029, 3.79, 0.142, 192, 106, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
2233, 3hujF, 0.5029, 3.95, 0.083, 242, 108, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
2234, 2uylN, 0.5029, 4.28, 0.088, 213, 114, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2235, 6mnoA, 0.5028, 4.10, 0.119, 196, 109, 6235 TCR BOUND TO I-AB PADI4 
2236, 6mnmA, 0.5028, 4.03, 0.120, 196, 108, 6256 TCR BOUND TO I-AB PADI4 
2237, 6idgL, 0.5028, 4.04, 0.120, 217, 108, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
2238, 5ihbC, 0.5028, 4.13, 0.083, 212, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33
2239, 5ebmA, 0.5028, 4.30, 0.088, 218, 113, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
2240, 5d6cA, 0.5028, 4.13, 0.093, 219, 108, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
2241, 5a1zI, 0.5028, 3.82, 0.065, 120, 108, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
2242, 4r7nJ, 0.5028, 4.07, 0.084, 211, 107, FAB C2E3
2243, 4q0xH, 0.5028, 4.02, 0.072, 216, 111, CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2
2244, 4n22A, 0.5028, 4.03, 0.112, 642, 107, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (50 UM CA2+)
2245, 4ei5H, 0.5028, 4.10, 0.110, 230, 109, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
2246, 4buhA, 0.5028, 3.86, 0.065, 236, 107, HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV
2247, 3vwjD, 0.5028, 3.83, 0.085, 241, 106, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
2248, 6mxrB, 0.5027, 4.06, 0.083, 217, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
2249, 6dfjL, 0.5027, 3.94, 0.085, 214, 106, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO DENV-1 ENVELOPE PROTEIN DIII 
2250, 5wv4B, 0.5027, 2.54, 0.116, 124, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT
2251, 5ur8B, 0.5027, 4.01, 0.084, 215, 107, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
2252, 5mjvC, 0.5027, 4.04, 0.029, 257, 105, REBUILD AND RE-REFINED MODEL FOR HUMAN PARECHOVIRUS 1
2253, 5menE, 0.5027, 3.83, 0.065, 240, 107, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
2254, 1yntB, 0.5027, 4.01, 0.099, 218, 111, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
2255, 1lmkE, 0.5027, 4.08, 0.055, 238, 110, THE STRUCTURE OF A BIVALENT DIABODY
2256, 1dgiR, 0.5027, 3.81, 0.093, 301, 107, CRYO-EM STRUCTURE OF HUMAN POLIOVIRUS(SEROTYPE 1)COMPLEXED WITH THREE DOMAIN CD155
2257, 1a5fH, 0.5027, 4.10, 0.089, 212, 112, FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
2258, 6dfqB, 0.5026, 3.75, 0.093, 239, 107, MOUSE DIABETOGENIC TCR I.29 
2259, 5yw3C, 0.5026, 2.82, 0.138, 124, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN THR36LYS VARIANT 
2260, 5lxgH, 0.5026, 4.02, 0.064, 119, 110, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 IN AN OPEN CONFORMATION
2261, 5cbeA, 0.5026, 3.88, 0.066, 125, 106, E10 IN COMPLEX WITH CXCL13
2262, 4z8fL, 0.5026, 4.01, 0.084, 214, 107, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
2263, 4w2pC, 0.5026, 3.88, 0.064, 120, 109, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
2264, 4tnwY, 0.5026, 4.02, 0.072, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2265, 4p5tE, 0.5026, 3.92, 0.112, 188, 107, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
2266, 4eupI, 0.5026, 4.03, 0.093, 201, 107, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
2267, 4elmH, 0.5026, 3.97, 0.112, 211, 107, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
2268, 4aehH, 0.5026, 4.35, 0.088, 219, 114, CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
2269, 3qeuD, 0.5026, 4.13, 0.110, 202, 109, THE CRYSTAL STRUCTURE OF TCR DMF5
2270, 3hujH, 0.5026, 3.94, 0.083, 245, 108, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
2271, 3gsnB, 0.5026, 3.91, 0.084, 243, 107, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
2272, 3fb8A, 0.5026, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
2273, 3fb6A, 0.5026, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
2274, 3f7yA, 0.5026, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
2275, 3f5wA, 0.5026, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
2276, 3bn9E, 0.5026, 4.01, 0.084, 211, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
2277, 2vweE, 0.5026, 4.29, 0.088, 219, 114, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2278, 2vl5A, 0.5026, 4.32, 0.105, 218, 114, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2279, 2jccL, 0.5026, 3.87, 0.103, 194, 107, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2280, 2eytC, 0.5026, 3.99, 0.092, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2281, 2cdgB, 0.5026, 3.79, 0.075, 244, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
2282, 1qunM, 0.5026, 3.12, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2283, 1qunI, 0.5026, 3.12, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2284, 1mhhD, 0.5026, 4.06, 0.089, 214, 112, ANTIBODY-ANTIGEN COMPLEX
2285, 1k4cA, 0.5026, 4.29, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
2286, 6mxsB, 0.5025, 4.06, 0.083, 217, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
2287, 6jjcB, 0.5025, 4.37, 0.064, 193, 110, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) SEMI-EMPTY VLP 
2288, 5vk6A, 0.5025, 4.30, 0.088, 219, 113, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
2289, 5viyJ, 0.5025, 3.90, 0.054, 223, 111, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2290, 5viyH, 0.5025, 3.90, 0.054, 223, 111, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2291, 5ihbD, 0.5025, 4.05, 0.075, 209, 106, STRUCTURE OF THE IMMUNE RECEPTOR CD33
2292, 5i18H, 0.5025, 4.32, 0.062, 211, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1
2293, 5c0bD, 0.5025, 3.91, 0.093, 197, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
2294, 4z95L, 0.5025, 4.00, 0.084, 214, 107, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
2295, 4tnwV, 0.5025, 4.01, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2296, 4tnwJ, 0.5025, 4.02, 0.072, 222, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2297, 4p1xD, 0.5025, 4.15, 0.055, 257, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2298, 4i9wE, 0.5025, 4.16, 0.080, 211, 112, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
2299, 4djmH, 0.5025, 3.27, 0.084, 201, 95, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
2300, 3ze1E, 0.5025, 4.05, 0.063, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2301, 3uttJ, 0.5025, 3.90, 0.073, 245, 109, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
2302, 3riaJ, 0.5025, 4.01, 0.072, 215, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2303, 3rhwJ, 0.5025, 4.01, 0.072, 215, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2304, 3naaH, 0.5025, 4.08, 0.089, 225, 112, CRYSTAL STRUCTURE OF FAB15 MUT5
2305, 2zg3A, 0.5025, 4.00, 0.084, 210, 107, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5 IN COMPLEX WITH 3 -SIALYLLACTOSE
2306, 2wmpA, 0.5025, 3.47, 0.143, 215, 98, STRUCTURE OF THE E. COLI CHAPERONE PAPD IN COMPLEX WITH THE PILIN DOMAIN OF THE PAPGII ADHESIN
2307, 2vlkD, 0.5025, 3.82, 0.114, 199, 105, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2308, 2vljD, 0.5025, 3.82, 0.114, 199, 105, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2309, 2vl5C, 0.5025, 4.16, 0.106, 218, 113, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2310, 2uylB, 0.5025, 4.29, 0.088, 213, 114, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2311, 2dblH, 0.5025, 4.04, 0.071, 219, 112, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2312, 1ze3C, 0.5025, 3.04, 0.095, 205, 95, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N- TERMINAL DOMAIN) WITH FIMC AND THE PILIN DOMAIN OF FIMH
2313, 1xcqD, 0.5025, 4.10, 0.080, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2314, 1qunO, 0.5025, 3.12, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2315, 1qunK, 0.5025, 3.12, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2316, 1ob1B, 0.5025, 4.02, 0.090, 219, 111, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
2317, 1a4jB, 0.5025, 4.09, 0.080, 217, 112, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
2318, 6eqbE, 0.5024, 4.00, 0.119, 244, 109, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
2319, 6eh9A, 0.5024, 3.98, 0.136, 202, 110, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2320, 5w23I, 0.5024, 4.16, 0.080, 219, 112, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2321, 4wfhG, 0.5024, 4.16, 0.080, 210, 112, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
2322, 4wffG, 0.5024, 4.16, 0.080, 210, 112, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
2323, 4tnwG, 0.5024, 4.02, 0.072, 222, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2324, 4r7nF, 0.5024, 4.05, 0.084, 211, 107, FAB C2E3
2325, 4l3eD, 0.5024, 3.96, 0.103, 199, 107, THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26YBETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
2326, 4jo3L, 0.5024, 4.03, 0.075, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
2327, 4izlB, 0.5024, 4.12, 0.045, 278, 110, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2328, 4amkH, 0.5024, 3.92, 0.091, 215, 110, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
2329, 3w0wD, 0.5024, 3.97, 0.112, 204, 107, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
2330, 3vfgL, 0.5024, 3.93, 0.105, 211, 105, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
2331, 3ulvF, 0.5024, 4.10, 0.089, 217, 112, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2332, 3uluH, 0.5024, 4.23, 0.080, 225, 112, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2333, 3qeuB, 0.5024, 3.87, 0.075, 238, 107, THE CRYSTAL STRUCTURE OF TCR DMF5
2334, 3bn9C, 0.5024, 4.02, 0.084, 210, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
2335, 1ahwE, 0.5024, 4.10, 0.080, 214, 112, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2336, 1afvH, 0.5024, 4.27, 0.087, 220, 115, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2337, 6dwcA, 0.5023, 4.13, 0.102, 217, 108, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
2338, 5t5fH, 0.5023, 4.16, 0.097, 212, 113, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
2339, 5ikcB, 0.5023, 4.03, 0.073, 210, 110, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2340, 4z7oE, 0.5023, 4.00, 0.064, 216, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2341, 4y1aD, 0.5023, 3.84, 0.102, 205, 108, IMMUNE COMPLEX
2342, 4r7dN, 0.5023, 4.06, 0.084, 211, 107, FAB HU 15C1
2343, 4mswA, 0.5023, 4.29, 0.088, 219, 113, Y78 ESTER MUTANT OF KCSA IN HIGH K+
2344, 4m62M, 0.5023, 4.19, 0.093, 113, 108, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
2345, 4i3rH, 0.5023, 4.36, 0.079, 228, 114, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
2346, 4g8fA, 0.5023, 3.87, 0.132, 184, 106, CRYSTAL STRUCTURE OF CLONE42 TCR
2347, 4ei6D, 0.5023, 3.97, 0.112, 241, 107, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
2348, 4ei5D, 0.5023, 4.02, 0.111, 242, 108, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
2349, 3zdzE, 0.5023, 4.05, 0.063, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2350, 3wiiI, 0.5023, 4.04, 0.090, 220, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
2351, 3phoA, 0.5023, 4.03, 0.111, 216, 108, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
2352, 3ogcA, 0.5023, 4.34, 0.088, 219, 113, KCSA E71A VARIANT IN PRESENCE OF NA+
2353, 3kpsD, 0.5023, 3.93, 0.152, 201, 105, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
2354, 3hmwH, 0.5023, 4.03, 0.063, 218, 111, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
2355, 3ef4C, 0.5023, 2.97, 0.136, 124, 88, CRYSTAL STRUCTURE OF NATIVE PSEUDOAZURIN FROM HYPHOMICROBIUM DENITRIFICANS
2356, 3clfH, 0.5023, 4.02, 0.081, 220, 111, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
2357, 2po6D, 0.5023, 3.95, 0.083, 244, 108, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2358, 1i7zC, 0.5023, 3.91, 0.103, 219, 107, ANTIBODY GNC92H2 BOUND TO LIGAND
2359, 6mxrL, 0.5022, 4.09, 0.083, 218, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
2360, 6dkpD, 0.5022, 3.98, 0.103, 192, 107, THE COMPLEX AMONG DMF5(ALPHA-D26Y; ALPHA-Y50A;BETA-L98W) TCR; HUMAN CLASS I MHC HLA-A2 AND MART-1(26-35)(A27L) PEPTIDE 
2361, 6dcvB, 0.5022, 4.14, 0.081, 226, 111, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2362, 5yw3B, 0.5022, 2.62, 0.140, 124, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN THR36LYS VARIANT 
2363, 5yfiH, 0.5022, 4.13, 0.061, 221, 114, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
2364, 5u17E, 0.5022, 3.96, 0.074, 244, 108, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2365, 5c0bI, 0.5022, 3.93, 0.103, 199, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
2366, 5c0aI, 0.5022, 3.91, 0.103, 197, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
2367, 4z7nE, 0.5022, 4.01, 0.064, 216, 110, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2368, 4xzuE, 0.5022, 4.06, 0.071, 208, 112, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2369, 4p1xB, 0.5022, 4.12, 0.055, 257, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2370, 4jzjA, 0.5022, 4.18, 0.062, 214, 113, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
2371, 3u46A, 0.5022, 3.95, 0.082, 225, 110, CH04H/CH02L P212121
2372, 3qynC, 0.5022, 3.76, 0.087, 196, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
2373, 3qfjD, 0.5022, 4.10, 0.102, 200, 108, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
2374, 3qdjE, 0.5022, 3.90, 0.075, 242, 107, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2375, 2vweL, 0.5022, 4.29, 0.088, 219, 114, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2376, 2oslA, 0.5022, 4.12, 0.089, 221, 112, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2377, 1tetH, 0.5022, 4.05, 0.071, 209, 112, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
2378, 1rjlB, 0.5022, 4.29, 0.088, 221, 114, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
2379, 1nn8T, 0.5022, 3.84, 0.065, 301, 108, CRYOEM STRUCTURE OF POLIOVIRUS RECEPTOR BOUND TO POLIOVIRUS
2380, 1nn8S, 0.5022, 3.84, 0.065, 301, 108, CRYOEM STRUCTURE OF POLIOVIRUS RECEPTOR BOUND TO POLIOVIRUS
2381, 1nn8R, 0.5022, 3.84, 0.065, 301, 108, CRYOEM STRUCTURE OF POLIOVIRUS RECEPTOR BOUND TO POLIOVIRUS
2382, 1hxmB, 0.5022, 4.21, 0.116, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
2383, 1afvK, 0.5022, 4.27, 0.087, 220, 115, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2384, 6fr8A, 0.5021, 3.89, 0.118, 202, 110, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2385, 6dwaA, 0.5021, 4.11, 0.102, 217, 108, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2386, 5ztdB, 0.5021, 2.76, 0.138, 124, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16VAL VARIANT 
2387, 5uddL, 0.5021, 4.11, 0.072, 221, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2388, 5mvzA, 0.5021, 4.26, 0.080, 221, 113, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
2389, 4wffE, 0.5021, 4.17, 0.080, 211, 112, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
2390, 4uujA, 0.5021, 4.38, 0.088, 219, 114, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
2391, 4p46A, 0.5021, 4.02, 0.120, 199, 108, J809.B5 Y31A TCR BOUND TO IAB3K
2392, 4odtL, 0.5021, 4.01, 0.084, 214, 107, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
2393, 4jfeE, 0.5021, 4.00, 0.110, 245, 109, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2394, 4jfdE, 0.5021, 4.02, 0.119, 245, 109, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2395, 4i9wG, 0.5021, 4.18, 0.080, 210, 112, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
2396, 3stzA, 0.5021, 4.37, 0.088, 219, 114, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
2397, 3qeqE, 0.5021, 3.76, 0.104, 243, 106, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2398, 3pqyJ, 0.5021, 3.79, 0.123, 240, 106, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2399, 3ffcE, 0.5021, 4.00, 0.101, 247, 109, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
2400, 2r4rH, 0.5021, 4.23, 0.107, 217, 112, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2401, 2h32H, 0.5021, 4.08, 0.071, 211, 112, CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
2402, 1xf5C, 0.5021, 4.07, 0.093, 220, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
2403, 1uwxM, 0.5021, 4.05, 0.072, 218, 111, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
2404, 1eajA, 0.5021, 4.07, 0.064, 124, 110, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
2405, 6mnnA, 0.5020, 3.98, 0.120, 196, 108, 6236 TCR BOUND TO I-AB PADI4 
2406, 6jjdB, 0.5020, 4.37, 0.064, 193, 110, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) FULL VLP 
2407, 6dc9M, 0.5020, 4.08, 0.084, 215, 107, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
2408, 4r97C, 0.5020, 4.07, 0.081, 218, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
2409, 4p1xH, 0.5020, 4.12, 0.055, 258, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2410, 4djmB, 0.5020, 3.20, 0.106, 202, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
2411, 3ze0E, 0.5020, 4.06, 0.063, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2412, 3stlA, 0.5020, 4.38, 0.088, 219, 114, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
2413, 3riaH, 0.5020, 4.03, 0.072, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2414, 3rhwH, 0.5020, 4.03, 0.072, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2415, 3nifE, 0.5020, 4.06, 0.063, 216, 111, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2416, 2vxvH, 0.5020, 4.05, 0.073, 222, 110, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
2417, 2jkwA, 0.5020, 2.78, 0.138, 124, 87, PSEUDOAZURIN M16F
2418, 2itcA, 0.5020, 4.37, 0.088, 219, 114, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
2419, 2hfeA, 0.5020, 4.38, 0.088, 219, 114, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2420, 1nqbA, 0.5020, 3.92, 0.065, 232, 108, TRIVALENT ANTIBODY FRAGMENT
2421, 1lk3H, 0.5020, 4.30, 0.070, 219, 114, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
2422, 6fxnD, 0.5019, 4.10, 0.054, 215, 111, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2423, 6fr7A, 0.5019, 3.90, 0.118, 203, 110, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2424, 6dfvA, 0.5019, 4.01, 0.083, 190, 108, MOUSE DIABETOGENIC TCR 8F10 
2425, 5xotD, 0.5019, 3.97, 0.111, 203, 108, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
2426, 5tpwH, 0.5019, 4.09, 0.080, 211, 112, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT THE GLUN2A
2427, 5mhrP, 0.5019, 4.25, 0.061, 213, 114, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2428, 5jziD, 0.5019, 4.00, 0.110, 207, 109, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
2429, 5j9pA, 0.5019, 4.39, 0.088, 219, 114, KCSA IN VITRO
2430, 4risH, 0.5019, 4.03, 0.081, 228, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
2431, 4jo4M, 0.5019, 4.04, 0.075, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
2432, 3vi3H, 0.5019, 3.92, 0.065, 218, 108, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
2433, 3sqoL, 0.5019, 3.91, 0.113, 213, 106, PCSK9 J16 FAB COMPLEX
2434, 3rifH, 0.5019, 4.07, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2435, 3ri5I, 0.5019, 4.01, 0.072, 199, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2436, 3o9wC, 0.5019, 4.00, 0.157, 203, 108, RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
2437, 3erxA, 0.5019, 2.54, 0.174, 123, 86, HIGH-RESOLUTION STRUCTURE OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN
2438, 3ef4B, 0.5019, 2.74, 0.138, 124, 87, CRYSTAL STRUCTURE OF NATIVE PSEUDOAZURIN FROM HYPHOMICROBIUM DENITRIFICANS
2439, 2p7tA, 0.5019, 4.30, 0.088, 219, 113, CRYSTAL STRUCTURE OF KCSA MUTANT
2440, 2ok0H, 0.5019, 4.16, 0.089, 216, 112, FAB ED10-DNA COMPLEX
2441, 2nw2A, 0.5019, 3.94, 0.140, 196, 107, CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
2442, 2nljB, 0.5019, 4.31, 0.088, 218, 113, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
2443, 2ih3A, 0.5019, 4.40, 0.087, 219, 115, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2444, 2hvkA, 0.5019, 4.30, 0.088, 219, 113, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
2445, 2cdeF, 0.5019, 3.96, 0.064, 244, 109, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2446, 2b1hH, 0.5019, 4.18, 0.080, 226, 112, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
2447, 1t5rE, 0.5019, 4.28, 0.045, 271, 112, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2448, 1oazJ, 0.5019, 4.07, 0.089, 122, 112, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
2449, 1figL, 0.5019, 4.07, 0.112, 215, 107, ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
2450, 6qeeC, 0.5018, 4.22, 0.089, 225, 112, NANODISC RECONSTITUTED HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)-EQ MUTANT IN COMPLEX WITH UIC2 FAB AND ZOSUQUIDAR. 
2451, 6jmqC, 0.5018, 4.22, 0.053, 214, 113, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
2452, 6jjdC, 0.5018, 4.34, 0.064, 216, 110, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) FULL VLP 
2453, 6jjcC, 0.5018, 4.42, 0.063, 216, 111, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) SEMI-EMPTY VLP 
2454, 5w06H, 0.5018, 4.26, 0.071, 216, 113, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
2455, 5uddJ, 0.5018, 4.11, 0.072, 224, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2456, 5mvjD, 0.5018, 4.02, 0.131, 218, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2457, 5mp5D, 0.5018, 4.02, 0.131, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2458, 5kbdB, 0.5018, 3.60, 0.098, 201, 102, STRUCTURAL STUDIES OF TRANSCRIPTION FACTOR P73 DNA BINDING DOMAIN BOUND TO PA26 20-MER RESPONSE ELEMENT
2459, 5cmaA, 0.5018, 4.05, 0.084, 213, 107, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
2460, 4r7nN, 0.5018, 4.06, 0.084, 211, 107, FAB C2E3
2461, 4r7dF, 0.5018, 4.07, 0.084, 211, 107, FAB HU 15C1
2462, 4mzrB, 0.5018, 3.77, 0.078, 234, 103, CRYSTAL STRUCTURE OF A POLYPEPTIDE P53 MUTANT BOUND TO DNA
2463, 4mxvE, 0.5018, 3.99, 0.112, 211, 107, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2464, 3us0D, 0.5018, 3.75, 0.087, 192, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
2465, 3qh3B, 0.5018, 3.76, 0.085, 245, 106, THE CRYSTAL STRUCTURE OF TCR A6
2466, 3qeuA, 0.5018, 4.05, 0.111, 195, 108, THE CRYSTAL STRUCTURE OF TCR DMF5
2467, 3opzH, 0.5018, 4.08, 0.054, 220, 111, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
2468, 2zg1A, 0.5018, 4.01, 0.084, 208, 107, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF SIGLEC-5 IN COMPLEX WITH 6 -SIALYLLACTOSE
2469, 2n7aA, 0.5018, 4.06, 0.102, 145, 108, SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN
2470, 2gcyA, 0.5018, 4.18, 0.083, 216, 109, HUMANIZED ANTIBODY C25 FAB FRAGMENT
2471, 2f54K, 0.5018, 3.91, 0.111, 206, 108, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2472, 2b1aH, 0.5018, 4.18, 0.080, 226, 112, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
2473, 1r3iH, 0.5018, 4.39, 0.087, 219, 115, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
2474, 1p5uA, 0.5018, 3.06, 0.097, 206, 93, X-RAY STRUCTURE OF THE TERNARY CAF1M:CAF1:CAF1 CHAPERONE:SUBUNIT:SUBUNIT COMPLEX
2475, 1mjjA, 0.5018, 4.07, 0.084, 218, 107, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2476, 1fgnH, 0.5018, 4.20, 0.080, 214, 113, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
2477, 6nz7L, 0.5017, 3.95, 0.084, 214, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
2478, 6jmrC, 0.5017, 4.16, 0.054, 214, 112, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
2479, 6bzuH, 0.5017, 4.22, 0.120, 215, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2480, 5wkfI, 0.5017, 3.74, 0.132, 198, 106, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
2481, 5u72E, 0.5017, 3.97, 0.074, 243, 108, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2482, 5u6qE, 0.5017, 3.96, 0.083, 244, 108, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2483, 5gzoL, 0.5017, 3.92, 0.094, 213, 106, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2484, 5epmE, 0.5017, 4.13, 0.089, 218, 112, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
2485, 4z92C, 0.5017, 4.05, 0.029, 257, 105, CRYSTAL STRUCTURE OF PARECHOVIRUS-1 VIRION
2486, 4wfgG, 0.5017, 4.17, 0.080, 210, 112, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
2487, 4gkzA, 0.5017, 3.96, 0.127, 202, 110, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
2488, 4g8gD, 0.5017, 4.05, 0.110, 204, 109, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
2489, 4etqA, 0.5017, 4.13, 0.080, 217, 113, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
2490, 4dcqB, 0.5017, 4.14, 0.071, 218, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10 AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM)
2491, 3u9pL, 0.5017, 4.03, 0.093, 212, 107, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
2492, 3nigH, 0.5017, 4.04, 0.063, 216, 111, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2493, 3lhpL, 0.5017, 4.12, 0.056, 111, 108, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
2494, 3iu4L, 0.5017, 4.04, 0.112, 213, 107, ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
2495, 3bj91, 0.5017, 4.16, 0.156, 116, 109, CRYSTAL STRUCTURE OF THE SURROGATE LIGHT CHAIN VARIABLE DOMAIN VPREBJ
2496, 1uwxH, 0.5017, 4.06, 0.072, 218, 111, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
2497, 1rzgA, 0.5017, 4.02, 0.072, 223, 111, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
2498, 1qseD, 0.5017, 4.05, 0.093, 200, 108, STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
2499, 1iaiH, 0.5017, 4.07, 0.080, 219, 112, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
2500, 6r2sA, 0.5016, 3.96, 0.093, 213, 107, THE STRUCTURE OF PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO HUMAN ANTIBODY DB9 
2501, 6fr6A, 0.5016, 4.02, 0.136, 202, 110, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2502, 6erxD, 0.5016, 4.20, 0.054, 215, 112, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2503, 5wkhD, 0.5016, 3.77, 0.113, 198, 106, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
2504, 5w0kL, 0.5016, 4.08, 0.112, 210, 107, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2505, 5tz2H, 0.5016, 4.24, 0.080, 213, 113, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
2506, 5swsE, 0.5016, 3.84, 0.123, 239, 106, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
2507, 5mvjB, 0.5016, 4.04, 0.131, 218, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2508, 5d7iF, 0.5016, 3.97, 0.074, 243, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
2509, 5d2lO, 0.5016, 3.95, 0.120, 187, 108, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2510, 5b1jC, 0.5016, 2.54, 0.128, 124, 86, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
2511, 4oduB, 0.5016, 4.05, 0.084, 212, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
2512, 4nqcH, 0.5016, 3.97, 0.074, 243, 108, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2513, 4ma7H, 0.5016, 4.19, 0.080, 218, 113, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
2514, 4l4tE, 0.5016, 3.97, 0.074, 243, 108, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
2515, 4eupG, 0.5016, 4.06, 0.102, 201, 108, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
2516, 4elmF, 0.5016, 4.03, 0.111, 224, 108, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
2517, 4alaH, 0.5016, 3.98, 0.082, 208, 110, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
2518, 3wxvH, 0.5016, 4.01, 0.064, 119, 110, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1
2519, 3us0B, 0.5016, 3.76, 0.087, 193, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
2520, 3ri5G, 0.5016, 4.12, 0.071, 200, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2521, 3pqyE, 0.5016, 3.76, 0.105, 240, 105, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2522, 3opzI, 0.5016, 4.09, 0.054, 220, 111, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
2523, 3nidH, 0.5016, 4.05, 0.063, 216, 111, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2524, 3idyL, 0.5016, 4.05, 0.074, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
2525, 3idyC, 0.5016, 4.05, 0.074, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
2526, 3f7vA, 0.5016, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
2527, 2po6H, 0.5016, 3.95, 0.083, 244, 108, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2528, 2itdA, 0.5016, 4.37, 0.088, 219, 114, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
2529, 2dweA, 0.5016, 4.30, 0.088, 219, 113, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
2530, 1mhhB, 0.5016, 4.10, 0.089, 215, 112, ANTIBODY-ANTIGEN COMPLEX
2531, 1dbmH, 0.5016, 3.94, 0.036, 219, 111, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2532, 1b6dA, 0.5016, 4.00, 0.084, 212, 107, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
2533, 6qexC, 0.5015, 4.19, 0.088, 225, 113, NANODISC RECONSTITUTED HUMAN ABCB1 IN COMPLEX WITH UIC2 FAB AND TAXOL 
2534, 6dfqD, 0.5015, 3.83, 0.084, 237, 107, MOUSE DIABETOGENIC TCR I.29 
2535, 5swsD, 0.5015, 4.07, 0.101, 198, 109, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
2536, 5otjB, 0.5015, 4.09, 0.072, 222, 111, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2537, 5it2H, 0.5015, 4.19, 0.080, 218, 112, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY 693-10-B06 FAB FRAGMENT
2538, 5hdbH, 0.5015, 4.05, 0.063, 216, 111, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
2539, 4z7oH, 0.5015, 4.05, 0.072, 216, 111, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2540, 4wfeG, 0.5015, 4.17, 0.080, 210, 112, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
2541, 4rgnD, 0.5015, 4.24, 0.088, 210, 113, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2542, 4p3dL, 0.5015, 4.16, 0.120, 218, 108, MT1-MMP:FAB COMPLEX (FORM II)
2543, 4nqeE, 0.5015, 3.97, 0.074, 243, 108, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2544, 4nqdE, 0.5015, 3.97, 0.083, 243, 108, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2545, 4izlA, 0.5015, 4.13, 0.064, 280, 110, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2546, 4iycA, 0.5015, 4.10, 0.045, 277, 110, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
2547, 4gq9H, 0.5015, 4.01, 0.081, 218, 111, CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
2548, 3vxqB, 0.5015, 3.90, 0.103, 242, 107, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
2549, 3utsI, 0.5015, 4.01, 0.102, 201, 108, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
2550, 3p0vM, 0.5015, 4.02, 0.084, 212, 107, ANTI-EGFR/HER3 FAB DL11 ALONE
2551, 3hujE, 0.5015, 3.99, 0.092, 199, 109, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
2552, 3h9sE, 0.5015, 3.93, 0.084, 245, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE
2553, 2zpkH, 0.5015, 4.15, 0.071, 207, 112, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
2554, 2zahB, 0.5015, 4.36, 0.047, 296, 106, X-RAY STRUCTURE OF MELON NECROTIC SPOT VIRUS
2555, 1x9rB, 0.5015, 2.92, 0.130, 104, 92, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE OXIDISED FORM
2556, 1k4dA, 0.5015, 4.42, 0.087, 219, 115, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
2557, 1f5wA, 0.5015, 4.08, 0.064, 124, 110, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
2558, 6iuvC, 0.5014, 4.24, 0.062, 224, 113, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
2559, 6igtB, 0.5014, 4.10, 0.092, 117, 109, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
2560, 5mp5L, 0.5014, 4.03, 0.131, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2561, 5mp5F, 0.5014, 4.03, 0.131, 216, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2562, 5ec1A, 0.5014, 4.29, 0.088, 219, 113, KCSA WITH V76ESTER MUTATION
2563, 5ebwA, 0.5014, 4.31, 0.088, 218, 113, KCSA WITH G77ESTER MUTATION
2564, 4s1sH, 0.5014, 4.24, 0.080, 228, 113, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H5.F-185917 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
2565, 4nrzH, 0.5014, 4.17, 0.089, 226, 112, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
2566, 4n2mA, 0.5014, 3.89, 0.114, 643, 105, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (E354A 0 MM CA2+)
2567, 4guqB, 0.5014, 3.94, 0.095, 198, 105, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
2568, 4en3B, 0.5014, 3.93, 0.084, 240, 107, CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
2569, 4elkD, 0.5014, 4.08, 0.111, 242, 108, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
2570, 4djmG, 0.5014, 3.21, 0.106, 199, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
2571, 3utpK, 0.5014, 4.01, 0.102, 201, 108, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
2572, 3sknG, 0.5014, 4.04, 0.103, 197, 107, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
2573, 3s96A, 0.5014, 4.04, 0.072, 218, 111, CRYSTAL STRUCTURE OF 3B5H10
2574, 3qh3C, 0.5014, 4.06, 0.093, 194, 108, THE CRYSTAL STRUCTURE OF TCR A6
2575, 3p11L, 0.5014, 4.03, 0.084, 211, 107, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION
2576, 3nifH, 0.5014, 4.06, 0.063, 219, 111, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2577, 3fb5A, 0.5014, 4.30, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
2578, 2xzqH, 0.5014, 4.00, 0.090, 215, 111, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF
2579, 2pyeD, 0.5014, 4.00, 0.101, 195, 109, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
2580, 2jk5A, 0.5014, 4.31, 0.088, 219, 113, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
2581, 1qfuH, 0.5014, 4.24, 0.096, 223, 114, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2582, 1q9wD, 0.5014, 3.97, 0.082, 226, 110, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2583, 1i9eA, 0.5014, 3.79, 0.113, 115, 106, TCR DOMAIN
2584, 6ol5B, 0.5013, 4.00, 0.103, 213, 107, STRUCTURE OF IGLB12 FAB IN COMPLEX WITH ANTI-IDIOTYPE IB3 FAB 
2585, 6ddvB, 0.5013, 4.24, 0.071, 222, 113, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2586, 6by2A, 0.5013, 4.31, 0.088, 219, 113, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
2587, 6am5E, 0.5013, 3.99, 0.074, 242, 108, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE SMLGIGIVPV 
2588, 5u16H, 0.5013, 3.97, 0.074, 243, 108, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2589, 5t0yI, 0.5013, 4.08, 0.071, 217, 112, 2A10 ANTIBODY FAB FRAGMENT
2590, 5o14L, 0.5013, 3.99, 0.084, 212, 107, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2591, 5jueH, 0.5013, 4.21, 0.088, 225, 113, CRYSTAL STRUCTURE OF UIC2 FAB
2592, 5dr5L, 0.5013, 4.01, 0.084, 215, 107, CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097
2593, 4zezI, 0.5013, 3.95, 0.110, 207, 109, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
2594, 4z7qH, 0.5013, 4.04, 0.072, 216, 111, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
2595, 4yxlH, 0.5013, 4.29, 0.079, 218, 114, CRYSTAL STRUCTURE OF SYRIAN HAMSTER PRION PROTEIN COMPLEXED WITH POM1 FAB
2596, 4x7tH, 0.5013, 4.11, 0.080, 222, 112, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2597, 4u6hA, 0.5013, 4.10, 0.071, 217, 112, VACCINIA L1/M12B9-FAB COMPLEX
2598, 4rgnF, 0.5013, 4.24, 0.088, 210, 113, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2599, 4n2hA, 0.5013, 4.05, 0.112, 639, 107, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D177A 0 MM CA2+)
2600, 4grmB, 0.5013, 3.65, 0.087, 240, 104, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
2601, 4gg6F, 0.5013, 3.84, 0.075, 243, 107, PROTEIN COMPLEX
2602, 3qeqD, 0.5013, 3.86, 0.152, 194, 105, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2603, 3phqA, 0.5013, 4.10, 0.102, 216, 108, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
2604, 3l5wA, 0.5013, 4.02, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
2605, 3fb7A, 0.5013, 4.30, 0.088, 219, 113, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
2606, 3dxaO, 0.5013, 3.84, 0.103, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2607, 1uweX, 0.5013, 3.91, 0.132, 213, 106, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2608, 1uweL, 0.5013, 4.00, 0.121, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2609, 1nj9H, 0.5013, 4.16, 0.062, 215, 112, COCAINE HYDROLYTIC ANTIBODY 15A10
2610, 1fskL, 0.5013, 4.26, 0.097, 220, 113, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2611, 1fskI, 0.5013, 4.26, 0.097, 220, 113, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2612, 1fskF, 0.5013, 4.26, 0.097, 220, 113, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2613, 1fskC, 0.5013, 4.26, 0.097, 220, 113, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2614, 6oc3D, 0.5012, 3.92, 0.094, 213, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
2615, 6igtD, 0.5012, 4.10, 0.092, 116, 109, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
2616, 5wkhI, 0.5012, 3.75, 0.132, 198, 106, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
2617, 5tq0H, 0.5012, 4.12, 0.080, 212, 113, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN THE PRESENCE OF EDTA
2618, 5o14D, 0.5012, 4.02, 0.084, 215, 107, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2619, 4x7tB, 0.5012, 4.02, 0.084, 218, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2620, 4w2pA, 0.5012, 3.91, 0.064, 126, 109, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
2621, 4p4kD, 0.5012, 3.80, 0.104, 241, 106, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
2622, 4ofyA, 0.5012, 3.99, 0.087, 230, 104, CRYSTAL STRUCTURE OF THE COMPLEX OF SYG-1 D1-D2 AND SYG-2 D1-D4
2623, 4kq4L, 0.5012, 3.95, 0.132, 214, 106, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
2624, 4dzbB, 0.5012, 4.00, 0.111, 244, 108, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
2625, 3ze0H, 0.5012, 4.05, 0.072, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2626, 3v4vM, 0.5012, 4.18, 0.080, 213, 113, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
2627, 3qynB, 0.5012, 3.64, 0.087, 193, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
2628, 3p0vL, 0.5012, 4.03, 0.084, 212, 107, ANTI-EGFR/HER3 FAB DL11 ALONE
2629, 3j2zH, 0.5012, 4.01, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2630, 3j2zF, 0.5012, 4.01, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2631, 3j2zD, 0.5012, 4.01, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2632, 3j2zB, 0.5012, 4.01, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2633, 3j2yH, 0.5012, 4.01, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2634, 3j2yF, 0.5012, 4.01, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2635, 3j2yD, 0.5012, 4.01, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2636, 3j2yB, 0.5012, 4.01, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2637, 3gi9H, 0.5012, 4.30, 0.096, 217, 114, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2638, 3d3vD, 0.5012, 4.05, 0.093, 200, 108, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(34-DIFLUOROPHENYLALANINE)) PEPTIDE
2639, 2ih1A, 0.5012, 4.29, 0.088, 219, 113, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2640, 2atkA, 0.5012, 4.46, 0.087, 219, 115, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
2641, 1tupC, 0.5012, 3.85, 0.038, 195, 104, TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA
2642, 1iqwH, 0.5012, 4.19, 0.097, 221, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
2643, 6dkpE, 0.5011, 3.99, 0.074, 242, 108, THE COMPLEX AMONG DMF5(ALPHA-D26Y; ALPHA-Y50A;BETA-L98W) TCR; HUMAN CLASS I MHC HLA-A2 AND MART-1(26-35)(A27L) PEPTIDE 
2644, 5xctA, 0.5011, 4.05, 0.072, 167, 111, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
2645, 5udcE, 0.5011, 4.16, 0.071, 220, 112, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2646, 5u6qG, 0.5011, 3.99, 0.074, 239, 108, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2647, 5kzpG, 0.5011, 3.96, 0.082, 226, 110, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
2648, 5iw1A, 0.5011, 4.07, 0.093, 189, 108, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
2649, 5eu6E, 0.5011, 3.97, 0.138, 244, 109, HLA CLASS I ANTIGEN
2650, 4x6dG, 0.5011, 3.95, 0.093, 200, 107, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
2651, 4x6cF, 0.5011, 3.87, 0.075, 243, 107, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2652, 4r7dH, 0.5011, 4.08, 0.075, 212, 107, FAB HU 15C1
2653, 4p3cL, 0.5011, 4.06, 0.121, 218, 107, MT1-MMP:FAB COMPLEX (FORM I)
2654, 4nrxD, 0.5011, 4.27, 0.088, 228, 113, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2655, 4lcuA, 0.5011, 4.31, 0.088, 219, 113, STRUCTURE OF KCSA WITH E118A MUTATION
2656, 3zdxH, 0.5011, 4.05, 0.072, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2657, 3vxsE, 0.5011, 3.89, 0.093, 242, 107, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
2658, 3vg9C, 0.5011, 4.24, 0.080, 224, 113, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
2659, 3ujtH, 0.5011, 4.30, 0.088, 207, 113, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
2660, 3qynD, 0.5011, 3.64, 0.087, 190, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
2661, 3p0yL, 0.5011, 4.02, 0.084, 213, 107, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
2662, 3or7A, 0.5011, 4.29, 0.088, 219, 113, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
2663, 3mxvH, 0.5011, 4.15, 0.089, 220, 112, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
2664, 1tsrC, 0.5011, 3.85, 0.038, 195, 104, P53 CORE DOMAIN IN COMPLEX WITH DNA
2665, 1t5rA, 0.5011, 4.14, 0.054, 265, 111, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2666, 1r3lB, 0.5011, 4.31, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
2667, 6e4xY, 0.5010, 3.73, 0.106, 208, 104, HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2) 
2668, 6e3hH, 0.5010, 4.08, 0.072, 226, 111, CRYSTAL STRUCTURE OF S9-3-37 BOUND TO H5 INFLUENZA HEMAGGLUTININ 
2669, 5yw3D, 0.5010, 2.56, 0.128, 124, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN THR36LYS VARIANT 
2670, 5vkeA, 0.5010, 4.30, 0.088, 219, 113, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
2671, 5tq2H, 0.5010, 4.05, 0.080, 205, 112, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT GLUN1 AND GLUN2A
2672, 5tljF, 0.5010, 4.16, 0.100, 219, 110, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
2673, 5lgyA, 0.5010, 3.77, 0.058, 196, 103, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
2674, 5c0aD, 0.5010, 3.92, 0.103, 197, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
2675, 3us2G, 0.5010, 3.70, 0.097, 193, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
2676, 3us2C, 0.5010, 3.70, 0.097, 193, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
2677, 3us2A, 0.5010, 3.70, 0.097, 193, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
2678, 3t3pE, 0.5010, 4.06, 0.072, 214, 111, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2679, 3t3mE, 0.5010, 4.05, 0.072, 214, 111, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2680, 3s96C, 0.5010, 4.12, 0.071, 218, 112, CRYSTAL STRUCTURE OF 3B5H10
2681, 3pqyS, 0.5010, 3.76, 0.173, 174, 104, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2682, 3mltH, 0.5010, 4.17, 0.062, 215, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
2683, 1qrnD, 0.5010, 4.02, 0.093, 200, 108, CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
2684, 1ncbH, 0.5010, 4.16, 0.080, 221, 113, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2685, 1bqrA, 0.5010, 2.79, 0.126, 124, 87, REDUCED PSEUDOAZURIN
2686, 6mtoH, 0.5009, 4.18, 0.062, 219, 113, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
2687, 5xcrA, 0.5009, 4.07, 0.055, 166, 110, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
2688, 5szfH, 0.5009, 4.10, 0.071, 217, 112, 2A10 FAB FRAGMENT 2.54 ANGSTOMS
2689, 5mvzH, 0.5009, 4.29, 0.079, 221, 114, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
2690, 5mp5B, 0.5009, 4.03, 0.131, 217, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2691, 5girH, 0.5009, 4.20, 0.116, 208, 112, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
2692, 5bq7A, 0.5009, 4.09, 0.071, 220, 112, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT
2693, 4z7qE, 0.5009, 4.06, 0.072, 214, 111, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
2694, 4r7nL, 0.5009, 4.08, 0.084, 211, 107, FAB C2E3
2695, 4pj8C, 0.5009, 3.95, 0.131, 197, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
2696, 3ze1H, 0.5009, 4.05, 0.072, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2697, 3vwjC, 0.5009, 4.07, 0.092, 193, 109, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
2698, 3us2I, 0.5009, 3.71, 0.097, 193, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
2699, 3uluF, 0.5009, 4.36, 0.096, 217, 114, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2700, 3sdxF, 0.5009, 3.87, 0.084, 242, 107, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2701, 3pqyO, 0.5009, 3.85, 0.104, 240, 106, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2702, 3ixxG, 0.5009, 4.13, 0.089, 221, 112, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
2703, 3dxaI, 0.5009, 4.05, 0.131, 199, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2704, 3d39D, 0.5009, 4.07, 0.093, 200, 108, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
2705, 2q8aH, 0.5009, 4.19, 0.082, 199, 110, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2706, 2h8pA, 0.5009, 4.29, 0.088, 219, 113, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2707, 1yuhB, 0.5009, 4.23, 0.088, 218, 114, FAB FRAGMENT
2708, 1x9uA, 0.5009, 3.10, 0.129, 105, 93, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE REDUCED FORM
2709, 1rfdL, 0.5009, 3.90, 0.104, 218, 106, ANTI-COCAINE ANTIBODY M82G2
2710, 1hklH, 0.5009, 4.08, 0.098, 217, 112, FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
2711, 6r3kA, 0.5008, 4.06, 0.094, 126, 106, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR 
2712, 6igtC, 0.5008, 4.08, 0.082, 116, 110, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
2713, 6d78E, 0.5008, 3.84, 0.075, 240, 106, THE COMPLEX BETWEEN HIGH-AFFINITY TCR DMF5(ALPHA-D26Y;BETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35)PEPTIDE 
2714, 6cdmD, 0.5008, 4.08, 0.098, 218, 112, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2715, 6avgB, 0.5008, 3.89, 0.132, 196, 106, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
2716, 5ysgC, 0.5008, 2.80, 0.138, 119, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
2717, 5v7rL, 0.5008, 4.00, 0.103, 215, 107, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-7.1 FAB
2718, 5bzdA, 0.5008, 4.03, 0.084, 213, 107, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2719, 5bk3B, 0.5008, 4.08, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2720, 4qrrE, 0.5008, 3.80, 0.094, 241, 106, CRYSTAL STRUCTURE OF HLA B*3501-IPS IN COMPLEX WITH A DELTA-BETA TCR CLONE 12 TCR
2721, 4qokD, 0.5008, 3.92, 0.112, 194, 107, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
2722, 4pj5E, 0.5008, 3.98, 0.083, 243, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
2723, 4p23A, 0.5008, 4.03, 0.120, 199, 108, J809.B5 TCR BOUND TO IAB/3K
2724, 4mxvL, 0.5008, 4.02, 0.112, 211, 107, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2725, 4l4vE, 0.5008, 3.97, 0.083, 243, 108, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
2726, 4hfuH, 0.5008, 4.26, 0.071, 224, 113, CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
2727, 4bwuB, 0.5008, 2.53, 0.174, 123, 86, THREE-DIMENSIONAL STRUCTURE OF THE K109A MUTANT OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN AT PH 5.5
2728, 3utsE, 0.5008, 3.96, 0.073, 246, 109, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
2729, 3us1A, 0.5008, 3.71, 0.097, 193, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR RESPONSE ELEMENT CONTAINING A TWO BASE PAIR GC SPACER BETWEEN HALF SITES
2730, 3u46H, 0.5008, 3.96, 0.082, 228, 110, CH04H/CH02L P212121
2731, 3pl6C, 0.5008, 4.10, 0.128, 191, 109, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
2732, 3of6A, 0.5008, 3.89, 0.120, 240, 108, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
2733, 3jbf7, 0.5008, 3.92, 0.101, 123, 109, COMPLEX OF POLIOVIRUS WITH VHH PVSP19B
2734, 3hplA, 0.5008, 4.41, 0.087, 219, 115, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
2735, 2xqyJ, 0.5008, 4.38, 0.096, 216, 114, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
2736, 2oz4L, 0.5008, 4.03, 0.103, 214, 107, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2737, 2nr6E, 0.5008, 4.04, 0.121, 211, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2738, 2jkwB, 0.5008, 2.75, 0.149, 124, 87, PSEUDOAZURIN M16F
2739, 2ak4N, 0.5008, 4.14, 0.108, 204, 111, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
2740, 1xcqB, 0.5008, 4.13, 0.089, 218, 112, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2741, 1t5rC, 0.5008, 4.14, 0.054, 269, 111, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2742, 1r3kB, 0.5008, 4.30, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
2743, 1ogaD, 0.5008, 3.83, 0.133, 199, 105, A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
2744, 6oc3B, 0.5007, 3.92, 0.094, 213, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
2745, 6fy1H, 0.5007, 4.10, 0.080, 226, 112, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
2746, 6fy0I, 0.5007, 4.05, 0.090, 216, 111, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2747, 6ey0F, 0.5007, 3.91, 0.092, 131, 109, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
2748, 5w1vN, 0.5007, 3.99, 0.140, 202, 107, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
2749, 5niuA, 0.5007, 4.07, 0.094, 126, 106, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
2750, 5hyjE, 0.5007, 3.96, 0.073, 246, 109, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
2751, 5c09I, 0.5007, 3.80, 0.104, 200, 106, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
2752, 5bzwA, 0.5007, 4.02, 0.084, 213, 107, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2753, 5a3iC, 0.5007, 4.29, 0.070, 226, 114, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
2754, 4zdhA, 0.5007, 3.91, 0.075, 201, 106, CRYSTAL STRUCTURE OF JKA6 TCR
2755, 4z7nH, 0.5007, 4.06, 0.072, 216, 111, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2756, 4r7dJ, 0.5007, 4.07, 0.084, 212, 107, FAB HU 15C1
2757, 4r7dD, 0.5007, 4.08, 0.084, 211, 107, FAB HU 15C1
2758, 4mayC, 0.5007, 4.09, 0.128, 191, 109, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
2759, 4ma8H, 0.5007, 4.30, 0.079, 218, 114, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
2760, 4lccB, 0.5007, 3.99, 0.074, 238, 108, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1
2761, 4l5fL, 0.5007, 4.01, 0.112, 213, 107, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
2762, 4jffD, 0.5007, 4.04, 0.102, 197, 108, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2763, 4g9fE, 0.5007, 3.72, 0.076, 250, 105, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
2764, 4bxvB, 0.5007, 2.64, 0.163, 123, 86, THREE-DIMENSIONAL STRUCTURE OF THE MUTANT K109A OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN AT PH 7.0
2765, 3v4vH, 0.5007, 4.18, 0.080, 211, 113, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
2766, 3rdtA, 0.5007, 4.02, 0.120, 199, 108, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
2767, 3dxaD, 0.5007, 3.95, 0.123, 199, 106, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2768, 3bkyH, 0.5007, 4.08, 0.081, 226, 111, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
2769, 2xraL, 0.5007, 4.03, 0.093, 215, 107, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
2770, 2vc2H, 0.5007, 4.02, 0.073, 219, 110, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
2771, 2ialB, 0.5007, 3.82, 0.066, 239, 106, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2772, 2gj6D, 0.5007, 4.08, 0.093, 200, 108, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2773, 2bdnH, 0.5007, 4.21, 0.080, 217, 113, CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY 11K2
2774, 1zibA, 0.5007, 2.76, 0.126, 124, 87, REDUCED PSEUDOAZURIN
2775, 1yntD, 0.5007, 4.06, 0.098, 218, 112, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
2776, 1xedD, 0.5007, 3.36, 0.091, 105, 99, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2777, 1r3jB, 0.5007, 4.29, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
2778, 1kj2B, 0.5007, 3.83, 0.096, 117, 104, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
2779, 6nz7I, 0.5006, 3.97, 0.093, 214, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
2780, 5sx4L, 0.5006, 3.98, 0.075, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
2781, 5nixA, 0.5006, 4.06, 0.094, 126, 106, STRUCTURE OF HUMAN PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) WITH LOW MOLECULAR MASS INHIBITOR
2782, 5iw1E, 0.5006, 4.05, 0.101, 189, 109, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
2783, 4x7sL, 0.5006, 4.01, 0.084, 218, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
2784, 4wfhE, 0.5006, 4.22, 0.080, 211, 113, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
2785, 4p3dB, 0.5006, 4.16, 0.120, 218, 108, MT1-MMP:FAB COMPLEX (FORM II)
2786, 4ozfG, 0.5006, 3.89, 0.132, 193, 106, JR5.1 PROTEIN COMPLEX
2787, 4gg6H, 0.5006, 3.90, 0.083, 243, 108, PROTEIN COMPLEX
2788, 3vxrE, 0.5006, 3.95, 0.093, 242, 108, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
2789, 3t3pH, 0.5006, 4.04, 0.072, 216, 111, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2790, 3ri5J, 0.5006, 4.11, 0.071, 215, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2791, 3pwpD, 0.5006, 4.07, 0.093, 200, 108, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
2792, 3o2dL, 0.5006, 4.16, 0.102, 216, 108, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
2793, 3nidE, 0.5006, 4.06, 0.063, 214, 111, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2794, 3mxwH, 0.5006, 4.06, 0.090, 220, 111, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
2795, 3mnvB, 0.5006, 4.07, 0.099, 208, 111, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
2796, 3dxaJ, 0.5006, 3.88, 0.103, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2797, 3dxaE, 0.5006, 3.87, 0.103, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2798, 3dggA, 0.5006, 4.06, 0.084, 217, 107, CRYSTAL STRUCTURE OF FABOX108
2799, 3bdyL, 0.5006, 4.22, 0.110, 217, 109, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
2800, 2p5wE, 0.5006, 3.80, 0.085, 242, 106, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2801, 6my4L, 0.5005, 4.08, 0.083, 218, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
2802, 6bzuB, 0.5005, 4.21, 0.130, 216, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2803, 6awnB, 0.5005, 4.28, 0.079, 218, 114, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2804, 5xmoA, 0.5005, 2.62, 0.140, 124, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16PHE/THR36LYS VARIANT 
2805, 5u72G, 0.5005, 3.85, 0.084, 243, 107, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2806, 4x6bA, 0.5005, 3.95, 0.103, 196, 107, BK6 TCR APO STRUCTURE
2807, 4qlrA, 0.5005, 3.93, 0.110, 130, 109, LLAMA NANOBODY N02 RAISED AGAINST EAEC T6SS TSSM
2808, 4n2dA, 0.5005, 4.09, 0.131, 636, 107, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D123N 0 MM CA2+)
2809, 4iycD, 0.5005, 4.11, 0.055, 278, 110, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
2810, 3zdzH, 0.5005, 4.06, 0.072, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2811, 3v4pM, 0.5005, 4.08, 0.080, 211, 112, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
2812, 3sobL, 0.5005, 4.04, 0.103, 213, 107, THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
2813, 3rifF, 0.5005, 4.09, 0.071, 171, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2814, 3qpqF, 0.5005, 4.24, 0.088, 220, 113, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2815, 3qeuE, 0.5005, 3.74, 0.075, 243, 106, THE CRYSTAL STRUCTURE OF TCR DMF5
2816, 3nacH, 0.5005, 4.27, 0.088, 225, 114, CRYSTAL STRUCTURE OF FAB15 MUT7
2817, 3i9gH, 0.5005, 4.07, 0.063, 222, 111, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
2818, 3gi8L, 0.5005, 4.05, 0.112, 220, 107, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2819, 3erxB, 0.5005, 2.51, 0.163, 123, 86, HIGH-RESOLUTION STRUCTURE OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN
2820, 3ef4A, 0.5005, 2.78, 0.138, 124, 87, CRYSTAL STRUCTURE OF NATIVE PSEUDOAZURIN FROM HYPHOMICROBIUM DENITRIFICANS
2821, 3dxaN, 0.5005, 3.94, 0.123, 199, 106, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2822, 2ntfH, 0.5005, 4.04, 0.090, 222, 111, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
2823, 2hjfA, 0.5005, 4.31, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
2824, 1uywH, 0.5005, 4.18, 0.071, 218, 112, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
2825, 1p2cD, 0.5005, 4.04, 0.112, 211, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
2826, 1l7iL, 0.5005, 4.00, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
2827, 1i9rH, 0.5005, 4.14, 0.072, 219, 111, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2828, 1gpoM, 0.5005, 4.06, 0.139, 218, 108, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
2829, 1cz8L, 0.5005, 4.02, 0.084, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2830, 6i9iB, 0.5004, 4.02, 0.093, 216, 107, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
2831, 6bftB, 0.5004, 4.03, 0.093, 214, 107, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
2832, 5o4yB, 0.5004, 4.11, 0.094, 118, 106, STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR
2833, 5mp1D, 0.5004, 4.06, 0.131, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2834, 5gisH, 0.5004, 4.24, 0.116, 210, 112, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
2835, 5e1aA, 0.5004, 4.37, 0.088, 219, 113, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
2836, 4yxhH, 0.5004, 4.31, 0.079, 218, 114, CRYSTAL STRUCTURE OF DEER PRION PROTEIN COMPLEXED WITH POM1 FAB
2837, 4r7dP, 0.5004, 4.09, 0.093, 211, 107, FAB HU 15C1
2838, 4q6iL, 0.5004, 4.04, 0.112, 218, 107, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2839, 4nwtH, 0.5004, 4.00, 0.045, 232, 110, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
2840, 4lbeA, 0.5004, 4.32, 0.088, 219, 113, STRUCTURE OF KCSA WITH R122A MUTATION
2841, 4krpC, 0.5004, 4.04, 0.084, 211, 107, NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
2842, 3vwkD, 0.5004, 3.92, 0.084, 242, 107, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
2843, 3us2J, 0.5004, 3.59, 0.098, 182, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
2844, 3of6C, 0.5004, 4.00, 0.110, 243, 109, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
2845, 3nigE, 0.5004, 4.07, 0.063, 214, 111, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2846, 3lh8B, 0.5004, 4.07, 0.108, 282, 102, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
2847, 3gb7A, 0.5004, 4.31, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
2848, 3fo0L, 0.5004, 4.05, 0.103, 216, 107, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
2849, 3axyA, 0.5004, 3.21, 0.042, 166, 95, STRUCTURE OF FLORIGEN ACTIVATION COMPLEX CONSISTING OF RICE FLORIGEN HD3A 14-3-3 PROTEIN GF14 AND RICE FD HOMOLOG OSFD1
2850, 2yplD, 0.5004, 4.08, 0.065, 199, 108, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
2851, 2bocA, 0.5004, 4.41, 0.087, 219, 115, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
2852, 1q72L, 0.5004, 3.92, 0.123, 218, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
2853, 1cz8X, 0.5004, 4.02, 0.084, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2854, 1cicB, 0.5004, 4.25, 0.096, 217, 114, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
2855, 1ahwA, 0.5004, 3.94, 0.104, 214, 106, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2856, 6rcqA, 0.5003, 4.08, 0.072, 222, 111, PFRH5-BINDING MONOCLONAL ANTIBODY R5.011 
2857, 6okqE, 0.5003, 4.08, 0.075, 210, 107, CRYSTAL STRUCTURE OF THE SF12 FAB 
2858, 6avuL, 0.5003, 4.07, 0.103, 211, 107, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
2859, 6avgE, 0.5003, 3.96, 0.102, 245, 108, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
2860, 5xbmB, 0.5003, 4.25, 0.080, 221, 113, STRUCTURE OF SCARB2-JL2 COMPLEX 
2861, 5w23H, 0.5003, 4.26, 0.071, 219, 113, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2862, 5sx5L, 0.5003, 4.04, 0.084, 212, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
2863, 5mvjL, 0.5003, 4.03, 0.131, 219, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2864, 5mvjF, 0.5003, 4.04, 0.131, 218, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2865, 5k9jL, 0.5003, 3.92, 0.094, 212, 106, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.
2866, 4z7vE, 0.5003, 3.88, 0.143, 199, 105, L3-12 COMPLEX
2867, 4kaqH, 0.5003, 4.16, 0.089, 220, 112, STRUCTURE OF RITUXIMAB FAB
2868, 4j1uA, 0.5003, 4.02, 0.093, 210, 107, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2869, 4alaL, 0.5003, 4.08, 0.121, 212, 107, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
2870, 3zdyH, 0.5003, 4.07, 0.072, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2871, 3uypA, 0.5003, 3.99, 0.065, 226, 108, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 4 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2872, 3us2H, 0.5003, 3.67, 0.087, 182, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
2873, 3us2D, 0.5003, 3.59, 0.098, 182, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
2874, 3us2B, 0.5003, 3.67, 0.087, 182, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
2875, 3u9pM, 0.5003, 4.05, 0.093, 211, 107, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
2876, 3riaG, 0.5003, 4.08, 0.071, 200, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2877, 3rhwG, 0.5003, 4.08, 0.071, 200, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2878, 3kxfN, 0.5003, 4.12, 0.108, 204, 111, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
2879, 3j6lB, 0.5003, 4.02, 0.093, 121, 108, KINETIC AND STRUCTURAL ANALYSIS OF COXSACKIEVIRUS B3 RECEPTOR INTERACTIONS AND FORMATION OF THE A-PARTICLE
2880, 3ixxI, 0.5003, 4.13, 0.089, 221, 112, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
2881, 2zg2A, 0.5003, 4.01, 0.075, 214, 107, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5
2882, 2ataA, 0.5003, 3.75, 0.058, 197, 103, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
2883, 1pg7X, 0.5003, 4.15, 0.080, 220, 112, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
2884, 1f5wB, 0.5003, 4.02, 0.093, 121, 108, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
2885, 1ahwD, 0.5003, 3.93, 0.104, 214, 106, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2886, 6foeL, 0.5002, 4.07, 0.093, 214, 107, BAXB01 FAB FRAGMENT
2887, 6fn4C, 0.5002, 4.25, 0.089, 225, 112, APO FORM OF UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
2888, 6dfvC, 0.5002, 3.98, 0.083, 200, 108, MOUSE DIABETOGENIC TCR 8F10 
2889, 6bfsL, 0.5002, 4.03, 0.093, 212, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2890, 6avqL, 0.5002, 4.07, 0.103, 211, 107, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
2891, 6a0xE, 0.5002, 3.90, 0.065, 223, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
2892, 5x0tD, 0.5002, 3.96, 0.132, 213, 106, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
2893, 5wkfJ, 0.5002, 4.00, 0.120, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
2894, 5trpL, 0.5002, 4.14, 0.102, 217, 108, CRYSTAL STRUCTURE OF THE UNLIGANDED DH270 COOPERATING LINEAGE MEMBER DH272
2895, 5nphH, 0.5002, 4.14, 0.071, 214, 112, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2896, 5kvfL, 0.5002, 4.02, 0.121, 220, 107, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
2897, 5do2L, 0.5002, 4.05, 0.084, 214, 107, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
2898, 4pozC, 0.5002, 4.08, 0.084, 211, 107, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
2899, 4pj8D, 0.5002, 4.07, 0.092, 243, 109, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
2900, 4janH, 0.5002, 4.14, 0.063, 218, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
2901, 4h88H, 0.5002, 4.30, 0.079, 218, 114, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
2902, 3vxmE, 0.5002, 4.00, 0.083, 243, 108, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
2903, 3us1D, 0.5002, 3.59, 0.098, 182, 102, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR RESPONSE ELEMENT CONTAINING A TWO BASE PAIR GC SPACER BETWEEN HALF SITES
2904, 3riaI, 0.5002, 4.08, 0.071, 199, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2905, 3rhwI, 0.5002, 4.08, 0.071, 199, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2906, 3qh3D, 0.5002, 4.00, 0.083, 241, 108, THE CRYSTAL STRUCTURE OF TCR A6
2907, 3qfjE, 0.5002, 3.96, 0.084, 245, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
2908, 3q5yD, 0.5002, 3.90, 0.121, 238, 107, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
2909, 2ypvH, 0.5002, 4.14, 0.088, 215, 113, CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
2910, 2w0fA, 0.5002, 4.31, 0.088, 218, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
2911, 2vl5B, 0.5002, 4.02, 0.112, 217, 107, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2912, 2r29H, 0.5002, 4.20, 0.071, 216, 113, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
2913, 2oslB, 0.5002, 3.90, 0.114, 213, 105, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2914, 2hg5A, 0.5002, 4.30, 0.088, 219, 113, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2915, 2bobA, 0.5002, 4.32, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
2916, 1riuL, 0.5002, 4.04, 0.103, 218, 107, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
2917, 1qygL, 0.5002, 3.92, 0.104, 218, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
2918, 1h3pL, 0.5002, 4.05, 0.121, 219, 107, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
2919, 6i8sH, 0.5001, 4.14, 0.072, 214, 111, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
2920, 6cs3C, 0.5001, 4.38, 0.064, 233, 109, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EXPANDED 1 PARTICLE (PH 7.2 AND 4 DEGREES CELSIUS) 
2921, 6cqrJ, 0.5001, 3.91, 0.102, 245, 108, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2922, 6bliB, 0.5001, 4.06, 0.084, 214, 107, RSV G PEPTIDE BOUND TO FAB CB002.5
2923, 5z0xB, 0.5001, 2.77, 0.138, 124, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16TYR VARIANT 
2924, 5yxgA, 0.5001, 3.91, 0.058, 287, 103, CRYSTAL STRUCTURE OF C-TERMINAL FRAGMENT OF SPAD FROM LACTOBACILLUS RHAMNOSUS GG GENERATED BY LIMITED PROTEOLYSIS 
2925, 5y23A, 0.5001, 2.87, 0.126, 123, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16PHE VARIANT 
2926, 5eocH, 0.5001, 4.37, 0.096, 212, 114, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
2927, 5dtfB, 0.5001, 4.05, 0.085, 214, 106, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
2928, 4x6bC, 0.5001, 3.95, 0.103, 186, 107, BK6 TCR APO STRUCTURE
2929, 4tnwF, 0.5001, 4.08, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2930, 4k3jL, 0.5001, 4.05, 0.084, 217, 107, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
2931, 4jo4L, 0.5001, 4.09, 0.084, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
2932, 4irjC, 0.5001, 4.02, 0.157, 202, 108, STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
2933, 4d9rL, 0.5001, 3.91, 0.075, 214, 106, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2934, 3zdxE, 0.5001, 4.07, 0.063, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2935, 3v4pH, 0.5001, 4.18, 0.080, 211, 113, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
2936, 3utsD, 0.5001, 4.04, 0.102, 200, 108, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
2937, 3t3mH, 0.5001, 4.04, 0.081, 216, 111, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2938, 3qjfB, 0.5001, 4.05, 0.073, 240, 109, CRYSTAL STRUCTURE OF THE 2B4 TCR
2939, 3q5yB, 0.5001, 3.91, 0.121, 238, 107, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
2940, 3mlwI, 0.5001, 4.08, 0.073, 228, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
2941, 3gkwL, 0.5001, 4.15, 0.111, 199, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
2942, 3b9kF, 0.5001, 4.21, 0.090, 117, 111, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
2943, 3aazL, 0.5001, 4.04, 0.121, 228, 107, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
2944, 2r6pF, 0.5001, 4.20, 0.071, 216, 113, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
2945, 2r6pD, 0.5001, 4.20, 0.071, 216, 113, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
2946, 2pcpD, 0.5001, 4.18, 0.080, 215, 112, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
2947, 2p5eD, 0.5001, 3.97, 0.084, 194, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2948, 2f19H, 0.5001, 4.05, 0.063, 221, 111, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
2949, 2b0sH, 0.5001, 4.12, 0.054, 226, 111, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
2950, 1nezG, 0.5001, 4.34, 0.045, 122, 112, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
2951, 1ncaH, 0.5001, 4.08, 0.062, 221, 112, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2952, 1id2B, 0.5001, 2.85, 0.126, 106, 87, CRYSTAL STRUCTURE OF AMICYANIN FROM PARACOCCUS VERSUTUS (THIOBACILLUS VERSUTUS)
2953, 1ap2D, 0.5001, 4.05, 0.064, 123, 109, SINGLE CHAIN FV OF C219
2954, 1adwA, 0.5001, 2.60, 0.163, 123, 86, PSEUDOAZURIN
